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 CHAPTER 1 – Food contaminants: an overview 
 
1.1 Introduction  
 
The contamination of food is a worldwide public health concern and is a leading cause of 
trade problems internationally. Contaminants are substances that, usually, have not been 
intentionally added to food. These substances may be present in food as a result of the 
various  stages  of  its  production,  packaging,  storage,  transport  or  holding.  In  addition, 
contamination may occur through environmental pollution of the air, water and soil, such 
as the case with toxic metals, PCBs and dioxins, or through the intentional use of various 
chemicals, such as pesticides, veterinary drugs and other agrochemicals. 
The range of toxicants found in food can be therefore broadly subdivided into: 
-  Contaminants  or  those  substances  that  inadvertently  get  into  our  food  as  by-
products of industrial manufacturing or waste or as residues from intentional food 
chemicals, such as pesticides. 
-  Naturally-occurring  toxicants  or  those  substances  that are found naturally  in  our 
food because they are products of plants, animals, and other organisms. 
-  Food processing toxicants or those substances that incidentally become part of our 
food as by-products of various processing situations. Also, other substances added 
intentionally  to  the  food  for  some  benefit  could  potentially,  if  added  in  excess, 
adversely affect the consumer. 
Since food additives and contaminants resulting from food manufacturing and processing 
can adversely affect health, WHO has implemented the Global Environment Monitoring 
System  -  Food  Contamination  Monitoring  and  Assessment  Programme  (GEMS/Food), 
which has informed governments, the Codex Alimentarius Commission and other relevant 
institutions,  as  well  as  the  public,  on  levels  and  trends  of  contaminants  in  food,  their 
contribution to total human exposure, and significance with regard to public health and 
trade. 
 
1.2 Classes of Contaminants  
 
Contaminating substances may enter the food chain at different stages: Through various 
constituents like fertilizer ingredients pesticides can enter food crops through plant roots, 
and  the  irrigation  water  derived  from  waste  water  treatment  plants.  Contaminants  in  
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forages and other feeds can be transmitted to animal products. Veterinary drugs can leave 
residues in animal products. Environmental chemicals such as heavy metals from many 
sources have sometimes been found as food contaminants. 
 
1.2.1 Pesticides 
 
Pesticides  play  an  important  role  in  food  production  by  controlling  insects,  weeds, 
organisms  responsible  for  plant  diseases,  and  other  pests.  In  protecting  food  plants, 
pesticides assist in ensuring substantial yield and providing consumers with a wide variety 
of foods at inexpensive prices. Pests are living organisms that occur where they are not 
wanted or that cause damage to crops, humans, or other animals. Most pesticides create 
some degree of risk of harm to humans, animals, or the environment because they are 
inherently designed to kill or otherwise adversely affect living organisms but be selective 
with regard to target species (Albert, 1979). At the same time, pesticides are useful to 
society, destroying potential disease-causing organisms and control insects, weeds, and 
other  pests.  Understanding  the  modes  of  action  of  pesticides  is  important  to  the  food 
toxicologist both for the design of compounds to be specific for the targeted species and 
for understanding potential adverse human health effects. 
Pesticides  have  several  modes  of  action. They  may  physically  alter  the  organism  in a 
mechanical way, which blocks their cellular processes. Examples include oil (petroleum 
products) that are used as sprays, which clog the respiratory mechanism of insects, or 
compounds like bypyridylium herbicides, which act by destroying the cell membranes of 
plants causing desiccation. Petroleum oils can also deter feeding or egg lying in some 
insects. Some pesticides are metabolic system inhibitors and restrict the transfer of energy 
within  the  target  organisms.  Inhibitory  pesticides  in  this  category  are  many,  such  as 
rotenone and cyanide, which disrupt respiratory functions in animals, or herbicides that 
inhibit seed germination or plant growth, and various fungicides that inhibit germination of 
spores.  Some  pesticides  require  metabolic  activation  into  the  toxic  form  before  they 
become toxic to the target pest. For example, sodium monofluoroacetate is converted to 
fluorocitrate  before  it  becomes  toxic  to  vertebrates.  Other  pesticides  owe  their 
effectiveness to the alteration of protein synthesis or enzyme disruption. Proteins, as the 
basic  building  blocks  of  all  cell  components,  are  crucial  and  substances  made  up  of 
proteins, such as enzymes, control many important cell functions. Pesticides can disrupt 
enzyme processes or denature proteins. Examples include inorganic copper compounds, 
dithiocarbamate fungicides, and phosphor amino acid herbicides, such as glyphosate and 
organophosphate insecticides. Other pesticides alter hormone actions that control many of  
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the biological functions of organisms, including growth and reproductive cycles. Several 
pesticides  simulate  or  otherwise  interfere  with  hormones  to  disrupt  these  cycles,  for 
example phenoxy herbicides that interfere with plant growth hormones, and insect growth 
regulators that interfere with cuticle formation in insects during molting. Nervous system 
disruptor pesticides affect mainly animal groups such as insects, nematodes, and rodents. 
Some  pesticides,  such  as  some  fumigant  pesticides,  are  narcotics.  Others  disrupt  the 
movement of nerve impulses, such as the organophosphate, carbamate, and pyrethroid 
pesticides. Some pesticides affect photosynthesis, the process of using sunlight energy to 
create  carbohydrates  from  carbon  dioxide  and  water.  Pesticides  that  disrupt 
photosynthesis prevent the plant from producing or storing energy and ultimately kill the 
plant, for example triazine, substituted urea and uracil herbicides. Finally, some pesticides 
work in more than one way and fall into more than one of these categories. The modes of 
action of many pesticides are not fully understood. Some pesticides are residual in action 
and continue to be effective for days, weeks, or months after their application. Examples 
are the triazine herbicides that persist in the soil and kill emerging weeds over the lifetime 
of  a  crop,  or  insecticides  that  remain  active  for  several  years  as  a  barrier  to  termites 
entering buildings. 
Modern pesticides are designed not to persist for long in the environment, which was a 
problem  associated  with  organochlorines  like  dichlorodiphenyltrichloroethane  (DDT). 
Modern pesticides act quickly and are then degraded to innoxious substances by chemical 
or  microbial  processes.  This  helps  prevent  their  build-up  in  crops  or  other  organisms. 
Pesticide  breakdown  depends  on  the  compound's  chemical  properties,  how  much  is 
applied, and how it is distributed, as well as environmental factors such as temperature, 
moisture, soil pH, and the availability of microorganisms. 
 
1.2.2 Metals 
 
Many metals, including heavy metals which have particular concerns for health problems, 
end up in our food supply and can be traced back to industry via effluent, sewage, dumps, 
and dust into the environment, and eventually into the food chain. Not all the traces of 
heavy metals in plants and animals are subsequent to human activity. Metals arise through 
absorption  processes  of  naturally  occurring  soil  components.  Arsenic,  cadmium,  lead, 
mercury,  and  nickel  are  the  most  prevalent  heavy  metals  with  health  concerns.  The 
definition of a heavy metal is one that has a specific gravity of more than 5 g/cm
3. By 
definition this would account for 60 metals, several of which are biologically essential, and  
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many others lack sufficient information regarding toxicity, including platinum, silver, and 
gold.  
Arsenic 
Arsenic  is  found  in  the  environment  and  originates  from  both  natural  and  industrial 
sources. Sources of arsenic exposure include air pollution, antibiotics given to commercial 
livestock, certain marine plants, chemical processing, coal-fired power plants, defoliants, 
drinking  water,  drying  agents  for  cotton,  fish,  herbicides,  insecticides,  meats  (from 
commercially  raised  poultry  and  cattle),  metal  ore  smelting,  pesticides,  seafood  (fish, 
mussels, oysters), specialty glass, and wood preservatives. 
Chronic arsenic poisoning occurs throughout the world because of high arsenic content in 
drinking water (greater than 1000 µg/L), in such places as Taiwan, Hungary, Chile, Inner 
Mongolia, Mexico and Bangladesh. In some Western United States, such as New Mexico, 
Arizona, Nevada, Utah, and Southern California, arsenic levels are in the 50±100 µg/L 
range and the health effects may be less pronounced. Epidemiological evidence implicates 
arsenic as an inducer of skin and bladder cancer and affecting heart disease, neurological, 
vascular, and cognitive function. 
 
Cadmium 
Cadmium  is  ubiquitous  and  is  actively  extracted  from  ores  for  commercial  purposes. 
Contributions to residues include industrial processes such as metal refining, coal and oil 
industry,  and  electroplating  plants.  Other  sources  of  cadmium  exposure  include  air 
pollution,  art  supplies,  bone  meal,  cigarette  smoke,  food  (coffee,  fruits,  grains,  and 
vegetables  grown  in  cadmium-laden  soil,  meats,  or  refined  foods),  freshwater  fish, 
fungicides,  highway  dusts,  incinerators,  mining,  nickel-cadmium  batteries,  oxide  dusts, 
paints,  phosphate  fertilizers,  power  plants,  seafood  (crab,  flounder,  mussels,  oysters, 
scallops), sewage sludge, softened water, smelting plants, tobacco and tobacco smoke, 
and welding fumes. 
Cadmium  is  concentrated  in  the  kidneys,  liver,  lungs,  and  in  blood-forming  organs. 
Ingestion of cadmium can lead to kidney damage and metabolic anomalies usually through 
enzyme inhibition. Itai-itai disease in Japan is an example of an illness caused by rice 
highly contaminated with cadmium. Cadmium is a cumulative poison but unlike lead, the 
definition of an exact toxicity limit has been difficult to determine because of bioavailabiliity 
questions. 
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Lead 
The main sources of lead pollution in the environment are industrial production processes 
and their emissions, road traffic with leaded petroleum, the smoke and dust emission of 
coal and gas. Other sources of lead exposure include air pollution, ammunition (shot and 
bullets), bathtubs (cast iron, porcelain, steel), batteries, canned foods, ceramics, chemical 
fertilizers, cosmetics, dolomite, dust, foods grown around industrial areas, gasoline, hair 
dyes and rinses, leaded glass, newsprint and colored advertisements, paints, pesticides, 
pewter, pottery, rubber toys, soft coal, soil, solder, tap water, tobacco smoke, and vinyl 
mini-blinds.  
Both the acute and chronic forms of lead poisoning occur. Acute toxicity occurs by the 
consumption of large single doses of soluble lead salts. Chronic toxicity can occur through 
the regular consumption of foodstuffs which may be only slightly contaminated with lead 
and represent the greater problem of cumulative poisoning. The mode of action of lead is 
related to the metal's high affinity for proteins, such as hemoglobin, plasma proteins, and 
the subsequent inhibition of protein-mediated processes. Lead ingestion leads to inhibition 
of the synthesis of red blood cells, which in turn compromises oxygen transport. When the 
binding capacity of blood proteins are exceeded, lead affects other organs, such as bone-
marrow, liver, nervous system, reproductive tissues, and kidney. Organic lead compounds 
are  particularly  troublesome  and  likely  lead  to  injuries  to  mental  development  with 
reduction in intelligence, growth, and cognitive function. Although lead has been largely 
eliminated from gasoline and the lead content of populations has fallen sharply, lead in 
water continues to be a problem in many countries, such as some parts of the United 
Kingdom.  Thus,  foodstuffs  contribute  to  the  lead  burden,  particularly,  lead  found  in 
vegetables,  fruits,  drinking  water,  beverages  (wine),  and  cereal  products.  Fruits  and 
vegetables mostly acquire their lead contamination through impurities in the air, which can 
be greatly reduced by washing. 
 
Mercury 
Mercury  has  been  extracted  since  ancient  times  and  is  used  in  electrical  devices, 
catalysts, thermometers, and pigments. Other sources of mercury exposure include air 
pollution, batteries, cosmetics, dental amalgams, diuretics (mercurial), electrical devices 
and  relays,  explosives,  foods  (grains),  fungicides,  fluorescent  lights,  freshwater  fish 
(especially large bass, pike, and trout), insecticides, mining, paints, pesticides, petroleum 
products,  saltwater  fish  (especially  large  halibut,  shrimp,  snapper,  and  swordfish), 
shellfish, and tap water.  
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Mercury  passes  into  the  environment  through  emissions  from  chemical  plants,  power 
stations,  often  as  effluents  and  sludge.  Mercury  becomes  concentrated  in  shellfish, 
crustaceans, and fish, and passes on in the food chain in its highly toxic form, methylated 
mercury. The Minamata sickness in Japan in 1965 was the result of consumption of fish 
taken from regions of the sea contaminated by industrial effluent. 
Methyl  mercury  compounds  are  the  most  toxic  of  heavy  metals.  Ingestion  of  organic 
mercury  results  in  distribution  to  the  liver,  kidneys,  and  brain.  Salts  of  mercury  cause 
tiredness,  loss  of  appetite,  weight  loss,  muscular  weakness,  perhaps  paralysis,  and 
eventually kidney failure. Methyl mercury damages the central nervous system and the 
immune system, and has been shown to produce teratogenic effects. 
 
Nickel 
Sources of nickel exposure include appliances, buttons, ceramics, cocoa, cold-wave hair 
permanent,  cooking  utensils,  cosmetics,  coins,  dental  materials,  food  (chocolate, 
hydrogenated oils, nuts, food grown near industrial areas), hair spray, industrial waste, 
medical  implants,  metal  refineries,  metal  tools,  nickel-cadmium  batteries,  orthodontic 
appliances, shampoo, solid-waste incinerators, stainless steel kitchen utensils, tap water, 
tobacco and tobacco smoke, water faucets and pipes, and zippers. 
High  nickel  concentrations  in tissues  has  been associated  with  depression  of  prolactin 
secretion, and inhibition of insulin secretion. Nickel has carcinogenic effects when inhaled, 
producing lung and nasal cancers. 
 
1.2.3 Industrial by-products and waste 
 
As noted above, many of the metals may find their way into our food as industrial by-
products or waste. Since the Industrial Revolution, industrial and mining operations have 
been  accompanied  by  industrial  waste,  which  may  be  toxic,  ignitable,  corrosive,  or 
reactive. Obviously, proper management is the key and improperly managed waste can 
pose dangerous health and environmental risks. It is estimated that, in the United States, 
the amount of hazardous waste generated by manufacturing industries has increased from 
4.5 million tons annually after World War II to some 265 million tons by 1990 (Council on 
Environmental  Quality,  1981).  Waste  is  generated  at  every  stage  in  the  production 
process,  use,  and  disposal  of  manufactured  products.  The  introduction  of  many  new 
technologies for the home and office (computers, drugs, textiles, paints and dyes, plastics) 
in recent times has introduced more hazardous waste, including toxic chemicals, into the  
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environment. The EPA estimated in 1980 that more than 70,000 different chemicals were 
being manufactured in the United States, with some 1,000 new chemicals being added 
each year (Petulla, 1988). The human health and environmental impacts of many of these 
chemicals are largely unknown. Industrial waste may be solid, liquid, or gaseous and is 
divided  into  hazardous  and  non-hazardous  waste.  Hazardous  waste  may  result  from 
manufacturing  or  other  industrial  processes.  Certain  commercial  products  such  as 
cleaning fluids, paints, or pesticides discarded by commercial establishments or individuals 
can also be defined as hazardous waste. The definition of hazardous waste has been 
further refined through regulations. Non-hazardous industrial waste is that which does not 
meet the EPA's definition of hazardous waste and is not municipal waste. 
 
1.3 Naturally-occurring toxicants 
 
Natural or raw foods contain an array of chemicals and only a few of these chemicals 
actually  possess  nutritional  importance.  Most  of  the  chemicals  found  in  food  neither 
enhance nor detract from the wholesomeness and nutrient quality of the food. They move 
through the gastrointestinal tract unchanged and exert little to no effect on surrounding 
tissues or other nutrients they pass. However, there is a group of chemicals found in foods 
that can affect health by impairing nutrient absorption, inhibiting or destroying nutrients 
(antinutrients), or acting as mutagens, teratogens or carcinogens. Such chemicals occur in 
food in small quantities and if the diet is nutritionally adequate and widely varied, these 
minute amounts of otherwise toxic compounds can be tolerated or rendered harmless. 
 
1.3.1 Plant and animal toxicants 
 
Many  plant  and  animal  foods  contain  natural  or  processing-induced  constituents  with 
biological activity in mammals. Among the plant family these are glycoalkaloids, amines, 
glucosinolates,  cyanogenic  glycosides,  protease  inhibitors,  oxalates,  coumarins, 
polyphenols, cyclopropenoid fatty acids, phytates, xanthines, and essential oils. Recently, 
various  lines  of  evidence  have  suggested  that  plant-derived  constituents  may  play  an 
important role in determining spontaneous rates of genetic damage and tumor incidence. 
On  the  other  hand,  genotoxic  constituents  such  as  certain  flavones,  anthraquinones, 
browning  products,  benzoxazinones,  and  acetals  have  been  identified  in  plant-derived 
foods, and unsaturated oilseed lipids have been found to increase cancers of certain sites, 
particularly intestine and breast, in laboratory animals.  
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Whether these constituents play a significant quantitative role in human health is a key 
scientific  issue  which  is  at  present  not  adequately  resolved.  With  the  increase  in  fish 
consumption for health or other individual preferences, concerns for higher exposures to 
animal toxins are increased. As will become apparent, whether to classify these as true 
animal toxins is debatable since they seem to be more microbial in their origin. Ciguatera 
is a form of poisoning caused by the consumption of finfish (barracudas, snappers, jacks, 
mackerel, and triggerfish) which have accumulated naturally-occurring toxins that originate 
from several dinoflagellate (algae) species that are common to ciguatera. Manifestations of 
ciguatera  usually  involves  a  combination  of  gastrointestinal,  neurological,  and 
cardiovascular disorders. Shellfish poisoning is caused by a group of toxins elaborated by 
planktonic  algae,  dinoflagellates,  upon  which  the  shellfish  feed.  The  toxins  are 
accumulated  and  metabolized  by  the  shellfish.  The  20  toxins  responsible  for  paralytic 
shellfish poisonings (PSP) are all derivatives of saxitoxin. The effects are predominantly 
neurological and include tingling, burning, numbness, drowsiness, incoherent speech, and 
respiratory paralysis. Scombroid poisoning is caused by the ingestion of fish that contain 
high  levels  of  histamine  and  other  vasoactive  amines  and  compounds.  Histamine  and 
other amines are formed by the growth of certain bacteria in the fish or any food that 
contains the appropriate amino acids. Fish poisoning can also occur by consumption of 
members of the pufferfish family. 
Tetrodotoxin has also been isolated from widely differing animal species, including the 
California newt, parrotfish, frogs of the genus Atelopus, the blue-ringed octopus, starfish, 
angelfish,  and  xanthid  crabs.  Recent  reports  of  the  production  of 
tetrodotoxin/anhydrotetrodotoxin  by  several  bacterial  species,  including  strains  of  the 
family Vibrionaceae, Pseudomonas sp., and Photobacterium phosphoreum, point toward a 
bacterial origin of this family of toxins. 
 
1.3.2 Microbial toxicants 
 
Microbiological  contamination  of food  should  cause more  concern  than  any  other food 
safety hazard. Bacteria are by far the most common and are responsible for many diverse 
foodborne diseases (Altekruse, 1997). According to the national FoodNet database, 76 
million persons were estimated to have contracted foodborne diseases in the United State 
in 2001. Because only a small minority of the cases seek medical attention, the number is 
likely  higher.  Many  people  who  experience  foodborne  disease  are  unaware  since  the 
characteristics are similar to those of the `flu'.  
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In 2001, the Centers for Disease Control and Prevention (CDC) released a report showing 
a decline in the major bacterial foodbone illnesses. According to the data, the four major 
bacterial  foodborne  illnesses  Campylobacter,  Salmonella,  Listeria,  and  E.  coli  O157, 
posted  a  21%  decline  in  the  past  six  years.  Campylobacter  infections  dropped  27%, 
infections  from  Listeria  fell  35%,  and  Salmonella  infections  decreased  by  15%.  E.  coli 
O157 infections dropped 21%, but all of that decline occurred since 2000. These declines 
signify important progress toward meeting the Healthy People 2010 objectives for reducing 
the incidence of disease caused by these bacterial infections. Other less common bacterial 
foodborne  illnesses  also  showed  significant  declines  since  1996.  Yersinia  infections 
decreased 49% and Shigella infections dropped by 35%. CDC notes the data do not show 
a  sustained  decline  in  some  infections  indicating  that  increased  efforts  are  needed  to 
further  reduce  the  incidence  of  foodborne  illness.  CDC  notes  several  factors  have 
contributed to the decline in foodborne illnesses. These include enhanced surveillance, the 
implementation of  Pathogen  Reduction/Hazard  Analysis  Critical  Control  Point  (HACCP) 
regulations in meat and poultry plants, HACCP regulation of fruit and vegetable juices, 
seafood HACCP, publication and outreach of good agricultural practices for fresh produce, 
increased  regulation  of  imported  food,  and  last,  but  certainly  not  least,  extensive  food 
safety education. Food safety education and research have played important roles with 
consumer educational efforts in this area (IFT expert report, 2000). 
 
1.3.3 Mycotoxins 
 
Animal  and  human  health  problems  related  to  food  products  contaminated  with  toxic 
metabolites  produced  by  fungal  growth  have  long  been  recognized.  The  Food  and 
Agriculture Organization has estimated that at least 25% of the world’s food crops are 
affected by mycotoxins annually (Food and Agriculture Organization of the United Nations, 
1996). Thus, many scientific reports have been published concerning the occurrence of 
mycotoxins in foods and feeds, and their impact on human and animal health. 
Recently,  there  have  been  reports  on  cocontamination  of  various  toxins,  i.e.,  aflatoxin 
B1/fumonisin B1 and ochratoxin A/aflatoxin B1, among others (Park, 1996; Harvey, 1989; 
Brownie,  1988).  Although  more  documentation  is  needed  on  the  levels  and  effects  of 
mycotoxin  cocontamination,  it  is  important  to  consider  that  food  commodities  are  a 
complex environment and that the individual effect of each toxin might be affected by the 
presence  of  other  toxins  or  food  constituents  (Rice,  1994).  Examples  of  mycotoxins 
affecting health include:  
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Aflatoxins: Historically, aflatoxins have undoubtedly been the group of mycotoxins of most 
concern because they have been shown to be both potent hepatotoxins and carcinogens 
in many species. Aflatoxin contamination of foods and feeds occurs when aflatoxigenic 
species of Aspergillus sp. successfully colonize a commodity, grow and find conditions 
appropriate for toxin production. The three species of Aspergillus that produce aflatoxins 
are  A.  flavus,  A.  parasiticus,  and  A.  nomius  (Wilson,  1994).  A.  flavus  is  a  common 
constituent of the microflora in air and soil throughout the world. It is prevalent in stored 
wheat,  corn,  cottonseed,  rice,  barley,  bran,  flour,  peanuts,  soybeans,  sorghum,  chili 
peppers,  copra,  millet,  tree  nuts,  and  green  coffee  beans,  among  other  commodities. 
Growth can occur even when products are stored under relatively low moisture, which 
eliminates the growth of competing species such as Penicillium and Fusarium. However, 
storage in hot or humid conditions can aggravate toxin formation. Aflatoxin contamination 
also  may  be  severe  when  developing  crops  are  exposed  to  drought  conditions 
(Shibamoto, 1993). 
Chemically,  aflatoxins  are  defined  as  a  series  of  18  known  bisulfuran  polycyclic 
compounds that fluoresce strongly in ultraviolet light (ca. 365 nm). Aflatoxins B1 and B2 
produce blue fluorescence, whereas G1 and G2 produce green fluorescence. Four other 
aflatoxins, M1, M2, B2A, and G2A are produced in small amounts. In some animal species, 
such as dairy cattle, aflatoxins B1 and B2 are partially metabolized to give the hydroxylated 
derivatives: aflatoxins M1 and M2, respectively. Other metabolic derivatives are aflatoxin P1 
and Q1 (Eaton, 1994). 
The  effect  of  aflatoxins  on  animals  is  quite  different  depending  on  age,  sex,  species, 
nutritional condition of the animal, dosage level, frequency, and composition of the diet. 
Sensitivity to the toxins varies greatly from species to species (i.e., the LD50 ranges from 
0.5 mg/kg for the duckling to 60 mg/kg for the mouse). Rats, poultry, and trout are highly 
susceptible to the effects of aflatoxin, whereas sheep, hamsters, mice, and pigs are fairly 
resistant.  The  organ  primarily  affected  is  the  liver,  but  changes  can  be  seen  in  most 
organs. 
The carcinogenicity, mutagenicity, teratogenicity, and acute toxicity of aflatoxins have been 
well documented (Ellis, 1991). Aflatoxin B1 is the most important in terms of occurrence 
and toxicity, and the most potent of the naturally occurring carcinogens. In susceptible 
experimental animals, cancer has been induced in low doses that are comparable to levels 
present in contaminated human diets (Buss, 1990). 
Preharvest prevention of aflatoxin formation is difficult; therefore, aflatoxins in foods and 
feeds are considered a continuous risk. Discontinuing the use of aflatoxin-contaminated  
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grains and oilseeds is not always practical. 
There is a need to manage the risks associated with aflatoxin contamination before using 
these products as animal feed or human food. Thus, several methods for decontamination 
and postharvest control have been reported (Lopez-Garcia, 1998). 
The  use  of  ammonia-heat  treatments  has  shown  effective  reduction  of  aflatoxin 
(Jorgensen,  1981).  Other  chemicals  such  as  monomethylamine,  sodium  hydroxide, 
sodium  hypochlorite,  and  hydrogen  peroxide  also  have  resulted  in  acceptable 
detoxification  in  several  commodities.  During  fermentative  production  of  ethanol,  little 
degradation of the toxin was achieved. Other decontamination approaches include food 
and  feed  processing  such  as  thermal  inactivation,  irradiation,  solvent  extraction, 
mechanical  separation,  density  segregation,  and  reduction  in  bioavailable  aflatoxin  by 
selective  chemisorption.  Biocontrol  methods  and  microbial  inactivation  have  been 
suggested as well as decontamination procedures (Phillips, 1994). 
Aflatoxins have become generally accepted to be poisonous and deleterious, and are now 
widely regulated in foods. In the U.S., the Food and Drug Administration (FDA) regulates 
feed and food containing aflatoxins at regulatory levels of 20 ppb of aflatoxin B1 for human 
foods and selected animal feed. 
Levels up to 300 ppb are permitted for specific commodities and under selected animal 
feeding operations, and 0.5 ppb of aflatoxin M1 in milk (Pitt, 1993).  
 
Fumonisins (Fumonisin B1 and Fumonisin B2): are natural toxins produced by Fusarium 
moniliforme and other Fusarium species; these molds are common natural contaminants 
of corn. Fumonisins have been linked to fatalities in horses and swine. Recent studies 
have demonstrated the presence of fumonisins in human foods, including corn meal and 
breakfast cereals. Epidemiological investigations demonstrating a possible association of 
F.  moniliforme  with  esophageal  cancer  and  recent  animal  studies  indicating  the 
carcinogenicity  of fumonisin  B1  have  highlighted  the  need to  ensure  that foods  do  not 
contain  excessive  amounts  of  fumonisins.  Deoxynivalenol  (DON),  commonly  called 
vomitoxin, is a natural toxin produced by several molds of the genus Fusarium, especially 
F. graminearum, which is a common contaminant of several grains, including wheat, corn, 
barley, and rye. DON has been associated with a number of adverse health effects in 
humans and animals. Several adverse weather related DON contamination episodes in 
the United States motivated the FDA to issue advisory levels for food (wheat) and feed in 
1982 and updated levels in 1993. FDA is continuing to study the scope and toxicological 
significance of the DON problem in order to make a determination as to whether further  
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regulatory measures are needed to control DON in food and feed products. 
 
Ochratoxin A: is a naturally-occurring nephrotoxic fungal metabolite produced by certain 
species of the genera Aspergillus and Penicillium. It is mainly a contaminant of cereals 
(corn, barley, wheat, and oats) and has been found in edible animal tissues as well as in 
human blood sera and milk. Studies indicate that this toxin is carcinogenic in mice and 
rats. It is not completely destroyed during the processing and cooking of food, therefore 
the implication for risk to human health and safety must be considered. 
 
Patulin: is a mycotoxin produced by several species of mold fungi including Penicillium 
expansum,  the  causal  organism  of  apple  rot.  Apple  juice  prepared  from  apples 
contaminated  with  Penicillium  expansum  could  be  a  possible  source  of  patulin  in  the 
human diet. The World Health Organization (WHO) has recommended a maximum patulin 
level of 50 ppb based on a toxicological assessment. At least 12 countries regulate patulin 
at 30-50 ppb. The United Kingdom's Food Advisory  Committee announced recently its 
intention to establish control measures on patulin. FDA identified patulin as a potential 
hazard  in  fruit  juice  in  its  juice  HACCP  proposal.  In  the  Codex  Alimentarius,  FDA 
participated in negotiations as to what limitation on patulin in apple juice is appropriate for 
apple juice and concentrate in international commerce. 
 
1.4 Food processing toxicants 
 
During  the  processing  of  foods,  products  may  be  produced  that,  if  present  in  large 
amounts, could potentially adversely affect health. For example, cooking certain meats at 
high temperatures creates chemicals that are not present in uncooked meats. A few of 
these chemicals may increase cancer risk, such as polycyclic aromatic hydrocarbons and 
heterocyclic amines. Another example is when nitrates and nitrites react with secondary 
amines  to  form  nitrosamine.  Nitrosamines  are  mutagens  which  have  been  linked  to 
cancers. Nitrates and nitrites are used to preserve meats and contribute to prevention of 
growth of Clostridium botulinum, the bacterium responsible for producing the highly potent 
botulinum toxin. 
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1.4.1 Polycyclic aromatic hydrocarbons 
 
Polycyclic aromatic hydrocarbons (PAH) are produced when any incomplete combustion 
occurs. Thus, they are found in polluted air, cooking oil fumes, tobacco smoke, smoked 
foods and foods cooked at high temperature.  
Most PAHs are not carcinogenic, although a few are, for example benzo(a)pyrene. They 
appear mainly in meats cooked during high temperature grilling. Microwaving does not 
produce PAHs, and foods other than meats contain negligible amounts of PAHs. Foods 
low in fat, or cooked beneath the source of heat, contain many fewer PAHs, so the type of 
food cooked and the method of cooking are important determinants of PAHs.  
Breathing air containing PAHs can occur in the workplace of coking, coal-tar, and asphalt 
production plants, smokehouses, and municipal trash incineration facilities. Breathing air 
containing PAHs can also occur from cigarette smoke, wood smoke, vehicle exhausts, 
asphalt roads, or agricultural burn smoke. Coming in contact with air, water, or soil near 
hazardous  waste  sites  can  also  increase  exposure  to  PAHs.  Eating  grilled  or  charred 
meats,  contaminated  cereals,  flour,  bread,  vegetables,  fruits,  meats,  and  processed  or 
pickled  foods  increases  an  individual's  exposure  to  PAHs.  Drinking  PAH-contaminated 
water  or  cow's  milk  can  increase an  individual's  exposure  to  PAHs.  Nursing  infants of 
mothers living near hazardous waste sites may be exposed to PAHs through their mother's 
milk. 
 
1.4.2 N-nitrosamines 
 
Nitrosamines are a class of chemical compounds that were first described over 100 years 
ago.  In  1956  it  was  reported  that  dimethylnitrosamine  produced  liver  tumors  in  rats. 
Approximately 300 of these compounds have been tested and 90% of them have been 
found to be carcinogenic in a wide variety of experimental animals. Dimethylnitrosamine 
(DMNA)  (also  called  N-nitrosodimethylamine  or  NDMA)  is  a  member  of  a  group  of 
chemicals known as nitrosamines which are recognized as cancer-causing substances. 
DMNA is a volatile liquid, which dissolves easily in water and in oil. It can be broken down 
by light or microorganisms but, in their absence, DMNA can persist in water for a very long 
time. Even in a sewage treatment plant, DMNA degrades only very slowly. Nitrosamines 
(including DMNA) are also formed in tobacco smoke. An interesting observation is that the 
concentration of nitrosamines in side-stream smoke from a cigarette has 20-200 times 
more nitrosamines than the mainstream smoke. Exposure to very smoky rooms can result  
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in as much DMNA exposure as smoking. Most nitrosamines are mutagens and a number 
are transplacental carcinogens. Most are organ-specific. For instance, DMNA causes liver 
cancer in experimental animals, whereas some of the tobacco-specific nitrosamines cause 
lung cancer. Since nitrosamines are metabolized the same in human and animal tissues, it 
seems  highly  likely  that  humans  are  susceptible  to  the  carcinogenic  properties  of 
nitrosamines. 
Foods which contain nitrogen sources and amines have particularly high levels of DMNA 
and other  nitrosamines.  Amines  occur  commonly  and  sodium nitrite  is  added  to  cured 
meats  to  prevent  toxin  production  by  Clostridium  botulinum.  Such  foods  are  bacon, 
prepared meats, fish, tomatoes, spinach, beer, and many others. In the body, nitrosamines 
are formed as a result of these nitrates and nitrites (present in meat and other food and 
vegetables as preservatives) reacting with saliva in the mouth or with gastric juices in the 
stomach. DMNA can also be formed naturally as a result of certain biological processes 
associated with bacteria. 
Cured meats can contain nitrosamines because meats contain amines and sodium nitrite, 
a source of nitrosating agents added to cured meats as a preservative. Of all the cured 
meats, bacon has received the most attention. It almost always contains detectable levels 
of nitrosamines, principally nitrosopyrrolidine and, to a lesser extent, DMNA. The very high 
cooking temperatures used to fry bacon are conducive to nitrosamine formation. In the late 
1970s, extensive attention was focused on the issue of nitrosamines in cured meats and 
the removal of sodium nitrite as a food additive was considered. 
However, the prospect of sodium nitrite removal presented a formidable dilemma for the 
regulatory agencies. Removal of sodium nitrite would prevent nitrosamine formation, but it 
might also increase the risk of botulism poisoning. 
Sodium nitrite and sodium chloride together are particularly effective against Clostridium 
botulinum. The solution to the dilemma was to limit the addition of sodium nitrite to 120 
ppm, the lowest level found to be effective in controlling growth and toxin production by 
Clostridium botulinum. 
Ascorbic acid also inhibits nitrosamine formation. The addition of 550 ppm of ascorbic acid 
is now required in the manufacture of cured meat in the United States. Actually, most 
cured meat manufacturers add erythorbic acid (a less expensive isomer of ascorbic acid) 
rather than ascorbic acid. Another antioxidant, alpha-tocopherol (vitamin E), is added to 
some cured meats to inhibit nitrosamine formation. As a result of these strategies, there 
are now significantly lower levels of nitrosamines in fried bacon and other cured meats 
than  there  were  some  years  ago.  Ascorbic  acid,  erythorbic  acid,  and  alpha-tocopherol  
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inhibit nitrosamine formation due to their oxidation and N reduction properties. 
Dimethylnitrosamine has been found in beer, formed by direct-fire drying of barley malt, an 
ingredient  used  in  making  beer.  By  converting  the  process  from  direct-fire  drying  to 
indirect-fire  drying,  the  nitrosating  agents  and  the  formation  of  DMNA  were  markedly 
reduced. Thus beer now contains only 2% of the DMNA that was present 20 years ago. 
Nitrosamines  can  form  in  the  gastric  juice  of  the  human  stomach,  referred  to  as 
endogenous  nitrosation.  Bacteria  in  the  mouth  chemically  reduce  nitrate,  which  is 
prevalent in many vegetables, to nitrite, which in turn can form nitrosating agents. Many 
foods contain amines that can react with nitrosating agents in the acidic stomach to form 
nitrosamines. 
Nitrosamines are carcinogenic in animals. Current exposure is probably closer to 0.1 µg 
per day due to successful efforts over the past 20 years to reduce nitrosamine formation in 
foods and beverages. In contrast, there is an estimated exposure of 17 µg per day from 
cigarette smoking. An enormous amount of indirect evidence indicates that nitrosamines 
are human carcinogens. For instance, tobacco-specific nitrosamines are one of the major 
groups  of  chemical  carcinogens  in  tobacco  products  and  no  doubt  remains  about  the 
causal  link  between  tobacco  use  and  cancer.  But,  it  is  difficult  to  evaluate  the  risk  of 
cancer from daily exposure of 1 µg from foods and beverages. The same difficulty applies 
to  the  risk  assessment  of  the  exposure  to  minute  amounts  of  aflatoxin,  PAHs,  and 
heterocyclic amines in a variety of foods and beverages. 
 
1.4.3 Heterocyclic amines 
 
Heterocyclic amines (HCAs) are the carcinogenic chemicals formed from the cooking of 
muscle meats such as beef, pork, fowl, and fish (Bjeldanes, 1982, 1983; Felton, 1994; 
Sugimura,  2002).  HCAs  form  when  amino  acids  (the  building  blocks  of  proteins)  and 
creatine  (a  chemical  found  in  muscles)  react  at  high  cooking  temperatures.  Some  17 
different HCAs have been found, resulting from the cooking of muscle meats, that may 
pose human cancer risk. Research conducted by the National Cancer Institute (NCI) as 
well  as  by  Japanese  and  European  scientists  indicates  that  HCAs  are  created  within 
muscle  meats  during  most  types  of  high  temperature  cooking.  Further  evaluation  is 
needed of  the  relationship  between methods  of  cooking  meat and  the  development of 
specific  types  of  cancer.  One  study  conducted  by  researchers  from  NCI's  Division  of 
Cancer Epidemiology and Genetics found a link between individuals with stomach cancer 
and the consumption of cooked meats. Those who ate their beef medium-well or well-done  
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had more than three times the risk of stomach cancer than those who ate their beef rare or 
medium-rare. They also found that people who ate beef our or more times a week had 
more than twice the risk of stomach cancer than hose consuming beef less frequently. 
Additional studies have shown that an ncreased risk of developing colorectal, pancreatic, 
and breast cancer is associated with intakes of well-done, fried, or barbequed meats. 
 
1.5 Novel foods and natural toxicants 
 
Functional food has been defined as food either natural or formulated, which will enhance 
physiological performance or prevent or treat diseases and disorders (Wildman, 2001) or 
as defined by the Food and Nutrition Board of the National Academy of Sciences, any food 
or  food  ingredient  that  may  provide  a  health  benefit  beyond  the  traditional  nutrients  it 
contains. The functional food market has likely doubled in the past ten years to over $10 
billion  and  many  food  companies  are  taking  full  advantage  of  the  public's  growing 
awareness  of  food  in  health.  Thus,  a  natural  extension  of  the  functional  food  area  is 
modifying or cultivating food plants and animals to maximize their ability to produce the 
desirable compounds that are important to health, for example more vitamin E, vitamin A. 
Genetic  modification  (GM)  of  plants  or  animals  for  the  purpose  of  producing  more 
functional foods, is at the cutting edge of food science (Reilly, 2000; Harlander, 2002). 
Some have claimed that this is a new “second generation” of GM crops, being developed 
to be genetically modified to express traits for delivering apparent benefits to the consumer 
and unlike the “first generation” developed for delivering only producer benefits. Others will 
contend that because the density of nutritive and health-beneficial functional chemicals 
can vary dramatically among plants and animals, with levels often being quite low or non-
existent, there is a need to develop strategies that would improve the composition of such 
chemicals in certain foods. Conventional breeding techniques can be used to achieve this 
goal, but GM is an attractive alternative that would enable investigators to overcome the 
genetic diversity within existing germplasm that limit the extent of improvement that can be 
achieved  through  conventional  techniques.  Examples  include  the  engineering  of  beta-
carotene  in  rice  grains,  elevating  iron  content  in  rice,  enhancing  vitamin  C  content  in 
lettuce, increasing flavonols in tomato.  
The  research  is  complex  because  often  there  is  a  need  not  only  to  understand  the 
biochemical pathway for producing such metabolites, but also a need to appreciate the 
complexity  of  the  metabolites  trafficking  through  the  organism,  which  likely  require  the 
identification of several genes for use in a transgenic improvement strategy.  
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Safety  considerations  for  a  functional  food  derived  by  GM  should  not  be  treated  any 
differently from the functional food derived by conventional plants or animals. Alterations 
introduced into the genome are very specific and minor, altering one or a few genes and 
their  gene  products.  The  overall  safety  evaluation  of  a  GM  functional  food  will  be 
conducted under the concept known as “substantial equivalence” where GM products with 
one  or  a  few  new  introduced  traits  remain  substantially  equivalent  to  their  traditional 
counterparts (Cockburn, 2002; Kuiper, 2002).  
Over  50  GM  crops  have  undergone  such evaluation  and  been  judged  safe,  via World 
Health  Organization  and  the  Food  and  Agriculture  Organization  of  the  United  Nations 
(FAO/WHO, 2000). Overall, the safety assessment is focused on those genes and their 
products that are introduced into the new variety. Typically, the emphasis is placed on 
proteins expressed by the introduced atypical gene. 
Consumption of DNA, regardless of the source, is considered highly digestible and safe 
(Beever, 2000; Jonas, 2001). For novel organisms not judged substantially equivalent to 
the traditional counterpart, which might be the situation when a large number of genes are 
introduced or the nutritional content has been altered substantially, a more thorough safety 
evaluation will be needed. 
If the parent plant is known to have antinutrient properties, natural toxicants, or allergenic 
substances,  the  novel  organism  will  be  tested  to  determine  the  concentration  of  such 
compounds. Currently, the safety assessment approach for such products is voluntary in 
the United States; however, a mandatory system is likely to be imposed by the FDA in the 
near future. 
 
1.5.1 Natural toxicants 
 
Plants  have  in  their  arsenal  an  array  of  thousands  of  chemicals  noxious  or  toxic  to 
bacteria, fungi, insects, herbivores, and or other species feeding upon them. 
Fortunately for humans, this chemical diversity also includes many compounds that are 
beneficial to health: nutrients, antioxidants, anticarcinogens, and many compounds with 
medicinal  value.  Most  plant  species  in  the world  are  not  edible, many  because  of the 
toxins  they  produce.  Plant  domestication  has  gradually  reduced  the  levels  of  these 
compounds so that the plant foods we eat today are far less toxic than their wild parents. 
However,  such  domestication  has  resulted  in  modern  food  plants  being  much  more 
susceptible to disease. Toxins range from known carcinogens to skin irritants. A few lipid-
soluble plant toxins are capable of bioaccumulation, for example, solanine from potatoes.  
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Toxin  concentrations  in  a  plant  can  vary  tremendously  and  the  concentration  can  be 
dictated  dramatically  by  environmental  stress  on  the  plant  (drought,  heat/cold,  mineral 
deficiencies, etc.), and disease. Also, different varieties of plant species can differ in the 
levels of toxins and nutritional value. 
 
1.5.2 Antinutrients 
 
Antinutrients, although not necessarily toxic per se, are plant compounds which decrease 
the nutritional value of a plant food, usually by making an essential nutrient unavailable or 
indigestible when consumed by humans/animals, i.e. cause nutritional deficiencies. For 
example, phytate, a common component of most seeds and cereals, forms a complex with 
many important minerals, making less of the minerals available or making an antimineral 
substance.  Antinutritives  can  have  important  health  implications  particularly  with 
populations facing malnutrition or in marginal nutritional states (Janssen, 1997). 
Several substances are antinutrients because they interfere with protein digestion, or the 
absorption or utilization of amino acid Phytohaemagglutinin are compounds referred to as 
lectin or hemagglutinin and have been used by immunologists for years to trigger DNA 
synthesis in T lymphocytes, and more recently, to activate latent human immunodeficiency 
virus  type  1  (HIV-1,  AIDS  virus)  from  human  peripheral  lymphocytes.  In  addition  to 
inducing mitosis, lectins are known for their ability to agglutinate many mammalian red 
blood cell types, alter cell membrane transport systems, alter cell permeability to proteins, 
and generally interfere with cellular metabolism. Lectins originate from plants, particularly 
legumes.  Bean  lectins,  extracted  from  raw  beans,  bind  to  intestinal  mucosal  cells  and 
interfere  with  absorption  of  amino  acids,  thyroxine,  and  various  lipophilic  compounds. 
Ricin,  found  in  the  castor  bean,  is  toxic  and  causes  intestinal  cell  necrosis.  Protease 
inhibitors are proteins that inhibit proteolytic enzymes usually by binding to the active sites. 
Ovomucoid and ovoinhibitor are protease inhibitors found in raw eggs, which inactivate 
trypsins. Elastase is inhibited by protease inhibitors found in soybeans, kidney beans and 
sand potatoes. Many are heat-labile but some are heat-resistant. 
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1.5.3 Antiminerals 
 
Besides phytic acid, which can interfere with bivalent and tervalent metal ions, oxalic acid, 
gossypol,  glucosinolates,  and  dietary  fiber  are  other  known  substances  that  can 
compromise mineral status. Oxalic acid reduces the availability of essential bivalent ions 
and is rich in rhubarb, spinach, and celery. 
Foods  rich  in  oxalic  acid  exhibiting  an  oxalic  acid  to  calcium  ratio  higher  than  1  may 
decrease  calcium  availability.  Foods  rich  in  glucosinolates  such  as  cabbage,  legumes, 
rutabaga, and turnips may compromise iodine absorption promoting goiter. Gossypol is 
found in the cotton plant and forms insoluble chelates with many essential metals, such as 
iron. However, processing of cotton seed removes up to 99% of the gossypol. Dietary fiber 
has the capacity to complex with various metals, such as calcium, magnesium, zinc and 
phosphorus. 
 
1.5.4 Allergenic compounds 
 
Genetic modification of foods ultimately results in alteration of protein products either in 
quantity or the introduction of new proteins. The synthesis of new proteins into foods may 
present concerns about safety, particularly allergenicity (Hefle, 1996; Taylor, 1997; Wal, 
1999). Although all allergens are not proteins, most are and, fortunately, only a few of the 
many diverse proteins found in foods are allergenic when ingested. It is important that the 
potential allergenicity of an introduced protein be evaluated because the incidence of food 
allergies  can  be  traumatic  and  life-threatening.  A  task  force  of  the  International  Food 
Biotechnology Council (IFBC) and the Allergy and Immunology Institute of the International 
Life Sciences Institute (ILSI) developed a decision tree approach for the assessment of 
potential allergenicity of plants produced by GM in 1996. The decision tree approach was 
modified  by  the  FAO/WHO  and  focuses  on  evaluating  the  source  of  the  gene,  the 
sequence  homology  of  the  newly  introduced  protein  to  known  allergens,  the 
immunoreactivity of the novel protein with serum IgE from individuals with known allergies 
to  the  source  of  the  transferred  genetic  material  (Taylor,  2001).  It  is  useful  to  have 
information regarding various physical and chemical properties of the novel protein, for 
example heat and digestive stability. It is likely that application of such criteria to GM foods 
will provide assurance that the novel protein in question will be assessed adequately for 
safety. However, some consumers and interest groups who are opposed to agricultural 
biotechnology have repeatedly called for mandatory labeling of such foods. Labeling would  
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be generic and of limited value to consumers with respect to information regarding specific 
food allergies. 
 
1.6 Pharmaceuticals and other emerging contaminants 
 
A  large  amount  of  drugs  and  their  metabolites  are  released  in  the  environment  and 
potentially enter in the food chain. These class of compounds are classified as “emerging 
contaminants”  and  are  under  observation  all  around  the  western  countries. 
Antidepressants,  anti-inflammatory  drugs,  antibiotics,  sexual  steroids,  birth  control  pills, 
seizure medication, cancer treatments, pain killers, tranquilizers and cholesterol-lowering 
compounds have been detected in varied water sources.  
Pharmaceutical industries, hospitals and other medical facilities are obvious sources, but 
households also contribute a significant share. People often dispose of unused medicines 
by  flushing  them  down  toilets,  and  human  excreta  can  contain  varied  incompletely 
metabolized  medicines.  These  drugs  can  pass  intact  through  conventional  sewage 
treatment facilities, into waterways, lakes and even aquifers.  
Personal care products also are showing up in water. Generally these chemicals are the 
active ingredients or preservatives in cosmetics, toiletries or fragrances. For example, nitro 
musks, used as a fragrance in many cosmetics, detergents, toiletries and other personal 
care products, have attracted concern because of their persistence and possible adverse 
environmental impacts. Some countries have taken action to ban nitro musks. Also, sun 
screen agents have been detected in lakes and fish.  
Some  scientists  believe  pharmaceuticals  do  not  pose  problems  to  humans  since  they 
occur at low concentrations in water. Other scientists say long-term and synergistic effects 
of pharmaceuticals and similar chemicals on humans are not known and advise caution. 
They  are  concerned  that  many  of  these  drugs  have  the  potential  of  interfering  with 
hormone production. Chemicals with this effect are called endocrine disrupters and are 
attracting the attention of water quality experts.  
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CHAPTER 2 – Analytical techniques for food contaminants 
 
2.1 Introduction 
 
Numerous analytical systems for screening, identifying, and quantifying contaminants in 
foods  have  been  developed  over  the  years.  The  more  appropriate  term  is 
“microcontaminants”  since  in  many  cases  they  are  present  at  a  relatively  low 
concentration. They represent almost all kinds of known analytical approaches including 
microbiological, immunochemical, and physicochemical techniques. Each of the existing 
techniques has its own advantages and drawbacks that must be carefully considered in 
the selection of the most convenient detection/confirmation system for a particular analyte 
in a given matrix.  
Contaminants  show  large  variation  in  molecular  structure  and,  consequently,  in 
physicochemical properties and biological activity. In addition, they have in common their 
presence in foods at relatively low, often sub-ppm levels, and their tendency to coexist with 
derived breakdown products which in many cases also must be included in the analysis. 
Application  of  microbiological  or  immunochemical  techniques  offers  the  advantage  of 
screening contaminants in foods with little or no previous sample preparation. Application, 
on the other hand, of physicochemical techniques, allows quantification and more tentative 
identification of residues in those samples found positive. The analytical problem for food 
contaminants is complicated by the fact that it is not known whether contaminants exist, 
and if they exist, the type and quantity are not known. 
The analytical methods are standardized by such organizations as the U.S. Food and Drug 
Administration  (FDA),  U.S.  Department  of  Agriculture  (USDA),  U.S.  Environmental 
Protection Agency (EPA), Association of Official Analytical Chemists (AOAC), Institute of 
Food Technologists (IFT) and National Food Processors Association. Similar Institution 
are present at EU level. 
In  the White  Paper  on  Food  Safety  of    January  12
th  2000  the  European  Commission 
announced a series of initiatives to improve and complete the legislation on food and feed 
controls.  In  this  regard,  Regulation  (CE)  N°   882/20 04  on  official  controls  performed  to 
ensure the verification of compliance with feed and food law, animal health and animal 
welfare rules was adopted by the European Parliament and the Council on 29 April 2004.  
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2.2 Sample selection 
 
The first step in food analysis is sample selection. Ideally, a sample will be identical to the 
material from which it has been removed. Samples can be chosen at random, by judgment 
of the analyst, or according to a system based on timing or location (such as daily at noon, 
or within a specific portion of the product or its container). 
Samples must be representative, collected without contamination, and properly handled 
for  the  analytical  results  to  be  meaningful.  If  the  analysis  is  not  to  be  performed 
immediately,  the  sample  will  probably  have  to  be  preserved  refrigerate  or  freezed  to 
prevent deterioration. 
Preservation involves the control of temperature, moisture, oxygen, and light, and may be 
as simple as sealing the sample in a container and placing it in a refrigerator. Containers 
must be dry, sterile, and unbreakable. 
 
2.3 Extraction 
 
Food  samples  frequently  have  to  undergo  extraction,  separation,  or  concentration 
procedures  prior  to  analysis.  Foods  contain  a  myriad  of  compounds  and  are  not 
homogeneous, often forcing the removal of interfering components and the isolation of the 
analyte before an analysis is attempted. Common procedures include distillation, filtration, 
and precipitation. The sample may also have to be homogenized, ground, or treated in 
some other way. Buldini and Smith reviewed a number of modern extraction techniques 
(Buldini, 2002; Smith, 2003), which include the following: 
 
Digestion 
-  Microwave oven digestion, with acids such as nitric or sulfuric, for solubilizing and 
oxidizing organic compounds to obtain free ions. Digestion by microwave is faster 
than the classical wet digestion. 
-  UV photolysis digestion, with hydrogen peroxide, for degrading organic compounds 
with hydroxyl radicals to obtain free ions. Small amounts of reagents are required, 
but digestion time is longer. 
 
Membrane 
-  Microfiltration or ultrafiltration, based on size exclusion. Polymer membranes are 
often used for separation.  
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-  Dialysis,  based  on  ionic  charge  and  size  exclusion.  Cellulose  membranes  are 
typically used. 
 
Solvent 
-  Solvent extraction, for dissolving compounds of interest. 
-  Pressurized  fluid  extraction,  at  the  near-supercritical  region,  where  extraction  is 
faster and more efficient. 
-  Supercritical fluid extraction, above the critical pressure and temperature of carbon 
dioxide,  which  is  nontoxic  and  nonpolluting.  Extraction  is  completed  in  minutes 
instead of hours, and thermal degradation is reduced. 
-  Microwave-assisted  extraction,  usually  requiring  <  15  mL  solvent,  <  10  min 
extraction time, and no elevated pressure. 
 
Sorbent 
-  Solid-phase extraction and microextraction, where analytes are held by sorbents 
such as silica or polymers, and then solubilized and eluted. 
 
Headspace 
-  Purge  and  trap  (or  dynamic  headspace),  in  which  the  analyte  is flushed from a 
liquid or gaseous sample and concentrated in a cryogenic trap. 
-  Adsorbent  trap,  where  a  synthetic  porous polymer  adsorbs  a  gas  which  is  then 
desorbed. 
The digestion methods are employed for extracting ions, and the other methods are used 
to extract compounds. Dialysis is used for both. Some of the extraction methods, such as 
supercritical fluid and sorbent, are used in conjunction with analytical techniques. 
 
2.4 Instrumental technique selection 
 
The analyst decides the problem to be solved and plans the analyses required, choosing 
techniques for their appropriateness using criteria in a number of categories: 
 
Ability to conduct analysis 
Sample size, reagents, instruments, cost, final state of sample (destroyed or intact) 
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Fundamental characteristics 
Precision, accuracy, sensitivity, specificity, detection limit, reproducibility. 
 
Personnel concerns 
Safety, simplicity, speed 
 
Technique status 
Official method, in-house method 
 
Official methods are developed by being comprehensively studied and compared between 
laboratories. Standardized official methods include those published by AOAC International, 
American Association of Cereal Chemists and American Oil Chemists’ Society (Official 
Methods of Analysis of AOAC International, 2003; Approved Methods of the AACC 2001).  
More specialized method collections, such as Food Chemical Codex for determination of 
additives, have also been compiled (Food Chemical Codex, 2004). Many techniques are 
not listed as official because they are relatively new or have not yet been applied to certain 
types  of  samples.  In  these  cases,  in-house  methods  may  be  used  if  they  have  been 
validated (Wood, 1999). 
 
2.5 Analytical techniques 
 
A multitude of analytical techniques are available for food. The number of instrumental 
methods has been steadily growing, and can be broadly categorized as chromatographic, 
spectroscopic, physical, and biological. 
 
2.5.1 Chromatographic techniques 
 
Chromatography is based on distribution or partition of a sample solute between stationary 
and mobile phases. Chromatographic techniques in common use today in food analysis 
include gas chromatography (GC), high-performance liquid chromatography (HPLC), and 
supercritical fluid chromatography (SFC). These often serve as a separation method when 
connected  to  another  instrument  such  as  a  mass  spectrometer,  which  serves  as  the 
detector. 
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Gas Chromatography (GC) 
GC was introduced in the 1950s and has been applied to a wide range of foods. It is 
applicable  to  volatile  substances  that  are  thermally  stabile;  LC  and  SFC  are  more 
appropriate chromatographic methods for analysis of amino acids, peptides, sugars, and 
vitamins. GC is useful for analysis of nonpolar compounds, although polar compounds 
may be analyzed if derivatized first.  
Isolation of the analyte from the sample matrix is particularly important in GC to avoid false 
responses  from  matrix  degradation  products.  Headspace  methods  (including  direct 
sampling  of  the  headspace),  distillation,  and  solvent  extraction  are  often  employed. 
Detectors include thermal conductivity (which is nonspecific), flame ionization (for most 
organic  compounds),  electron  capture  (mainly  for  pesticide  residues),  and  flame 
photometric  (for  pesticides  and  sulfur  compounds).  The  most  common  food  analysis 
applications for GC involve carbohydrates, drugs, lipids, and pesticides (Lehotay, 2002). 
Improvements in chromatography are constantly occurring. For instance, a new approach 
is  comprehensive  chromatography,  which  allows  a  sample  to  be  separated  along  two 
independent  axes.  Comprehensive  two-dimensional  gas  chromatography,  GC  X  GC, 
consists of a high-resolution column with a nonpolar stationary phase, a modulator for 
separating  the  eluate  into  many  small  fractions,  and  a  second  column  which  is  short, 
narrow, and polar. This technique has been applied to fatty acids, flavors, and pesticides 
(Dallüge, 2003). 
 
High-Performance Liquid Chromatography (HPLC) 
HPLC was developed in the 1960s as an improvement over column liquid chromatography 
and has been used to measure non-volatile food components. Spectroscopic detectors are 
often employed and nowadays mass spectrometry with electrospray interface is the more 
popular  hyphenated  configuration  for  an  almost  universal  applicability.  Normal-phase 
HPLC, in which the stationary phase is a polar adsorbent and the mobile phase is a non-
polar solvent, is often used for fat-soluble vitamins and carbohydrates. Reversed-phase 
HPLC, with a non-polar stationary phase and polar mobile phase, is more popular because 
of its wider application. Ion-exchange HPLC, with a functionalized organic resin as packing 
material, is used for detection of inorganic ions and analysis of carbohydrates and amino 
acids. HPLC is currently the most popular food analysis technique (GC is second) and is 
most used for amino acids, carbohydrates, drugs, lipids, and proteins.  
A  new  application  of  this  technique  is  comprehensive  two-dimensional  liquid 
chromatography  gas  chromatography,  LC  X  GC.  Triglycerides  can  first  be  separated  
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according  to  double  bond  content  and  then  by  carbon  number.  Janssen  et  al. 
demonstrated fingerprinting of olive oil, which can be applied to place of origin analysis, by 
separation into mono-, di-, and triglycerides as well as sterols, esters, and other compound 
classes (Janssen, 2003). 
 
Supercritical Fluid Chromatography (SFC) 
Supercritical carbon dioxide serves as the mobile phase in SFC; an open tubular column 
or a packed column is employed as the stationary phase, and any GC or LC detector is 
used. Instrumentation first became available in the 1980s. Smith reviewed the history and 
applications of supercritical fluids, citing its use in separating lipids from food matrices as a 
chief advantage over other methods (Smith, 1999). However, SFC is prone to operational 
difficulties  and  is  a  normal-phase  method;  reversed-phase  HPLC  is  often  viewed  as 
preferable. 
 
2.5.2 Spectroscopic techniques 
 
Spectroscopy  is  based  on  interactions  of  matter  with  electromagnetic  radiation. 
Interactions can take the form of absorption and emission, and can be detected by using 
emission, transmission, and reflection designs. Food scientists most often deal with the 
ultraviolet (UV), visible (Vis), infrared (IR), radio (nuclear magnetic resonance, NMR), and 
microwave  (electron  spin  resonance,  ESR)  regions  of  the  spectrum,  and  use 
spectroscopic techniques for quantitative and qualitative analyses. 
 
UV, Vis, and Fluorescence 
UV  and  Vis  spectroscopy  measure  absorbed  radiation  and  have  been  used  in  food 
laboratories for many years. A food component that absorbs in the ultraviolet or visible 
range may be analyzed at its characteristic wavelength in a UV-Vis spectrophotometer, as 
long as there are no interfering compounds. 
Fluorescence  spectroscopy  deals  with  emitted  radiation,  and  can  be  three  orders  of 
magnitude  more  sensitive  than  UV  or  Vis  spectroscopy.  Many  organic  molecules 
fluoresce,  including  bacteria  and  some  pesticide  residues,  making  fluorescence 
spectroscopy an option for detecting food contamination. 
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Infrared (IR)absorption 
Many molecular groups absorb IR light at specific wavelengths in an infrared spectrum, 
with the fingerprint region of the spectrum leading to positive identification of compounds. 
This long-standing technique has been expanded upon in recent years. 
Fourier  transform  infrared  (FTIR)  spectrometers  are  now  used  on  production  lines  for 
determining concentrations of fat, protein, and moisture. This on-line method of analysis 
has a large advantage over other techniques because the sample does not have to be 
extracted  or  treated  in  any  way.  Attenuated  total  reflectance  (ATR)  deals  with  internal 
reflection of IR light, and it has been used to examine sugars and trans fatty acids. High-
pressure and high-temperature ATR cells have been developed. 
This technique can be enhanced by using multiple internal reflection (MIR), in which light is 
bounced off the surface several times. Further developments in the optical components 
are needed before this method can be used more extensively on foods. 
The newest IR technique is diffuse reflectance infrared Fourier transform (DRIFT), which 
measures  the  sum  of  surface-reflected  light  and  light  that  has  been  absorbed  and 
reemitted (Wilson, 1999). DRIFT has been employed recently to monitor production and 
detect compounds in coffee.  
 
Raman 
Raman  spectroscopy  is  a  complementary  technique  to  IR  spectroscopy.  IR  absorption 
depends  on  changes  in  dipole  moment,  meaning  that  polar  groups  have  strong  IR 
responses. Raman scattering deals with changes in polarizability of functional groups, so 
non-polar groups produce intense responses. Proteins and amino acids lend themselves 
to Raman spectroscopy, and carbohydrates, lipids, and minor food components are also 
examined by this technique. In addition to basic research on molecular structure, Raman 
spectroscopy is now being used for industrial process control (Li-Chan, 1996). 
 
Atomic Absorption and Atomic Emission 
Atomic  absorption  spectroscopy  (AAS)  is  based  on  absorption  of  UV-Vis  radiation  by 
atomized minerals, whereas atomic emission spectroscopy (AES) uses the emission of 
radiation by a sample. Samples must usually be ashed, dissolved in water or dilute acid, 
and vaporized. In AAS, samples are atomized by nebulizer and burner (flame AAS), or by 
a graphite furnace (electrothermal AAS). Electrothermal AAS uses smaller samples and 
has much lower detection limits than flame AAS, but it is more costly and less precise. In 
AES,  atomization  and  excitation  can  be  performed  by  flame  or  by  inductively  coupled  
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plasma (ICP), where samples are heated to over 6000 K in the presence of argon. Both 
AAS  and  AES  measure  trace  metal  concentrations  in  complex  matrices  with  excellent 
precision and accuracy. AAS is the more established technique, with a wider variety of 
instruments available, but ICP-AES can be used to measure more than one element in a 
sample and can measure compounds that are stable at high temperatures. Both AAS and 
AES have supplanted classical methods for detecting minerals in food. 
 
Mass Spectrometry (MS) 
A mass spectrometer ionizes molecules to produce charged fragments that are separated 
by  size  and  charge.  MS  has  been  used  for  identification  and  analysis  of  complex 
compounds since the early 1960s. The coupling of separation techniques with MS, which 
began  in  the  1970s,  has  overcome  the  main  analytical  problem  with  chromatographic 
techniques — namely, ambiguity about the identity of the analyte. MS is frequently used in 
combination with GC, HPLC, ICP, and capillary electrophoresis, and there are tandem MS-
MS instruments. Three new ionization techniques used in food analysis are electrospray 
ionization  (ESI,  where  multiply  charged  ions  are  produced  by  repeated  formation  and 
explosion of charged droplets), heated nebulizer-atmospheric pressure chemical ionization 
(HN-APCI, where a gas-phase ion-molecule reaction process allows the analyte molecules 
to be ionized under atmospheric pressure), and matrix-assisted laser desorption/ionization 
(MALDI, where a sample is crystallized in a matrix of small aromatic compounds, and the 
crystal  is  subjected  to  a  pulsed  ultraviolet  laser  that  fragments  the  molecules).  MS 
techniques  have  been  used  to  analyze  the  gamut  of  food  components,  including 
antioxidants,  aroma  compounds,  carbohydrates,  drug  residues,  lipids,  peptides  and 
proteins, toxins, and vitamins (Careri, 2002).  
 
Nuclear Magnetic Resonance (NMR) and Electron Spin Resonance (ESR) 
NMR is a spectroscopic method in which atomic nuclei that are oriented by a magnetic 
field absorb characteristic frequencies in the radio range. ESR deals with electrons and 
microwave  frequencies.  These  techniques  have  several  advantages:  they  are  non-
destructive, do not usually require sample separation or extraction, and can analyze the 
interior of a sample. Drawbacks include lower sensitivity and selectivity than some other 
techniques. NMR experiments are performed using continuous wave (magnetic field held 
constant  and  oscillating  frequency  varied,  or  vice  versa)  or  pulse  (short  time,  large 
amplitude) methods; ESR uses continuous wave. Available NMR instruments include low-
resolution  (for  moisture  or  oil  content),  high-resolution  liquid  (analysis  of  liquid  phase),  
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high-resolution solid (analysis of solid phase), and magnetic resonance imaging (three-
dimensional views of cross sections of foods). 
Virtually any food can be analyzed by NMR and ESR. NMR is often used to examine 
physical  properties  such  as  melting,  crystallization,  polymorphism,  and  oil  content, and 
ESR  is  used  for  detecting  free  radicals  produced  in  physical  and  chemical  processes. 
Mannina et al. summarized the principles of NMR and applied the technique to analyzing 
free acidity, fatty acid profile, and sterol, squalene, and chlorophyll content as methods of 
authenticating olive oil (Manina, 2003).  
 
Other Spectroscopic Techniques 
Consumers  rely  on  color,  flavor,  odor,  and  texture  to  determine  the  quality  of  food. 
Colorimeters are used to qualitate and quantitate food color, with measurements based on 
hue, lightness, and saturation, and are often used in conjunction with sensory and shelf-life 
studies. A digital camera and computer graphics software have recently been applied to 
the analysis of surface color of food (Yam, 2003). 
Refractometry is based on the change in velocity of light by the analyte. Refractive index 
measurements are useful in determining concentrations of beverages, sauces, and other 
liquid foods. HPLC instruments sometimes have refractometer detectors. 
Polarimetry is the study of the rotation of polarized light by optically active substances. 
Polarimetry is used to distinguish optical isomers, identify and characterize optically active 
substances, and measure their change in concentration during reactions. It is commonly 
applied to the measurement of oils in the flavor industry, sugars, and starches. Circular 
dichroism  and  optical  rotatory  dispersion  are  based  on  the  interaction  of  circularly 
polarized light with optically active species; the former depends on wavelength and the 
latter on molar absorptivity. These techniques are often applied to amino acids, peptides, 
proteins, and complex natural products. 
Ultrasonic sensors have been applied to the determination of compositional and textural 
properties by measurement of velocity of ultrasound waves through a sample. Ultrasonic 
imaging  is  used  to  examine  structure  in  foods,  but  is  too  time-consuming  for  routine 
inspections (Coupland, 2003). 
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2.5.3 Physico-chemical techniques 
 
Electrochemical 
The most common electrochemical technique is the familiar pH electrode. An alternative to 
AAS and AES is the ion-selective electrode, which is sensitive to a particular ion. This 
technique is simple, rapid, and relatively inexpensive. However, these electrodes are not 
ion-specific, as there may be interference from ions other than those being examined. 
 
Electrophoresis 
The basis for gel electrophoresis, developed in the 1950s, is the separation of charged 
molecules when an electric field is applied. The main types of electrophoresis are non-
denaturing,  where  separation  is  according  to  charge,  shape,  and  size;  denaturing  or 
sodium  dodecyl  sulfate-polyacrylamide  gel  electrophoresis  (SDS-PAGE),  where  the 
separation  is  primarily  by  molecular  weight;  isoelectric  focusing,  which  separates  by 
charge; and two-dimensional, with separations in perpendicular directions by isoelectric 
focusing and SDS-PAGE. The analysis is carried out on a porous gel and is mainly used 
for studying nucleic acids and proteins. 
Capillary  electrophoresis  (CE),  developed  in  the  1980s,  uses  a  capillary  tube  and 
photometric detection. CE techniques include capillary zone electrophoresis, for charged 
analytes, and micellar electrokinetic chromatography, for neutral analytes. CE has been 
applied  to  analysis  of  amino  acids,  carbohydrates,  proteins,  and  vitamins,  as  well  as 
additives,  natural  toxins,  and  antibiotic  and  pesticide  residues.  Detection  limits  are 
relatively high, however, because of the low sample volume (Dong, 1999). 
 
2.5.4 Biological techniques 
 
Catalytic biosensors: Enzyme and Microbial Sensors 
Biosensors  consist  of  a  biological  recognition  element  that  produces  a  quantifiable 
response  in  a  signal  transduction  element  when  in  contact  with  the  analyte.  Enzyme 
biosensors  use  enzymes  to  generate  products  that  are  detected  by  acoustic, 
electrochemical,  optical,  and  photothermal  transduction  elements.  Microbial  biosensors 
use genetically modified microorganisms that are immobilized on a membrane or trapped 
in a matrix, with the transduction mechanism consisting of an oxygen or pH electrode, or a 
luminometer if luciferin is added. A popular type of optical element developed in the 1990s 
is surface plasmon resonance. These types of biosensors are often applied to detection of  
36 
contaminants  such  as  herbicides,  pesticides,  pathogens,  and  toxins,  as  well  as  food 
components  such  as carbohydrates and amino acids.  Improvements  in  response  time, 
sensitivity, and specificity are needed for wider acceptance of this technique (Patel, 2002; 
Mello, 2002).  
 
Affinity biosensors:Immunosensors 
Immunosensors are biosensors in which the biological recognition elements are antibodies 
that are attached to a solid support and bind to a particular antigen or antibody in the 
sample.  The  most  common  immunoassay  is  enzyme-linked  immunosorbent  assay 
(ELISA), in which an enzyme-linked antibody is applied after the antigen or antibody is 
bound. The antibody/antigen interaction is specific enough to allow detection of species of 
origin, and it is also used to detect allergens, enzymatic inactivation, genetically modified 
organisms, microbial contamination, and toxins. 
The principles of the immunological methods are presented in the next chapter. 
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CHAPTER 3 – Immunoassays in food analysis 
 
3.1 Introduction 
 
For the first screening of contaminants in foods several technologies were used as an 
alternative to conventional reference analytical methods. Of these, immunological methods 
are probably the best known and a high number of immunoassays are now available.  
The concept of immunoassay was first described in 1945 when Landsteiner suggested 
that  antibodies  could  bind  selectively  to  small  molecules  (haptens)  when  they  were 
conjugated  to  a  larger  carrier  molecule.  This  hapten-specific  concept  was  explored  by 
Yalow and Berson in the late 1950s, and resulted in an immunoassay that was applied to 
insulin  monitoring  in  humans.  This  pioneering  work  set  the  stage  for  the  rapid 
advancement of immunochemical methods for clinical use. 
The first application of immunologically based technology to pesticides was not reported 
until  1970,  when  Centeno  and  Johnson  developed  antibodies  that  selectively  bound 
malathion. A few years later, radioimmunoassays were developed for aldrin and dieldrin 
and for parathion. In 1972, Engvall and Perlman introduced the use of enzymes as labels 
for immunoassay and launched the term enzyme-linked immunosorbent assay (ELISA). In 
1980, Hammock and Mumma described the potential for ELISA for agrochemicals and 
environmental  pollutants.  Since  then,  the  use  of  immunoassay  for  food  analysis  has 
increased  dramatically.  For  example,  immunoassay  technology  has  become  a  primary 
analytical method for the detection of products containing genetically modified organisms 
(GMOs). 
 
The advantages of immunoassay technology relative to other analytical techniques include 
the following: 
 
-  low detection limits 
-  high analyte selectivity 
-  high throughput of samples 
-  reduced sample preparation 
-  versatility for target analytes 
-  cost effectiveness for large numbers of samples 
-  adaptability to field use.  
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As  is  the  case  with  every  analytical  method,  immunoassay  technology  has  limitations, 
including: 
 
-  interferences from sample matrices 
-  cross reactivity to structural analogs of the target analyte 
-  low availability of reagents 
-  longer assay development time than some classical analytical methods. 
 
The immunoassay is clearly not the best analytical method for all analytes in all situations. 
However, immunoassay technology is important for the analyst because it complements 
the classical methods, thus providing a screening method for many compounds and the 
only reasonable analytical choice for others. Most immunoassays can be used to obtain 
quantitative results with similar or greater sensitivity, accuracy and precision than other 
analytical  methods.  They  are  generally  applicable  to  the  analysis  of  small  molecules, 
including  pharmaceuticals  and  pesticides,  identification  of  pest  and  beneficial  species, 
characterization  of  crop  quality,  detection  of  GMOs,  product  stewardship,  detection  of 
disease and even monitoring for bacteria and bioterrorism. 
 
3.2 Principles of immunoassays 
 
3.2.1 Binding reagent 
 
The basis of all immunological methods is the recognition of an analyte, the antigen (Ag), 
by a reagent, the antibody (Ab), directed against it.  
Antibodies are produced by lymphocytes of vertebrates as part of the defence reaction to 
the invasion of bacteria, viruses, foreign proteins and other macromolecules, the so-called 
antigens. The sera of these vertebrates contain a number of antibodies (i.e. polyclonal 
antibodies) which are specific for the same antigen, but as they are produced by different 
cells, they may belong to different antibody classes and may recognize different parts of 
the molecule, i.e. different epitopes with different affinities. The selection of a single cell 
which produces only one type of antibody with the desired specificity and affinity and its 
fusion to immortalized cells leads to the production of monoclonal antibodies. These can 
be produced in cell culture in large amounts with a constant quality (Campbell, 1991). 
Most of the chemical contaminants found in food are too small (less than approximately 
1000 Da) to be antigenic, i.e. to activate the immune system of vertebrates. Therefore,  
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they  are  called  haptens.  Antibodies  against  haptens  can  be  obtained  only  if  they  are 
covalently coupled to a carrier protein (Hock, 2000; Vanderlaan, 1988). After injection of 
this immunoconjugate a number of antibodies with different specificities are produced by 
the animal. Among these antibodies are some recognizing the hapten and some binding 
only  epitopes  on  the  carrier  protein  or  the  linker  between  protein  and  hapten.  Careful 
selection leads to the desired cell lines.  
Antibodies are glycoproteins with a Y-structure and two binding sites for the antigen. The 
binding of the antigen is non-covalent using all forms of bonding which mediate protein-
protein  interaction  including  hydrophobic  interaction  (Rabbany,  1994).  Structural  loops 
which  are  responsible  for  the  high  affinity  of  these  interactions can  be formed  in  both 
molecules. It was also found that in the majority of binding reactions both the antigen and 
the antibody change their structure to optimize the interaction, thus resembling more of a 
handshake than a ‘key-lock’ mechanism (Campbell, 1991).  
The reaction between free antigen and antibody leading to the antibody-antigen complex is 
treated as an equilibrium reaction. The affinity constant (KA) is then defined as the ratio of 
the kinetic constants of the association reaction and of the dissociation reaction.  
Affinity describes the amount of antibody-antigen complex that will be found at equilibrium. 
High-affinity  antibodies  (i.e.  KA  10
12  L.mol
-1)  will  bound  larger  amounts  of  antigen  in  a 
shorter period of time then low-affinity antibodies (i.e. KA 10
4 L.mol
-1). 
In immunoassays for food analysis polyclonal (PAb) and monoclonal (MAb) antibodies are 
used.  Thanks  to  their  specificity  of  binding,  their  homogeneity  and  their  ability  to  be 
produced in unlimited quantities, MAbs are preferred to polyclonal ones, but they have 
several disadvantages: 
-  Difficulty selecting a suitable clone 
-  Difficulty scaling up production to commercial levels 
-  The need to separate the single Ab produced from other cell proteins 
-  Practical limitation to rodent species 
Many of these problems are addressed by new molecular biologic techniques that have 
revolutionized  the  production  of  Ab-like  molecules  (Jones,  1986;  George,  1997; 
Dall’Acqua, 1998).  
By using recombinant DNA and amplification technologies, binders can be produced from 
“naïve” DNA libraries, eliminating the need for immunization. Variable regions of the Ab, 
making up the complementarity determining regions, can be linked with constant regions 
to mimic a native Ab or can be linked in a much simpler fashion to produce a single chain 
fragment variable region Ab, which can be joined to produce multivalent binders (one type,  
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the  chelating  recombinant  Ab,  achieves  higher  binding  affinity  by  recognizing  adjacent 
epitopes on a large Ag) (Neri, 1995) or modified in other ways desired for a particular 
assay. Selection of suitable clones is made easier by phage display and other display 
technologies,  and  production  can  be  performed  in  Escherichia  coli  or  in  completely 
acellular systems. 
Investigators also have looked toward entirely different classes of molecules as possible 
binding  reagents.  Considerable  promise  has  been  shown  by  aptamers,  which  are 
polynucleotides  with  an  affinity  for  a  particular  ligand  (Osborne,  1997;  Ellington,  1990; 
Famulok, 1999). 
From a mixture of random polynucleotides, the ligand is used to pull out sequences for 
which it has affinity, then these are amplified using the polymerase chain reaction (PCR). 
After inducing further variations in the selected sequences, the cycle can be repeated. This 
process,  termed  SELEX  (systemic  evolution  of  ligands  by  exponential  enrichment), 
eventually  can  yield  molecules  with  affinities  and  specificities  comparable  to  those  of 
MAbs. 
The affinity of aptamers can be enhanced further by chemical modification; for example, 
an aptamer directed against an enzyme can be tethered to an inhibitor that binds tightly to 
the active site. 
Molecular  imprinting  is  another  approach  to  producing  polymers  with  desired  binding 
properties (Ansell, 1996; Andersson, 1997; Haupt, 1998). The polymerization of some type 
of versatile, monomeric unit is guided by a molecular template made up of the analyte of 
interest. Polymerization typically is allowed to proceed to formation of a solid mass, from 
which a particulate binding reagent is produced by grinding. Hence, this technique does 
not offer the advantage of a pure, defined binder, although it seems that binding properties 
can be reproduced fairly well. Molecular imprinting may be especially well suited to small 
molecules with limited aqueous solubility.  
Synthetic  soluble  ligand  binders  ultimately  could  have  the  advantages  of  a  completely 
defined structure, completely defined binding properties, and lower production costs. They 
also could be tailored to the overall assay design, for example with built-in fluorescence or 
enzymatic labeling. However, the cost of developing such ideal binders will be high, and 
the incentive has been diminished by the generally satisfactory performance of Abs in 
existing assays. 
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3.2.2 Imunoassay formats 
 
The  use  of  antibodies  as  analytical  reagents  leads  to  particular  assay  formats  and 
detection principles, which can generally be divided in those relying on the determination 
of  labels  and  those  managing  without  labels.  Label-free  assays  are  based  on  either 
secondary  immune  reactions  such  as  precipitation  and  agglutination  or  physical 
transducers such as piezoelectric crystals or integrated optical elements (Rogers, 1998). 
Antibodies (Figure 1A) or antigens or corresponding conjugates are immobilized onto the 
transducer,  which  allow  real-time  monitoring  of  the  binding  reaction.  This  principle  is 
directly related to the development of immuno- or, more in general, of affinity sensors. It 
gained attention because it requires only the addition of the sample to the immobilized 
antibody followed by the regeneration of the transducer surface. However, at present it is 
applicable only if the binding molecule has a sufficient size or molecular weight. 
Therefore, in particular for the determination of rather small molecules such as pesticides, 
mycotoxins, antibiotics, or hormones indirect formats based on labelled compounds are 
most  commonly  used,  with  the  enzyme  linked  immunoassay  (ELISA)  being  the  best 
established  one  (Tijssen,  1985;  Martlbauer,  1998).  Due  to  the  small  size  of  these 
compounds,  binding  of  only  one  antibody  at  a  time  is  possible.  Thus,  the  competitive 
assay format is used with the analyte from the sample competing either with an analyte 
enzyme conjugate for the limited number of immobilized antibody-binding sites (Figure 1B) 
or with immobilized analyte (derivatives) for binding sites of added labeled antibodies (this 
format is also called inhibition assay). The signal is obtained from the addition of enzyme 
substrates which are turned into colored, fluorescent or chemiluminescent active products. 
It decreases with increasing analyte concentration. 
In  some  cases,  e.g.  the  detection  of  toxins  being  proteins  originating  from  pathogenic 
bacteria  or  of proteins  being  indicative  for infection  with  a  disease  or  a  pathogen,  the 
analyte possesses more than one epitope and is of sufficient size to allow simultaneous 
binding of two antibodies. This leads to so-called sandwich-type immunoassays, in which 
the analyte is first bound to an immobilized capture antibody and then by an enzyme-
labeled  detection  antibody.  Again,  the  signal  is  obtained  after  adding  the  enzyme 
substrates, yet here the signal increases with analyte concentration since binding of the 
detection antibody occurs only at those sites where the analyte was previously captured 
(Figure 1C). This type of assay is approximately one to two orders of magnitude more 
sensitive  than  competitive  assays.  A  number  of  assays  based  on  these  principles  are 
commercially  available  either  as  96  well  microtiter  plate  assays  allowing  the  parallel  
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quantitative analysis of a number of samples or as dipstick formats for semi-quantitative 
screening of single food samples. 
 
Figure 1: Immunosensor principles based on immobilized antibodies; (A) direct sensing of 
the  binding  reaction  of  the  analyte;  (B)  competitive  assay  formats  based  on  analyte 
tracers, the label can be an enzyme, a fluorophore or even a radioisotope; (C) sandwich 
assay formats based on a second labeled antibody. 
 
 
 
Fluorescent dyes can also be used instead of enzymes as labels, the assays are then 
called fluorescence immunoassays (FIA). Detection can be based on the determination of 
the intensity of light emitted by the fluorophore used as label or being formed after the 
addition of enhancer solutions, or by energy transfer between two suitable dyes, on the 
influence on polarized light, or on time-resolved measurements taking advantage of the 
longer  fluorescence  lifetimes  of  the  fluorescent  probe  compared  to  the  non-specific 
background (Hage, 1999). Additional assay formats are possible if anti-idiotypic antibodies 
are available (Hennion, 1998) and by combining homogeneous incubation of reagents with 
Antibodies immobilizzed on solid support, i.e. 
well of microtiter plate, beads, transducer 
surface. 
A) Addition of 
sample 
C) Addition of sample 
and labelled antibodies 
B) Addition of sample and 
labelled analyte analogue 
Unlabelled immunosensor 
Competitive immunosensor 
Sandwich type immunosensor  
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heterogeneous affinity reactions. 
The  same  basic  principles  and  the  advantages  of  the  specificity  of  antigen  antibody 
recognition are also utilized in immunoaffinity chromatography (IAC) or other principles of 
immunocapture (IC). The recognizing antibody is immobilized on a suitable support, which 
may be magnetic beads or chromatographic material filled in a column, and then incubated 
with the sample. Separation of this support from the sample matrix leads to purification 
and enrichment of the analyte simultaneously. The analysis is often done by conventional 
methods such as HPLC after eluting the analyte. 
 
3.2.3 Antibodies immobilization 
 
Antibodies are proteins and as such they can be immobilized by all methods described for 
protein immobilization. However, in practice only some methods are often used. 
Conventional ELISAs are performed in microtiter plates, which are made of polystyrene 
activated for protein adsorption. Thus, the wells of these plates are coated with antibodies 
by incubating a defined volume of an antibody solution for several hours. Antibodies not 
adsorbed after the incubation are removed by washing the wells with a suitable buffer. 
The microtiter plates are used as disposables requiring no regeneration. 
Most of the immunosensor systems are designed for repeated use. Therefore, the proteins 
are often covalently immobilized using carriers with suitable functional groups. 
The latter can be introduced by modification with silanising reagents. Chemical binding of 
proteins may  cause  severe  conformational  change  on  the  protein  structure  due  to, for 
example,  multiple  binding  sites  and  thus  may  cause  a  significant  decrease  of  binding 
capacity. Modification of proteins with low molecular weight compounds such as biotin has 
proven to be a more gentle procedure, and since tight immobilization of proteins can be 
accomplished by taking advantage of the strong affinity between biotin and biotin-binding 
proteins  (avidin,  streptavidin,  neutravidin),  this  method  has  become  established  as  an 
alternative to covalent binding. Moreover, the amount of immobilized protein can easily be 
defined by the amount of biotinylated protein, as quantitative binding can be expected. 
Regeneration  of  the  antibody  analyte  binding  sites  can  be  achieved  by  a  number  of 
solutions,  such  as  those  containing  ethylene  glycol,  urea,  or  thiocyanate  or  buffers  of 
different pH. However, these regeneration protocols usually affect the binding capacity of 
the immobilized protein (Dietrich, 1995; Kramer, 1997), leading to a limited reusability of 
the system (Ivnitski et al., 1999) and requiring reversible immobilization of the antibodies. 
Thus, alternatively, the binding of antibodies to materials used for affinity purification of  
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antibodies, such as carriers with covalently immobilized binding proteins, e.g. protein G or 
protein A, is used as a quasi-reversible antibody immobilization method, as the antibodies 
can be eluted without damage of the binding material and freshly reloaded prior to the next 
assay (Rogers, 1998). 
Immobilization of antibodies, antigens or binding proteins leads to affinity reactors, through 
which  all  solutions  are  pumped  or  in  which  all  solutions  are  incubated  and  where  the 
affinity reactions and reactions of the tracers take place leading to detectable signals. 
These reactors are flow-through columns filled with beads (Dietrich, 1995; Kramer, 1997), 
glass  capillaries,  silicon  chip  reactors,  or  simple  conical  propylene  cells  in  which 
antibodycontaining electrodes were inserted (Pemberton, 1998). They can be microtiter 
wells to which optical fibers are attached for monitoring the optical densitiy of the solution 
or in which an electrode is integrated to determine the amount of electrochemically active 
product of the enzyme reaction (Skladal, 1995; Dequaire, 1999). Even a membrane or the 
surface of a transducer can serve as an affinity reactor. 
 
3.3 Immunosensor systems requiring no labels 
 
Acoustic sensors 
Piezoelectric crystals couple mechanical deformation and electric voltage. They oscillate at 
a particular vibration frequency, generally in the range of acoustic waves between 9 and 
14 MHz, with the resonant frequency being directly related to the mass deposited on the 
exciting electrodes.  
Different  types  of  waves  can  be  generated,  allowing  distinction  between  bulk  acoustic 
wave (BAW) sensors and surface acoustic wave (SAW) sensors (O’Sullivan, 1999). Since 
SAW devices are operated at higher frequencies, they are intrinsically more sensitive than 
BAW devices. Yet the latter ones are usually applied to food-relevant analyses probably 
because of the good availability of transducers and well-established measuring principles. 
The sensors are quartz wafers in the form of 10–16 mm disks, squares or rectangles, 
which are approximately 0.15 mm thick and sandwiched between two electrodes made of 
gold (Guilbault, 1994). 
These  electrodes  are  used  to  induce  an  oscillating  electric  field  perpendicular  to  the 
surface of the wafer. The electric field then produces a mechanical oscillation, a standing 
wave, in the bulk of the quartz wafer. When placed in an electronic oscillator, the portion of 
the  quartz  wafer  located  between  the  electrodes  vibrates  with  its  precise  fundamental 
frequency. The frequency output from the oscillator is identical to the resonant frequency  
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of the crystal and can be measured with a frequency counter. Binding of compounds to the 
electrodes due to, e.g., a biochemical binding reaction leads to an increase in mass and 
consequently,  to  a  decrease  of  the  resonant  frequency.  First  reports  were  based  on 
measurements in the gas phase only, requiring careful drying of the sensor surface after 
its incubation in a liquid sample. Later flow-through cells were developed, where only one 
side of the crystal is in contact with the flowing solution (Horacek, 1997). This allows real-
time monitoring of the affinity reaction (O’Sullivan, 1999). 
 
Optical immunosensors 
Optical immunosensors described here are based on optical waveguide structures which 
are used as substrates for biospecific layers, e.g. for immobilized antibodies. 
Electromagnetic waves propagate in a dielectric material which is embedded in a material 
of lower refractive index by multiple internal reflection at the boundary of the two materials. 
An external light beam is only then able to establish a guided wave in a dielectric if energy 
transfer  occurs  between  the  light  beam  and  the  guided  mode.  Thus,  a  laser  beam  is 
focussed  either  on  the  end  face  of  the  waveguide  or,  more  commonly,  prism,  lens  or 
grating coupling is used. Changing the angle of the external light beam with respect to the 
boundary of the waveguide modifies the exciting electromagnetic field until it matches the 
guided mode (Kooyman, 1997). 
An optimal angle can be defined for each waveguide structure. From an optical viewpoint 
surface binding processes change the waveguide configuration, in particular the refractive 
index profile, and by this the propagation velocity of the guided light wave. This can be 
measured, for example, through changes in the coupling conditions, i.e. through changes 
of the angle of the light beam leading to an excitation of guided modes. 
There is a strong similarity between the excitation of guided modes in a dielectric material, 
i.e. the coupling of light into a waveguide, and the excitation of a surface plasmon in a 
metal  layer.  Both  interact  by  the  evanescent  part  of  the  electromagnetic  field  with  the 
sample contacting the metal or the dielectric layer and hence both are used in label-free 
immunosensor systems (Tiefenthaler, 1992) as they can measure binding of molecules to 
the  waveguide  surface  through  resulting  changes  of  the  refractive  index.  The  lower 
detection limit for a given compound depends on the sensitivity of the device to monitor 
small changes of refractive index and also on the molecular weight of the compound of 
interest, because changes of the refractive index are directly proportional to the increase in 
the mass loading on the waveguide surface due to binding of the analyte. Thus, up to now 
this  approach  is  applicable  only  for  the  detection  of  high  molecular  weight  analytes.  
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However,  these  sensing  principles  offer  additional  features,  as  they  show  an  inherent 
surface sensitivity, and hence both the immobilization of the biorecognition layer on the 
surface and the following binding of the corresponding analyte can be monitored in real 
time. This allows immobilization under more or less standardized conditions as well as the 
evaluation of kinetic data, i.e. association and dissociation rate constants, and steady-state 
data suitable for quantitative analysis. 
 
3.4 Immunosensor systems using labels 
 
The integration of labels or labeled compounds in immunoanalysis is well-established in 
ELISA  and  FIA  (fluorescence  immunoassay),  and  bead-coupled  (e.g.  latex,  gold) 
immunoassay protocols. Compared to label-free formats detection of specific properties of 
the labels leads to improvements of the specificity, sensitivity, and lower detection limit of 
the assay. Hence, labeled compounds, i.e. tracers, are also introduced in immunosensor 
systems,  although  they  require  at  least  the  tracer  as  additional  reagent,  often  even 
additional incubation and washing steps and, consequently, more complex devices if they 
are to be fully automated. In the following, the most important principles of such systems 
are described considering only enzymes and fluorophores as labels. 
 
Fluorescence sensor systems 
Fluoroimmunoassays have increased in interest for almost 20 years as an alternative to 
radioimmunoassays in using cheap, stable and safe reagents and resulting in rapid and 
sensitive assays (Hemmila, 1985). Moreover, fluorescence detection is well-established for 
DNA-analysis using fluorescent intercalators or fluorescence-labeled primers. 
Fluorescence sensors are based either on optical fibers or on integrated optical devices. 
As described above, light propagates in dielectric materials if the electromagnetic waves of 
the light and the guided modes in the dielectric match. Traveling of the light beam in the 
waveguide leads to an electric field also in the lower refractive index material; this field 
decreases exponentially with increasing distance to the boundary between the materials. 
This electric field is called evanescent field and has a penetration depth of 50–500 nm for 
visible light. It can be used to excite fluorescent dyes and to collect emitted fluorescent 
light  if  the  optical  properties  match.  Thus  the  use  of  optical  fibers  or  waveguides  as 
transducers in fluorescence affinity sensors allows a separation of bound and unbound 
tracers through the evanescent field. As antibody labeling with fluorescent probes is an 
established  procedure  of  immunostaining  techniques,  most  of  the  fluorescent  
48 
immunosensor systems are based on either an inhibition assay format (Bier, 1992; Klotz, 
1998) or a sandwich format (Rowe, 1999), depending on the analyte to be determined. 
However, the use of labeled analyte analogues is also reported (Meusel, 1998; Charles, 
1999). 
 
Chemiluminescent systems 
Exploitation of chemiluminescent (CL) or bioluminescent (BL) reactions in immunoassay 
falls  into  two  main  areas:  components  of  a  chemiluminescent  (e.g.,  luminol)  or 
bioluminescent  reaction  (e.g.,  a  luciferase,  aequorin)  can  be  used  as  a  label,  or  a 
chemiluminescent or bioluminescent reaction can be used to monitor an enzyme label or 
its products.  
Chemiluminescent molecules  exploited  as  labels  include  luminol,  isoluminol,  acridinium 
esters,  thioesters  and  sulfonamides,  and  phenanthridinium  esters.  Separation  and 
nonseparation assays have been devised, based on isoluminol and acridinium ester labels 
(Kriska,  1991).  Isoluminol  derivatives  (ID)  have  been  most  widely  studied  in  the 
preparation  of  tracers  for  immunoassay  because  of  their  high  quantum  efficiency,  low 
molecular weight, well-known chemical structure, low cost and high stability. Moreover the 
light  efficiency  of  some  ID  may  be  modified  by  specific  binding  to  the  antibody,  thus 
allowing  the  development  of  homogenous  immunoassays  requiring  no  bound/free 
separation  step.  Recently  the  labelling  of  streptavidin  with  amino-buty-ethyl-isoluminol 
allowed the development of very sensitive immunoassay methods which take advantage of 
the biotin-avidin system (Messeri, 2005). 
To provide a highly sensitive analytical system, CL and BL can be used to analyze the 
amount of product generated by enzyme labels. CL and BL methods have been developed 
for many enzyme labels, e.g., alkaline phosphatase, glucose-6-phosphate dehydrogenase, 
horseradish  peroxidase,  Renilla  luciferase,  and  xanthine  oxidase.  Currently,  the  most 
successful enzyme assays are the enhanced CL method for a peroxidase label involving a 
mixture of luminol, hydrogen peroxide, and an enhancer (e.g., p-iodophenol) and the direct 
CL method for alkaline phosphatase, with an adamantyl 1,2-dioxetane phenyl phosphate 
as substrate. Both systems are very sensitive and produce long-lived light emission. 
 
Enzymes as labels 
Immunosensor systems based on the use of enzymes as labels can follow the same basic 
principles as enzyme immunoassays (Hage, 1999; Hennion, 1998) performed in microtiter 
plates.  The  sensor  systems  differ  from  ‘conventional’  immunoassays  in  the  degree  of  
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automation, the detection principle, the solid phase to which the antibody is bound, and the 
reusability of the bio-recognition layer. Reports deal with either horseradish peroxidase 
(HRP), alkaline phosphatase (AP), or urease as label, for which chromogenic, fluorogenic, 
chemiluminescent and electrochemical substrates are described. Thus, a protocol realized 
in  a  certain  sensor  system  may  be  comparable  to  that  of  a  microtiter  plate  assay 
comprising the steps of (1) antibody immobilization, (2) addition of sample, (3) addition of 
enzyme tracer (both solutions may be premixed and applied simultaneously, (4) washing, 
(5) addition and incubation of enzyme substrates, and (6) recording of the signal. A final 
step of (7) regeneration is included in reusable devices. 
Due to the complexity of the resulting procedure automation is achieved by the use of flow 
systems in which the various solutions are supplied and incubated in the ‘immunoreactor‘ 
through computer-controlled pumps and valves. Systems are described which allow the 
automated performance of the whole assay and which are thus suitable for direct coupling 
of the device to a sample line and thus for on-line monitoring of a process (Dietrich, 1995; 
Kramer, 1997). Most of the systems were described for the determination of pesticides in 
water. But there are also reports on the application to milk (progesterone) (Pemberton, 
1998), poultry (Salmonella) (Dill, 1999) and other food (Brooks, 1992). 
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CHAPTER 4 – Chemiluminescence 
 
4.1 Introduction 
 
Chemiluminescence (CL) is the light emission produced by a chemical reaction in which 
chemically  excited  molecules  decay  to  the  ground  state  and  emit  photons. 
Bioluminescence (BL) is a type of CL which naturally occurs in living organisms and is also 
used  in  vitro.  Measurement  of  light  from  a  chemical  reaction  is  very  useful  from  an 
analytical point of view, because in appropriate experimental conditions the light output 
intensity is directly related to the analyte concentration, thus allowing precise and accurate 
quantitative analysis. In addition, the kinetics of the light emission is usually a steady-state 
glow type, which simplifies sample handling and measurement procedures. 
CL  as  an  analytical  tool  has  several  advantages  over  other  analytical  techniques  that 
involve  light  (mainly  absorption  spectroscopy  and  fluorometry):  high  detectability,  high 
selectivity, wide dynamic range and relatively inexpensive instrumentation. 
The  superior  detectability  of  CL  measurements  is  partly  due  to  a  low  background.  In 
luminescence measurements two components of light reach the detector: the first one (i.e. 
the net analytical signal) is proportional to the analyte concentration, while the second 
component (i.e. the background) is an approximately constant light level due to various 
factors such as the phosphorescence of plastics, impurities in the reagents, emission from 
other sample components, detector dark current. Warm-up and drift of light source and 
detector,  and  interference  from  light  scattering  present  in  absorption  and  fluorescence 
methods are absent in CL, making the background light component much lower and thus 
achieving a significant gain in sensitivity.  
Selectivity  derives  from  the  fact  that  the  analyte  of  interest  generates  its  signal  in  the 
presence of compounds, which normally interfere in fluorescence measurement, and that 
do themselves not produce light when the chemiluminescent reagents are mixed together. 
Wide dynamic ranges allow samples to be measured across decades of concentrations 
without  dilution  or  modification  of  the  sample  cell.  This  is  due  to  the  way  the 
chemiluminescent signal is generated and measured, i.e. using no excitation source for 
light production and a phototransducer with an inherent wide range of response for light 
detection.  
The light emitted from chemi- and bioluminescent reactions is typically measured using a 
luminometer.  Luminometers  are  simple,  relatively  inexpensive  instruments  designed  to  
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measure sample light output, generally by integrating light emission for a given period of 
time. All luminometers basically consist of a sample chamber, a detector and a signal 
processing apparatus, and are used to measure emission from different sample formats 
(the most common being single tubes and microtitre plates).  
Photodiodes and photomultiplier tubes (PMTs) are the detection devices commonly found 
in  commercial  luminometers.  Even  if  improvements  in  photodiodes  have  made  them 
suitable  for  some  applications,  PMTs  are  still  the  detectors  of  choice  for  measuring 
extremely low levels of light.  
A relatively recent advancement in light detection technology for analytical purposes is 
represented  by  low-light  imaging  devices  based  on  intensified  Vidicon  tubes  or  high 
sensitivity charge-coupled devices (CCDs). These luminescence imaging instruments, also 
known as luminographs, allow not only the measurement of light intensity at the single-
photon level, but also the spatial distribution of the light emission on a target surface to be 
evaluated. 
CL  is  utilized  in  various  analytical  techniques  in  which  small  amounts  of  analytes  are 
detected and quantitated by measurement of the light emission (DeLuca, 1978; Kricka, 
1984; Baeyens, 1990). Chemiluminescent reaction systems often involve enzymes, such 
as  alkaline  phosphatase  (AP)  and  horseradish  peroxidase  (HRP),  and  suitable  CL 
substrates which allow for the detection of enzymes with very high efficiency (Bronstein, 
1989;  Beck,  1990;  Thorpe,  1986;  Thorpe,  1987).  These  enzymes  are  widely  used  as 
labels  in  the  development  of  immunoassays  (Kricka,  1988;  Ashihara,  1994)  blotting 
(Schneppenheim,  1987;  Bronstein,  1990)  and  gene  probe  assays  (Matthews,  1985). 
Coupled  enzymatic  bio-  and  chemiluminescent  analytical  methods  have  also  been 
developed: in particular, ATP involving reactions (kinases) have been coupled with the 
firefly luciferin-luciferase system, NAD(P)H producing or consuming enzymatic reactions 
(dehydrogenases) with bacterial luciferases, and the luminol/H2O2/HRP system has been 
coupled with oxidase enzymes (Roda, 1989; Carrea, 1986). Advances in molecular biology 
and the increasing need of ultrasensitive assays have led to the development of novel 
luminescence  systems  for  a  wide  variety  of  applications  in  genetic  research,  food 
technology,  environmental  monitoring  and  clinical  chemistry,  so  that  CL-based 
immunoassay and gene detection kits became commercially available and routinely used 
(Kricka, 1988; Ashihara, 1994; Matthews, 1985; Bronstein, 1990). 
CL imaging also represents a very promising detection system which is increasingly used 
for  the  ultrasensitive  quantitation  and  localization  of  analytes  in  a  wide  range  of 
applications  (Nicolas,  1994;  Hooper,  1994).  CL  imaging  is  suitable  for  filter  membrane  
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biospecific reactions, such as the Southern, Northern, or Western blot tests, and dot blot 
hybridization reactions. In these techniques nucleic acids or proteins are either blotted on 
filter  membrane  after  separation  by  gel  electrophoresis,  or  directly  dotted  on  the 
membrane. Nucleic acids are then hybridized with a complementary gene probe labeled 
with a hapten and detected by anti-hapten antibody conjugated with an enzyme and CL 
substrate; proteins are detected by specific antibody followed by anti-antibody conjugated 
with an enzyme and CL substrate. The main advantage with respect to other detection 
systems (i.e., colorimetric or even chemiluminescent with photographic detection) is the 
direct and rapid quantitative evaluation of the signal over a wide dynamic range. It can be 
used for the measurement of CL signals in microtitre plates, with the advantage of a one-
step  measurement  of  the  emission  from  the  whole  plate  (differently  from  conventional 
luminometers, that usually read the emission well by well or strip by strip). This may be an 
important  advantage  in  analytical  methods  relying  on  the  kinetic  behaviour  of  the  CL 
emission. CL imaging is also used to detect BL and CL in whole organs or plants, and on 
any kind of surfaces. It should be noted that CL imaging devices do not possess the very 
wide  dynamic  range  characteristic  of  photomultiplier  tube-based  instruments.  However, 
this limitation can be partly overcome by taking advantage of the intrinsic wide dynamic 
range of CL as detection principle. 
When coupled with an optical microscope, CL imaging is a very potent analytical tool for 
the  development  of  ultrasensitive  enzymatic  immunohistochemistry  (IHC)  and  in  situ 
hybridization (ISH) assays, allowing spatial localization and semiquantitative evaluation of 
the distribution of the labeled probe in tissue sections or single cells to be performed. 
 
4.2 Chemiluminescence reagents  
 
Labeling with enzymes is generally preferred to labeling with CL substances because of 
the possibility to obtain a higher sensitivity due to the amplification of the CL signal in the 
presence of an excess of the CL substrate. Moreover, with enzyme labels glow-type light 
emission kinetics can be usually obtained (e.g. the CL emission reaches a steady-state 
intensity),  which  permits  both  easy  handling  and  standardization  of  the  experimental 
conditions and quantitation of the labeled probe under investigation, because the steady-
state light intensity is directly related to the enzyme activity. 
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Figure 1: CL reactions commonly used in analytical chemistry 
 
 
 
AP and HRP are probably the most widely used CL labels, thanks to the availability of 
many different CL substrates which originate glow-type emission kinetics and permit the 
detection of very small amounts (in the order of 10
-18-10
-21 moles) of CL label. The most 
sensitive  and  widely  investigated  CL  substrates  for  AP  are  based  on  adamantyl-1,2-
dioxetane aryl phosphate derivatives (García-Campaña, 2001; Ito, 2003) while commercial 
substrates  for  HRP  are  mainly  luminol-based  reagents  (Figure  1).  Adamantyl  1,2-
dioxetane aryl phosphates are dephosphorylated by AP to give an unstable intermediate; 
decomposition of this intermediate produces an excited-state aryl ester that emits light. 
Luminol and its derivatives are oxidized by peroxides (usually hydrogen peroxide) giving 
light  emission.  This  CL  reaction  can  be  catalyzed  by  enzymes  other  than  HRP  (e.g. 
microperoxidase  and  catalase)  and  by  other  substances  (haemoglobin,  cytochrome  c, 
Fe(III) and other metal complexes). The presence of suitable molecules such as phenols 
(p-iodophenol), naphthols (1-bromo-2-naphthol) or amines (p-anisidine) increases the light 
production deriving from the HRP-catalyzed oxidation of luminol and produce glow-type 
kinetics (Van Dyke, 2002; Haddock, 2000). The use of other enzymes, such as glucose-6-
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phosphate dehydrogenase (Roda, 2000), b-galactosidase (O’Connell-Rodwell, 2002) and 
xanthine oxidase (Laxman, 2002; Paulmurugan, 2002; Contag, 2002) as CL labels has 
been reported. 
 
4.3 Chemiluminescence and immunoassay 
 
The sensitivity and detectability demonstrated by luminescence immunoassays are similar 
to,  or  even  better  than,  those  of  radioisotopes.  Indeed,  for  routine  clinical  analysis, 
radioimmunoassays have been almost completely replaced by luminescent immunoassays 
that  are  performed  by  fully  automated,  random  access  systems  optimized  for  clinical 
chemistry. Chemiluminescent immunoassays are also being utilized in other fields as well, 
including environmental and food analysis. Among the various immunoassay formats, CL 
offers by far the best performance when applied to sandwich-type assays, the sensitivity of 
which is determined primarily by the detection limit of the label. Most CL immunoassays 
are in a heterogeneous format, which requires separation between bound and free tracer 
that  is  usually  achieved  by  immobilizing  an  immunoreagent  on  a  solid-phase  such  as 
assay tubes, microtiter plate wells, or microparticles. The separation step also removes the 
sample constituents which will thus not affect the subsequent CL reaction. 
Chemiluminescent  immunoassays  employ  tracers  obtained  either  by  direct  labeling  of 
antigens or antibodies with CL molecules, or labeling with enzymes detectable with CL 
substrates.  Alternatively,  tracers  may  be  obtained  labeling  antigens  or  antibodies  with 
ruthenium  (II)  tris(bipyridyl)  which  is  detected  by  electrogenerated  chemiluminescence. 
Very efficient CL substrates are available for HRP and AP, which are the label enzymes 
most commonly used in immunoassay. Utilizing dioxetane phosphate substrates, 10-20 
moles of AP, corresponding to about 6000 molecules, was detected, which is the lowest 
detection limit so far achieved in CL enzyme detection (Bronstein, 1989). Recently, Maeda 
et al. reported the development of a new bioluminescent enzyme immunoassay (BLEIA) 
for hormones that utilizes acetate kinase as a label and in which the ATP produced by the 
label-catalyzed reaction is measured with the conventional luciferin/luciferase system: with 
this method a detection limit of 1-2x10
-20 moles of analyte was achieved (Ito, 2003). 
The  future  of  BL/CL  immunoassays  looks  bright,  thanks  to  the  availability  of  new 
biotechnological tools. BL immunoassays have been developed using photoproteins (e.g. 
recombinant aequorin) (Mirasoli, 2002) or even a firefly luciferase-coding DNA fragment as 
labels (Chiu, 1999). Various bifunctional bioluminescent molecules have been prepared 
and proposed for the development of immunoassays. Examples include: a thermostable  
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firefly luciferase–biotin complex obtained by fusing the BL protein with a biotin acceptor 
peptide (Tatsumi, 1996); chimeric antibodies incorporating a specific antibody and a BL 
label  (Casadei,  1990);  and  BL/CL  tracers  for  competitive  immunoassays,  obtained  by 
fusing  a  BL  protein  or  an  enzyme  suitable  for  CL  detection  with  a  protein  or  peptide 
analyte (Grigorenko, 2001). The latter approach is much more convenient than traditional 
chemical  conjugation  because  it  provides  virtually  unlimited  amounts  of  a  tracer 
characterized by a constant 1:1 analyte:label molar ratio, which is particularly suited for 
developing  ultrasensitive  assays.  Fusion  proteins  have  also  been  used  for  developing 
BRET-based open-sandwich BL immunoassays (OS-BLIA), which were demonstrated to 
be more sensitive than comparable FRET-based assays (Arai, 2001). The assay is based 
on  the  antigen-dependent  reassociation  of  the  antibody  heavy  chain  and  light  chain 
fragments, each one genetically fused either to Rluc or to EYFP. 
 
4.4 Chemiluminescence and high-throughput screening technology 
 
High-throughput  screening  technology  is  moving  towards  miniaturized,  high-density 
analytical  formats.  Microtiter  plate miniaturization  has  been achieved  by  increasing  the 
microwell  density  from  96  to  384  or  1536  wells  per  microplate.  Nanoliter-capacity-well 
arrays have also been proposed for the design of highly parallel analytical methods, as 
demonstrated with a BL ATP assay (Young, 2003). Small well volumes often result in fluid 
handling problems that have been partly overcome by “lab on a chip” approach, which 
combines the advantages of microwell-based analytical formats with the high density of 
microarrays (Kanigan, 2003).  
Microarrays  on  glass,  silicon,  or  other  surfaces  can  contain  up  to  thousands  of  probe 
molecule spots per square centimeter. In principle, any type of ligand-binding assay that 
relies on the binding of a target molecule present in solution by an immobilized capture 
molecule  (e.g.,  nucleic  acid–nucleic  acid,  antigen–antibody,  protein–protein,  ligand–
receptor) can be performed in a microarray format. Microarray-based assays using nucleic 
acid–nucleic  acid  interactions  (DNA  chips)  are  well  established  and  protein  microarray 
assays are becoming popular (Templin, 2002). As an example, protein microarrays have 
been  used  for  receptor–ligand  assays  in  order  to  identify  new  protein  ligands,  thus 
enabling HTS with very low sample consumption. Use of fluorescent and, possibly, BL/CL 
labels could represent the most suitable detection approach for microarray-based assays. 
"Lab on a chip" devices, consisting of fluidic channels etched in low density into a glass or 
plastic solid substrate, are able to process samples and reagents in a fast, serial manner.  
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These devices have been applied to drug discovery and development, allowing flexible 
assay formats utilizing small sample and reagents volumes. However, such devices will 
only  work  with very sensitive assays due to the short times that reagents dwell in the 
detection  zone  and  have  a  relatively  low  analytical  throughput.  Moreover,  re-using  the 
same device for many reactions can result in sample carryover as well as in degradation of 
the  device  components.  The  Living  Chip  technology  (Kanigan,  2000)  combines  the 
advantages of microwell-based analytical formats with the high density of microarrays, and 
probably represents the most versatile HTS technology available up to now. The Living 
Chip consists of a bidimensional array of channels and in the current implementation it has 
more than 10,000 channels per chip, each of them having a volume of 50 nL. The surfaces 
of the array are hydrophobic, while the interiors are hydrophilic, so that liquid is held in the 
channels by means of surface tension without cross-talk between adjacent channels. This 
device allows for performing simultaneously large numbers of chemical, biochemical, or 
cell-based micro-scale reactions. For example, by aligning and stacking a second chip on 
top of the first one, mixing of reagents may be performed on 10,000 or more samples, thus 
accomplishing massively parallel initiation of reactions. The Living Chip technology has 
been exploited in a variety of applications, such as the screening of compound libraries 
and  enzyme  activity  assays,  and  could  be  applied  to  both  homogeneous  and 
heterogeneous assays. Assay results can be monitored in parallel over the entire chip by 
different means, including fluorescence and BL/CL imaging techniques. 
These  new  assay  formats  should  dramatically  enhance  the  analysis  of  large  sets  of 
compounds  against  large  numbers  of  targets.  Nevertheless,  the  exigencies  of  drug 
screening  will  motivate  a  continued  application  of  state-of-the-art  technologies  to  the 
process of HTS. In this context, BL and CL techniques are certainly expected to play a 
more and more important role. 
 
References 
 
Arai R.; Nakagawa H.; Tsumoto K.; Mahoney W.; Kumagai I.; Ueda H.; Nagamune T. 
Demonstration  of  a  homogeneous  noncompetitive  immunoassay  based  on 
bioluminescence resonance energy transfer. Anal. Biochem. 289:77, 2001. 
Ashihara Y., Saruta H., Ando S., Kikuchi Y., Kasahara Y. In: AK Campbell, LJ Kricka, PE 
Stanley,  eds.  Bioluminescence  and  Chemiluminescence:  Fundamentals  and  Applied 
Aspects. Chichester: Wiley, 1994, pp 321-324. 
Baeyens WRG, De Keukeleire D, Korkidis K. Luminescence Techniques in Chemical and  
60 
Biochemical Analysis. New York: Marcel Dekker, 1990. 
Beck  S,  Köster  H.  Applications  of  dioxetane  chemiluminescent  probes  to  molecular 
biology. Anal Chem. 62:2258, 1990. 
Bronstein I., Voyta J. C., Edwards B. A comparison of chemiluminescent and colorimetric 
substrates in a hepatitis B virus DNA hybridization assay. Anal Biochem 180:95, 1989. 
Bronstein I., Voyta J. C., Lazzari K. G., Murphy O., Edwards B., Kricka L. J. Improved 
chemiluminescent detection of alkaline phosphatase. Biotechniques 8:310, 1990. 
Bronstein, I.; Brooks, E.; Voyta, J. C. J. Biolumin. Chemilumin. 1989, 4, 99-111. 
Carrea  G.,  Bovara  R.,  Mazzola  G.,  Girotti  S.,  Roda  A.,  Ghini  S.  Bioluminescent 
continuous-flow assay of adenosine 5'-triphosphate using firefly luciferase immobilized on 
nylon tubes. Anal Chem 58:331, 1986. 
Casadei J.; Powell M.J.; Kenten J.H. Expression and secretion of aequorin as a chimeric 
antibody by means of a mammalian expression vector. Proc. Natl. Acad. Sci. U. S. A. 
87:2047; 1990. 
Contag  P.  R.  Whole-animal  cellular  and  molecular  imaging  to  accelerate  drug 
development. Drug Discov. Today, 7:555, 2002. 
DeLuca M. Methods Enzymol. Volume 57. New York: Academic Press, 1978. 
García-Campaña, A. M.; Baeyens, W. R. G. Chemiluminescence in Analytical Chemistry; 
Marcel Dekker: New York, 2001. 
Grigorenko V.; Andreeva I.; Börchers T.; Spener F.; Egorov A. A genetically engineered 
fusion protein with horseradish peroxidase as a marker enzyme for use in competitive 
immunoassays. Anal. Chem. 73:1134, 2001. 
Haddock, S. H. D.; McDougall, C. M.; Case, J. F. The Bioluminescence Web Page, 2000, 
http://lifesci.ucsb.edu/~biolum/. 
Hooper C. E., Ansorge R. E., Rushbrooke J. G. Low-light imaging technology in the life 
sciences. J Biolumin Chemilumin 9:113, 1994. 
Ito K.; Nakagawa K.; Murakami S.; Arakawa H.; Maeda M. Highly sensitive simultaneous 
bioluminescent measurement of acetate kinase and pyruvate phosphate dikinase activities 
using a firefly luciferase-luciferin reaction and its application to a tandem bioluminescent 
enzyme immunoassay. Anal. Sci., 19:105, 2003. 
J.C.  Lewis  and  S.  Daunert,  Photoproteins  as  luminescent  labels  in  binding  assays. 
Fresenius J. Anal. Chem. 366 (2000), pp. 760–768. 
Kanigan  T.;  Brenan  C.;  Lafontaine  S.;  Soswoski  L.;  Madden  P.;  Hunter  I.  SPIE 
Proceedings, 3926:172, 2000. 
Kanigan  T.  S.;  Brenan  C.  J.;  Lafontaine  S.;  Sosnowski  L.;  Madden  P.;  Hunter  I.  W.  
61 
Monitoring enzymatic reactions in nanolitre wells. J. Microsc. 212:254; 2003. 
Kricka  LJ,  Stanley  PE,  Thorpe  GHG,  Whitehead  TP.  Analytical  Applications  of 
Bioluminescence and Chemiluminescence. London and New York: Academic Press, 1984. 
Kricka LJ, Stott RAW, Thorpe GHG. In: WP Collins, ed. Complementary Immunoassays. 
Chichester: Wiley, 1988, pp 169-179. 
Laxman B.; Hall D. E.; Swaroop Bhojani M.; Hamstra D. A.; Chenevert T. L.; Ross B. D.; 
Rehemtulla A. Noninvasive real-time imaging of apoptosis. Proc. Natl. Acad. Sci. USA, 
99:16551, 2002. 
Matthews J. A., Batki A., Hynds C., Kricka L. J. Enhanced chemiluminescent method for 
the detection of DNA dot-hybridization assays. Anal Biochem 151:205, 1985. 
Mirasoli M.; Deo S. K.; Lewis J. C.; Roda A.; Daunert S. Bioluminescence immunoassay 
for cortisol using recombinant aequorin as a label. Anal. Biochem. 306:204, 2002. 
Chiu  N.  H.;  Christopoulos  T.  K.  Two-site  expression  immunoassay  using  a  firefly 
luciferase-coding DNA label. Clin. Chem. 45:1954; 1999. 
Nicolas  J.C.  Applications  of  low-light  imaging  to  life  sciences.  J  Biolumin  Chemilumin 
9:139, 1994. 
O’Connell-Rodwell  C.  E.;  Burns  S.  M.;  Bachmann  M.  H.;  Contag  C.  H.  Trends  in 
Biotechnology 2002, 20, S19-S23. 
Paulmurugan  R.;  Umezawa  Y.;  Gambhir  S.  S.  Noninvasive  imaging  of  protein-protein 
interactions in living subjects by using reporter protein complementation and reconstitution 
strategies. Proc. Natl. Acad. Sci. USA, 99:15608, 2002. 
Roda A., Girotti S., Ghini S., Carrea G. Coupled reactions for the determination of analytes 
and enzymes based on the use of luminescence. J Biolumin Chemilumin 4:423, 1989. 
Roda, A.; Pasini, P.; Musiani, M.; Baraldini, M. Methods Enzymol. 2000, 305, 120-132. 
Schneppenheim R, Rautenberg P. Eur J Clin Microbiol 6:49-51, 1987. 
Tatsumi  H.;  Fukuda  S.;  Kikuchi  M.;  Koyama  Y.  Construction  of  biotinylated  firefly 
luciferases using biotin acceptor peptides. Anal. Biochem. 243:176; 1996. 
Templin M. F.; Stoll D.; Schrenk M.; Traub P. C.; Vöhringer C. F.; Thomas O.J. Protein 
microarray technology. Trends Biotechnol 20:160, 2002. 
Thorpe GHG, Kricka LJ. In: J Scholmerich, R Andreesen, A Kapp, M Ernst, WG Woods, 
eds.  Bioluminescence  and  Chemiluminescence:  New  Perspectives.  Chichester:  Wiley, 
1987, pp 199-208. 
Thorpe G. H., Kricka L. J. Enhanced chemiluminescent reactions catalyzed by horseradish 
peroxidase. Methods Enzymol 133:311, 1986.  
Van Dyke, K.; Van Dyke, C.; Woodfork, K. Luminescence Biotechnology: Instruments and  
62 
Applications; CRC Press: Boca Raton, 2002. 
Weigl HB, Bardell RL, Cabrera CR (2003) Adv Drug Deliver Rev 55:349–377 
Young, I.T., Moerman, R., Van Den Doel, L.R., Iordanov, V., Kroon, A., Dietrich, H.R.C., 
Van Dedem G. W. K.; Bossche A.; Gray B. L.; Sarro L.; Verbeek P. W.; Van Vliet L.J. 
Monitoring enzymatic reactions in nanolitre wells. J. Microsc. 212:254, 2003.  
63 
CHAPTER 5 - Development and validation of an ultrasensitive 
chemiluminescent  enzyme  immunoassay  for  aflatoxin  M1  in 
milk 
 
A fast and ultrasensitive chemiluminescent enzyme immunoassay for aflatoxin M1 in milk 
samples has been developed and validated. The method is an indirect competitive type 
format involving the immobilization of an aflatoxin M1-bovine serum albumin conjugate on 
384 well black polystyrene microtiter plates and the use of a secondary antibody labeled 
with  horseradish  peroxidase  detected  with  a  luminol-based  substrate.  Aflatoxin  M1 
standard solutions were prepared in milk-based buffer, and milk samples were analyzed 
without any cleanup procedure. The limit of quantification was 1 ppt, the coefficient of 
variation was below 9% for both intra- and interassay precision, and the recovery ranged 
from 96 to 122%. The method is specific, and other aflatoxins do not significantly cross-
react with the antibody. Twenty-four milk samples were analyzed, and a good correlation 
was observed (y = 0.98x + 1.71, r
2 = 0.98, n = 24) when the data were compared with a 
reference  high-performance  liquid  chromatography  method  with  a  fluorescent  detector. 
The  developed  method  is  suitable  for  an  accurate,  sensitive,  and  high-throughput 
screening  of  aflatoxin  M1  in  milk  samples  with  a  reduction  of  costs  and  increased 
detectability, as compared with previously developed immunoassays.  
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5.1 Introduction 
 
Aflatoxins  are  highly  toxic  mycotoxins  produced  by  three  species  of  Aspergillus 
(Aspergillus  flavus,  Aspergillus  parasiticus,  and  Aspergillus  nomius),  which  may 
contaminate a wide range of foods and animal feedstuffs stored under temperature and 
humidity conditions favorable to mold growth.  
Aflatoxin M1 is a hydroxylated metabolite of aflatoxin B1, formed when ruminants ingest 
feed contaminated with aflatoxin B1. Aflatoxin M1 is then excreted in milk (Polan, 1974; 
Van Egmond, 1989), and because it is relatively stable during milk pasteurization or other 
thermal treatments, it can also be present in milk-derived dairy products, such as cheese 
and yogurt (Galvano, 2001; Govaris, 2002).  
Because of its hepatotoxic and carcinogenic activity (International Agency for Research on 
Cancer, 1993), aflatoxin M1 contamination represents a risk for human health, especially 
for children, who are the major milk consumers. Aflatoxin M1 legal limits, ranging from 0 to 
1  mg/kg,  have  been  established  in  various  countries  worldwide,  and  in  particular,  the 
European Union limit for aflatoxin M1 in milk is 50 ppt (ng/kg) (European Commission, 
2001). Aflatoxin M1 is frequently present in commercial milk samples and dairy products, 
and various milk samples containing aflatoxin M1 levels greater than the legal limit were 
recently detected, thus causing "alert" among the European Union (Rapid alert system for 
food  and  feed,  2003),  the  World  Health  Organization,  and  the  Food  and  Agriculture 
Organization (World Health Organization, 2002).  
Several  methods  for  aflatoxin  M1  determination  have  been  developed,  and  high-
performance liquid chromatography (HPLC) with a fluorescent detector and enzyme-linked 
immunosorbent assays are mainly used in routine analysis (Stroka, 2002; van Egmond, 
2004). For an effective screening and monitoring of aflatoxin M1 in foodstuffs at ppt levels, 
analytical methods combining simplicity with high detectability and analytical throughput 
are required. This can be achieved by means of immunological methods in conjunction 
with a highly sensitive detection of the label. Previously developed enzyme immunoassays 
for  aflatoxin  M1  analysis  using  conventional  colorimetric  detection  with  chromogenic 
substrates (Thirumala-Devi, 2002; Sibanda, 1999) were allowed to reach detection limits 
not lower than 5-10 ppt in milk. In addition, they usually require a 60-120 min incubation 
time,  as  well  as  several  analytical  steps,  which  limits  their  extensive  use  for  a  rapid 
aflatoxin M1 screening (Badea, 2004; Rodriguez Velasco, 2003).  
Enzyme  labels  detected  by  chemiluminescent  (CL)  substrates,  such  as  the  
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luminol/peroxide/enhancer system for horseradish peroxidase (HRP) or dioxetane-based 
substrates  for  alkaline  phosphatase,  represent  the  most  sensitive  detection  system  in 
immunoassay development (Kricka, 1996; Ito, 2003). In addition, the CL signal detection 
can  be  performed  immediately  after  substrate  addition,  thus  shortening  the  overall 
analytical procedure when compared with conventional colorimetric assays. In the present 
work,  a  fast  and  ultrasensitive  CL  enzyme  immunoassay  for  aflatoxin  M1  has  been 
developed,  based  on  the  use  of  an  anti-aflatoxin  M1  rabbit  polyclonal  antibody 
characterized  by  a  very  high  affinity  constant.  An  aflatoxin  M1-BSA  conjugate  was 
synthesized and immobilized on 384 well black polystyrene microtiter plates for developing 
an indirect competitive type format immunoassay, in which a secondary anti-rabbit IgG 
labeled with HRP and a luminol/peroxide/enhancer CL system were used.  
 
5.2 Materials and Methods 
 
Materials.  Aflatoxins  M1,  M2,  B1,  B2,  G1,  and  G2,  1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDAC), Freud's complete adjuvant (FCA), goat anti-rabbit IgG-peroxidase 
conjugate,  bovine  nonfat-dried  milk,  certified  reference  materials  BCR  285  and  282 
(aflatoxin M1 in whole milk powder, 0.76 and 0.05 mg aflatoxin M1/kg, respectively), bovine 
serum albumin (BSA), and Tween 20 were all obtained from Sigma Chemical Co. (St. 
Louis, MO).  
Black 384 and 96 well or transparent 96 well polystyrene microtiter plates (Labsystems, 
Helsinki,  Finland)  were  used  for  the  CL  or  the  colorimetric  method,  respectively.  An 
enhanced  (luminol/peroxide/enhancer)  CL  system  (SuperSignal  ELISA  Femto)  (Pierce, 
Rockford, IL) was used for the measurement of HRP activity. Buffers were as follows: 
Coating buffer (0.05 M carbonate/bicarbonate buffer solution pH 9.6); blocking solution 
[0.01 M phosphate-buffered saline (PBS), pH 7.2-7.4, containing 2% nonfat-dried milk]; 
incubation buffer (PBS, pH 7.2-7.4, containing 3% nonfat-dried milk); washing buffer (PBS 
with 0.05% Tween 20). HPLC grade acetonitrile was purchased from Carlo Erba (Milan, 
Italy), and deionized water was purified on a Milli-Q system (Waters, Milford, MA).  
 
Instrumentation.  Hapten/protein  densities  analysis  was  performed  by  matrix-assisted 
laser  desorption/ionization  time-of-flight  mass  spectrometry  (MALDI/TOF-MS),  using  a 
Voyager De Pro (Applied Biosystems, Foster City, CA) instrument equipped with a pulsed-
N2 laser operating at 337 nm (Karas, 1991; Zaluzec 1995). Reagents were dispensed in 
microtiter  plates  using  a  Multidrop  384  dispenser  (Labsystems).  Microtiter  plates  were  
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incubated under shaking at 37° C using a Wellwarm sh aker-incubator (Labsystems).  
A chemiluminescence microtiter reader Luminoskan Ascent (Labsystems), which allows 
measurement of the CL signal from a whole 96 or 384 well microtiter plate within few 
minutes,  was  used.  As  an  alternative,  the  CL  signal  was  measured  using  a  LB  981 
imaging device (EG&G Berthold, Pforzheim, Germany), which employs a highly sensitive, 
back-illuminated, cooled CCD camera (Roda, 1996). A Multiskan EX spectrophotometric 
microtiter  reader  (Labsystems),  provided  with  492  nm  filter,  was  used  for  absorbance 
measurements.  
A Varian Star 9010 HPLC system (Varian, Palo Alto, CA) equipped with an isocratic m-flow 
pump and coupled to a Varian Fluorichrom scanning fluorescence detector was used for 
method validation. Data quantification was performed using a Varian Vista 402 integrator.  
 
Aflatoxin M1-BSA Conjugate (Antigen). Aflatoxin M1 has no reactive groups for direct 
coupling to a protein; therefore, it was first converted to aflatoxin M1-O-carboxymethyl-
oxime (aflatoxin M1-oxime) according to the method described by Chu et al. (Chu, 1977a). 
The antigen was prepared by conjugating aflatoxin M1-oxime to BSA in the presence of 
EDAC,  using  the  method  previously  described  by  Chu  et  al.  (Chu,  1977b)  for  the 
preparation of BSA-aflatoxin B1-oxime conjugate.  
The aflatoxin M1 to BSA conjugation ratio was determined by MALDI-TOF, by comparing 
the molecular weight  of the standard BSA with that of the aflatoxin  M1-BSA conjugate 
(Bacigalupo,  2005). The  matrix  (sinapinic  acid)  was  prepared  at a  concentration  of  10 
mg/mL in 1:1 (v/v)  water-acetonitrile (+0.1% trifluoroacetic acid). Protein samples were 
typically 10-50 pmol/mL in water-acetonitrile (2:1, v/v). Sample and matrix solutions were 
mixed in equal volumes, and then, 2 mL of the resulting solution was transferred to the 
target plate and left to dry at room temperature. Spectra were recorded at threshold laser 
irradiance for 50-150 shots in the linear mode at 25 kV, using an external linear calibration 
with  BSA  standard  solution.  Protein  conjugate  concentration  was  determined  using  a 
Bradford assay.  
 
Antibody Production and Characterization. Polyclonal antibodies against aflatoxin M1-
BSA  were  produced  in  rabbit  following  a  previously  described  protocol  (Roda,  1980). 
Briefly, 100 mg of aflatoxin M1-BSA conjugate was subcutaneously injected as an emulsion 
in saline solution and Freund's complete adjuvant for each immunization. Antiserum with 
adequate  titer,  affinity,  and  specificity  were  obtained  3-4  months  after  the  first 
immunization. Any anti-BSA present was eliminated by precipitation by adding BSA (0.3%)  
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to  the  rabbit  sera.  The  IgG-rich  fraction  was  isolated  by  salting-out  precipitation  with 
sodium  sulfate,  following  a  slight  modification  of  the  method  described  by  Axen  et  al. 
(Axen,  1967).  In  brief,  180 mg  of  Na2SO4 was  added  to  1 mL of  anti-BSA free  rabbit 
serum, and the mixture was stirred at 25° C for 45 m in and centrifuged at 4000g for 15 min. 
The supernatant was carefully removed, and the pellet was resuspended in 1 mL of PBS 
containing 18% Na2SO4, and the mixture was vortexed for 40 s and centrifuged at 4000g 
for 15 min. These steps were repeated 2-3 times, and then, the pellet was resuspended in 
1 mL of PBS and extensively dialyzed against PBS. The antibody was stored at -20° C in 
PBS  containing  100  mL/mL  trasylol.  Antibody  specificity  was  defined  by  evaluating  the 
extent of cross-reactivity (CR) with structurally related compounds, such as aflatoxins M2, 
B1, B2, G1, and G2, using an indirect competitive binding assay.  
 
Samples. Control Milk Samples. Control milk samples were prepared at three aflatoxin M1 
concentration  levels:  lower  (1  ppt),  middle  (10  ppt),  and  upper  (100  ppt)  levels.  In 
particular, 1 mL aliquots of pooled noncontaminated milk samples (i.e., with aflatoxin M1 
content lower than the detection limit of the developed immunoassay) were spiked with the 
appropriate amount of aflatoxin M1. Briefly, the standard solution of aflatoxin M1 (10 mg/mL 
in methanol) was diluted 1:10000 v/v with noncontaminated milk in order to achieve a 1000 
ppt  aflatoxin  M1  in  milk  stock  solution.  Aflatoxin  M1  fortified  milk  samples  were  then 
obtained by serial dilutions in noncontaminated milk.  
Milk Samples. A total of 24 milk samples of different kinds (whole fat, half-skimmed, and 
light) provided by "Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise" (Teramo, 
Italy), with aflatoxin M1 concentration previously evaluated by a validated reference HPLC 
method, were analyzed. Certified reference materials (aflatoxin M1 0.76 and 0.05 mg/kg), 
provided as powdered milk, were suspended in distilled water (0.1 g/mL) and dissolved by 
stirring.  
Milk  samples  were  centrifuged  at  3500g  for  10  min  at  4° C,  the  upper  fat  layer  was 
completely  removed,  and  the  aqueous  layer  (middle  portion)  was  directly  used  for  the 
analysis.  For  an  automatic  procedure,  the  sampling  system  was  set  up  to  collect  the 
appropriate middle portion of the centrifuged sample.  
 
Aflatoxin  M1-BSA  Immobilization.  The  developed  method  is  a  solid  phase  indirect 
competitive immunoassay, involving immobilization of the aflatoxin M1-BSA on 384 well 
polystyrene microtiter plates (96 well conventional microtiter plates were also used and the 
reagent  volume  was  5-fold  higher).  In  particular,  the  wells  of  the  microtiter  plate  were  
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coated  with  20  mL  of  150  ng/mL  aflatoxin  M1-BSA  in  coating  buffer.  The  plates  were 
incubated overnight at 4° C. After the plates were washed three times with washing buffer, 
60 mL of blocking solution was added to each well and the plates were further incubated at 
4° C for 2 h. The solution was discarded, and the pl ates were washed and vacuum-dried, 
and then, they were either used immediately or sealed with drying materials and stored at 
4° C until use.  
 
Enzyme  Immunoassay  Procedure.  To  perform  the  assay,  20  mL/well  of  sample  or 
aflatoxin M1 standard solution (aflatoxin M1 concentration in the range from 0.2 to 5000 ppt 
in incubation buffer) was added in duplicate to the antigen-coated plate followed by the 
addition of 20 mL/well of the anti-aflatoxin M1 polyclonal antibody diluted 1:60000 (v/v) in 
washing buffer (primary antibody). The wells were incubated with gentle shaking for 30 
min at 37° C. During incubation, a competition took  place between the free analyte and the 
solid phase-bound antigen for binding to antibodies. After they were washed four times 
with washing buffer, the plate was incubated for 30 min in the dark at 25° C with 20  mL/well 
of HRP-labeled anti-rabbit IgG (secondary antibody) diluted 1:4000 (v/v) in washing buffer.  
For the colorimetric method, the HRP activity of the tracer bound to the solid phase was 
measured  by  adding  100  mL/well  of  a  chromogen  [1,2-phenylenediamine  (0.5  mg/mL), 
H2O2 30% (0.25 mg/mL) in 0.1 M citrate buffer, pH 5.0]. After incubation in the dark at 25° C 
for 20 min, the enzymatic reaction was stopped with 4 N H2SO4 (100 mL/well), and the 
absorbance at 492 nm was recorded.  
For  the  CL  method,  the  peroxidase  activity  was  measured  using  a  CL  substrate  (30 
mL/well).  The  light  emission,  which  becomes  stable  within  2-3  min,  was  measured  by 
means of a microtiter plate luminometer reader using a 1 s integration time. Alternatively, a 
CCD-based luminograph was used, which allows simultaneously measuring the CL signal 
from a whole 384 or 96 well microtiter plate within 1 min.  
 
Calculations.  Aflatoxin  M1  concentrations  were  determined  by  interpolation  on  the 
calibration curve, where the bound enzyme activity, expressed as the ratio between signal 
at each concentration of analyte (B) and the bound activity in the absence of analyte (B0), 
was plotted against the log of analyte concentration. For each experiment, a calibration 
curve was determined by a nonlinear regression analysis of the standards' data using the 
following equation: 
Y= YO + (100 – YO) / (1 + 10 
[(b – x) c]) 
where Y = B/B0, YO = bottom asimptote (the    dose),  x  =  log  of  analyte  concentration  
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(ppt), b = log of analyte at midpoint of the curve (ppt), and c = slope.  
Linearization of the calibration curve was performed by plotting the bound enzyme activity, 
expressed as the logit of the ratio (in percent) between B and B0, against the log of analyte 
concentration. The best data fit was obtained by linear regression of the standard points. 
The milk aflatoxin M1 concentration was expressed as pg/mL (ppt) of milk.  
 
HPLC  Analysis.  To evaluate  the  accuracy  and to  validate the method,  a  comparative 
study  using  both  the  developed enzyme  immunoassay  and  HPLC  was  performed.  For 
HPLC analysis, 5 mL of the aqueous layer of the centrifuged milk samples was diluted 1:1 
(v/v) with water and submitted to a cleanup procedure using 3 mL C-18 SPE columns 
(Baker J. T., Phillipsburg, NJ) preconditioned with 2.5 mL of acetonitrile and 5 mL of water. 
The solution was applied to the cartridge, and then, the column was washed with 10 mL of 
water, followed by 20 mL acetonitrile/water 10:90 (v/v) and 10 mL of n-hexane. Aflatoxin 
M1 was eluted with 2 × 3 mL of dichloromethane/acetone 95:5 (v/v), and then, the solvent 
was  evaporated  under  a  nitrogen  stream.  The  fluorescent  hemi-acetal  aflatoxin  M1 
derivative (aflatoxin M2a)  was obtained by the addition of 250 mL of trifluoroacetic acid 
followed  by  15  min  of  stirring  in  the  dark  (Orti,  1986;  Orti,  1989).  The  solution  was 
subsequently  dried  by  evaporation  under  gentle  nitrogen  stream,  and  the  residue  was 
dissolved with 200 mL of mobile phase and analyzed by HPLC.  
Analysis of aflatoxin M1 was performed on a 250 mm × 4.6 mm i.d., 5 mm, Supelcosil LC-
18 column (Superchrom, Milan, Italy). The column was thermostated at 40° C, and the 
sample  injection  volume  was  20  mL.  The  mobile  phase  consisted  of  acetonitrile/water 
20:80 (v/v), and the flow rate was 1.2 mL/min. Aflatoxin M1 was eluted at a retention time 
of  5.6  min  and  detected  by  setting  the  fluorescence  detector  at  353  and  423  nm.  All 
analyses  were  performed  in duplicate. The  limits  of  detection  (LOD)  and  quantification 
(LOQ) of the HPLC method were 5 and 15 ppt, respectively.  
 
5.3 Results and Discussion 
 
Aflatoxin M1-BSA Characterization. The average molar ratio between aflatoxin M1 and 
BSA in the aflatoxin M1-BSA conjugate, as determined by the molecular weight obtained 
by  MALDI-TOF  mass  spectrometry,  was  6  mol  of  aflatoxin  M1  for  1  mol  of BSA. This 
indicated that the aflatoxin M1-BSA conjugate was characterized by a relative high hapten 
density,  thus  by  high  antigenicity.  In  addition,  mass  spectrometry  analysis  showed  the 
presence of a little amount of unconjugated  BSA, suggesting a high reaction efficiency.  
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The unreacted aflatoxin M1-oxime has been completely removed by extensive dialysis of 
the reaction mixture using a cellulose membrane with a cutoff of 14000 Da.  
The immobilization of an antigen monolayer on the solid phase is crucial to obtain a good 
analytical  performance  of  the  assay,  in  particular  to  minimize  the  nonspecific  and 
uncontrolled binding. For this reason, the synthesis of the aflatoxin M1-BSA was optimized 
by increasing the initial concentration of aflatoxin M1 in the reaction mixture in order to 
achieve a high aflatoxin M1 to BSA molar ratio, thus obtaining a molecule that would work 
as a powerful immunogen and allow proper antigen immobilization. In fact, at a relatively 
high conjugation ratio, few BSA and a high number of aflatoxin M1 molecules are available 
at  the  well  surface  for  antibody  binding,  with  low  steric  hindrance.  This  facilitates  the 
antibody binding to aflatoxin M1, thus improving the kinetics of antibody-antigen reaction, 
being the phenomenon less affected by diffusion of the antibody to the antigen-coated well 
surface.  The  aflatoxin  M1-BSA  derivative  characterization  by  MALDI-TOF  analysis  was 
crucial  to  achieve  the  above-reported  analytical  performance  and  for  a  good  assay 
standardization.  
 
Optimization  of  the  Enzyme  Immunoassay.  Aflatoxin  M1-BSA  and  Anti-Aflatoxin  M1 
Antibody Concentration. Preliminary experiments were performed to assess the optimal 
coating  antigen/antibodies  ratio.  Aflatoxin  M1-BSA  and  anti-aflatoxin  M1  antibody 
concentrations  were  optimized  by  comparing  dose-response  curves  obtained  using 
different  combinations  of  antigen  (50,  100,  and  150  ng/mL)  and  antibodies  dilutions 
(1:30000, 1:40000, and 1:60000 v/v), according to an optimized experimental design. A 
satisfying  compromise  between  the  lowest  LOD,  the  highest  sensitivity  (slope  of  the 
curve), and the widest linear dynamic range was obtained by using a 150 ng/mL aflatoxin 
M1-BSA solution in the immobilization step and a 1:60000 (v/v) dilution of the antibody 
(Figure 1).  
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Figure  1:  Calibration  curves  obtained  using  various  dilutions  of  anti-AFM1  polyclonal 
antibody (■ 1:60000, ● 1:40000, ▼ 1:30000 v/v). The aflatoxin M1-BSA conjugate was 
immobilized at the optimal concentration (150 ng/mL), and the curves are expressed as 
relative light units (RLU) against the log of aflatoxin M1 concentration (ppt). 
 
Comparison  between  Colorimetric  and  CL  Detection.  The  optimized  CL  enzyme 
immunoassay was compared with a conventional colorimetric method. By comparing the 
dose-response curves shown in Figure 2, it can be observed that the CL method provided 
a lower detection limit with respect to the colorimetric assay (0.25 and 5 ppt, respectively). 
In addition, the CL method provided a lower midrange of the calibration curve, i.e., the 
concentration giving 50% of the response (30 ± 2 and 82 ± 5 ppt, respectively), as well as 
a higher dynamic range of linearity. The fact that the CL detection offered an improved 
analytical performance in terms of detectability and dynamic range is not surprising, due to 
the superior characteristics of the detection system, being the CL signal linear for up to 6 
orders of magnitude (Kricka, 1982). Moreover, because the detectability of HRP enzymatic 
activity  is  at  least  100-1000  times  higher,  the  CL  system  is  particularly  suitable  for 
microsystems characterized by very small reading volumes (e.g., 30 mL, as used in the 
developed method). A further advantage obtained by using the CL detection is the rapidity 
of the assay, since the CL signal can be measured immediately after substrate addition, 
while the colorimetric assay requires a 20-30 min incubation step, as well as an enzyme 
activity blocking step, prior to signal detection. Indeed, thanks to the glow type emission 
kinetics of the enhanced CL substrate, the steady state light emission is reached 2-3 min 
after substrate addition and it is maintained for at least 15 min, thus allowing easy handling 
and standardization of the experimental conditions. The CL signal can be recorded either 
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with a CCD imaging device or with a conventional photomultiplier tube-based microtiter 
plate reader. The imaging device allows simultaneously measuring the light signal in the 
384 wells of the microtiter plate, and with the same imaging instrument, it is possible to 
perform simultaneous measurement in up to four 384 well microtiter plates; in addition, 
thanks to the use of correction optics (flat field correction lenses), no major effects on the 
light path and geometry have been observed. The light output can be measured using 1 
min  exposure  time.  On  the  other  hand,  the  microtiter  plate  reader  offers  better 
performance  in  terms  of  detectability  (10  times  higher  than  the  CCD  imaging),  but  it 
requires  longer  measurement  times.  Usually  a  1  s  acquisition  time  for  each  well  is 
necessary, which results, also considering the time required to slide the wells under the 
photomultiplier  tube,  in  approximately  a  6  min  total  measurement  time  for  a  384  well 
microtiter plate.  
 
Figure  2:  Representative  calibration  curves  obtained  in  milk-based  buffer  with  the 
immunoassay method for aflatoxin M1 using the colorimetric (●) and CL (■) detection. The 
curves  are  expressed  as  fraction  of  bound  enzyme  activity  (B/Bo)  against  the  log  of 
aflatoxin M1 concentration (ppt). Each curve point and the SD associated with it are the 
result of an averaging of 10 standard curves obtained in six different days. 
 
Enzyme Immunoassay Format. CL detection allows the use of 384 well microtiter plates 
with an assay volume of 20 mL, which is at least five times lower than that used in the 
conventional 96 well microtiter plate format (Roda, 2000). A 5-fold reduction in antibody, 
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labeled probe, and CL cocktail volume reduces the costs of the assay, while maintaining 
the same analytical performance.  
Because of the very small volume of samples and reagents used in the analysis and to the 
high density of wells of the microtiter plate format, the use of an automated system to 
dispense  samples  and  reagents  is  essential  to  control  the  analytical  steps  and  the 
reproducibility of the overall analytical procedure. In addition, more compact devices can 
be used. The combination of a small incubation volume with rapidity and sensitivity of the 
CL  detection  of  the  probe  allowed  the  development  of  a  sensitive  and  low  cost 
immunoassay, with which more than one hundred samples may be analyzed in the same 
analytical session, thus representing an attractive method for high-throughput screening 
(HTS).  
 
Analytical  Performance.  Antibody  Specificity.  The  antibody  specificity  was  defined  by 
evaluating the extent of CR% with aflatoxin M1 structurally related compounds, such as 
aflatoxins M2, B1, B2, G1, and G2. In particular, for each compound, a calibration curve was 
produced  using  the  same  analytical  conditions,  and then,  the  CR%  was  calculated for 
each compound as follows: 
100
b
a
% CR =  
where b is the concentration of tested compound corresponding to B/B0 = 0.5 and a is the 
concentration of aflatoxin M1 corresponding to the same B/B0 value.  
The antibody used is highly specific for aflatoxin M1. Indeed, all other tested aflatoxins do 
not significantly cross-react (Table 1), since they are able to cause a potential interference 
only if present at a concentration 10-100 times higher than aflatoxin M1.  
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Table 1: CR% of some aflatoxin M1 related compounds with the anti-aflatoxin M1 antibody. 
 
AFLATOXIN  CR
a % 
Aflatoxin M1  100 
Aflatoxin M2  4 
Aflatoxin B1  2 
Aflatoxin B2  1 
Aflatoxin G1  0.5 
Aflatoxin G2  0.5 
 
a CR% = (ppt of aflatoxin M1 that leads to 50% binding inhibition/ppt of aflatoxin that leads to 50% binding 
inhibition) x 100. 
 
Matrix Effect. To evaluate milk matrix effect, aflatoxin M1 calibration curves produced in 
either buffer (PBS), skimmed milk, or full-cream milk were compared. In addition, serial 
dilutions  (2-16-fold  with  PBS)  of  a  milk  sample  spiked  with  aflatoxin  M1  at  a  high 
concentration (100 ppt) were assayed by interpolation on a calibration curve produced in 
buffer  and  the  observed  concentration  values  were  compared  with  the  expected 
concentrations. Because a significant matrix effect was observed by comparing calibration 
curves and no linearity was observed among different dilutions of the fortified aflatoxin M1 
sample,  a  calibration  curve  in  milk-based  buffer  is  needed  to  avoid  samples  cleanup. 
Being calibration curves obtained by preparing aflatoxin M1 standards in buffer containing 
commercial  nonfat  dried  milk  (incubation  buffer)  overlapping  with  those  prepared  in 
centrifuged milk, we used incubation buffer to prepare calibration curves. The use of this 
milk-based buffer allowed analyzing all kinds of milk samples without interference and with 
good reproducibility.  
 
Calibration Curves. Figure 2 shows a mean standard curve in incubation buffer, obtained 
by averaging 10 standard curves from six different days. The RSD% of individual points 
ranged from 4 to 10%. The best fitting of the curve was obtained by a nonlinear regression 
using a three parameters function. The relative standard deviation (RSD%) calculated for 
the YO, b, and c coefficient values was equal to 3.1, 6.5, and 4.1%, respectively, and the 
R
2 was 0.998 ± 0.002. The results obtained with 10 standard curves generated either in 
the same day or on different days demonstrated that the developed assay is reproducible 
and precise.  
 
LOD. The LOD was calculated by interpolation on the aflatoxin M1 standard curve, as the  
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analyte concentration corresponding to the mean signal of B0 (obtained by averaging the 
signal of six replicate sets) minus three times its standard deviation (SD) (according to 
IUPAC, ISO, and AOAC harmonized guidelines) (Thompson, 2002), and it was 0.25 ppt.  
LOQ.  The  LOQ,  defined  as  the  aflatoxin  M1  concentration  producing  a  signal 
corresponding  to  aflatoxin  M1-free milk minus  10  times  its  SD  (Thompson,  2002),  was 
determined by analyzing six replicate sets of aflatoxin M1 fortified milk samples ranging 
from 1000 to 1 ppt. The LOQ of the validated method in milk samples was 1 ppt that is 
more than 20 times below the legal limit for aflatoxin M1 in milk. In addition, the LOD and 
the  LOQ  of  the  developed  enzyme  immunoassay  were  lower  than  those  of  previously 
developed  immunological  methods  and  commercially  available  kits  for  aflatoxin  M1 
analysis in milk samples (Thirumala-Devi, 2002; Rodriguez Velasco, 2003; Fremy, 1984).  
Within Assay and between Assay Precision and Bias. The precision of the method was 
determined by analyzing replicates of aflatoxin M1 fortified milk samples, which contained 
a nominal aflatoxin M1concentration of 1 (low level), 10 (medium level), and 100 (high 
level) ppt. The assays were carried out in six replicates on the same day for the within 
assay  precision  evaluation  and  in  six  different  days  for  the  between  assay  precision 
evaluation. The values of the mean, SD, and RSD were calculated at each theoretical 
concentration level and are summarized in Table 2. The RSD (%) and recovery (%) values 
demonstrate that, even at the lower LOQ, the precision and accuracy of the method are 
suitable for routine screening of aflatoxin M1 in a very low milk sample volume.  
Stability of the Coated Plates. Coated plates were vacuum-dried and stored at 4° C  under 
vacuum.  Stability  of  the  antigen-coated  plates  was  investigated  by  comparing  six 
calibration  curves  obtained  using  plates  stored  at  either  0,  1,  3,  6,  or  8  months. 
Experimental data show that vacuum storage of the antigen-coated plates at 4° C for up to 
6 months did not significantly alter the performance of the assay in terms of LOQ and 
LOD.  
 
Accuracy. To evaluate the accuracy of the assay, three fortified milk samples, containing a 
nominal aflatoxin M1 concentration of 1, 10, and 100 ppt, as well as two certified reference 
materials, were analyzed. Results are summarized in Table 2. Recovery values ranged 
from 96 to 122%, thus indicating an excellent accuracy of the assay when applied to real 
samples.  
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Table 2: Precision and Accuracy calculated by analyzing replicate samples spiked with 1, 
10, and 100 ppt of aflatoxin M1, as well as certified reference materials
a. 
Expected 
concentration (ppt) 
Found 
concentration (ppt) 
RSD (%)  Recovery (%) 
  Within-assay (n=6)   
1  1.10 ± 0.07  6.3  110 ± 7 
10  9.72 ± 0.38  3.9  97.2 ± 3.8 
100  99.4 ± 2.5  2.5  99.4 ± 2.5 
  Between-assay (n=6)   
1  1.22 ± 0.10  8.1  122 ± 10 
10  9.63 ± 0.54  5.6  96.3 ± 5.4 
100  98.5 ± 3.2  3.2  98.5 ± 3.2 
  Certified Reference Materials   
760  745 ± 17.2  2.3  98.0 ± 2.3 
50  48 ± 1.2  2.5  96.0 ± 2.4 
 
 
aThe report data are the mean values ± SD 
 
Milk Samples Analysis. A total of 24 milk samples were analyzed with the newly developed 
immunoassay  method.  Three  fortified  milk  samples  prepared  at  three  aflatoxin  M1 
concentration levels (1, 10, and 100 ppt) were used in each microtiter plate as control. For 
each sample, four determinations were performed on different days and the results were 
compared with those obtained using the reference HPLC method.  
Concordant results were obtained with the two methods: 22 samples were positive for 
aflatoxin  M1,  and  only  two  samples  were  scored  as  negative  (the  aflatoxin  M1 
concentrations  detected  by  HPLC  were  approximately  0.8  and  0.5  ppt).  The  linear 
regression  analysis  (Figure  3)  yielded  a  good  correlation between  methods  (y  = 0.  
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98x + 1.71, r
2 = 0.98, n = 24), even if a higher scattering of the data was observed for 
samples with aflatoxin M1 concentration lower than 50 ppt.  
These results prove that the developed enzyme immunoassay method can be applied for 
the  analysis  of  aflatoxin  M1  in  milk  samples  of  different  kinds  at  levels  of  regulatory 
relevance, with accuracy and precision comparable to those obtained with the reference 
method.  The  developed  CL  enzyme  immunoassay  is  a  robust  and  simple  assay 
characterized by a high sensitivity and analytical throughput, thanks to the combination of 
the CL detection of enzymatic activity with the use of a 384 well microtiter format.  
In addition, the procedure can be easily automated using conventional instrumentation, 
easily available in laboratories where a continuous screening for aflatoxin M1 in milk is 
performed. In the future, the method will also be validated for the determination of aflatoxin 
M1 milk-derived dairy products, such as cheese and yogurt. The continuous growth of the 
production  of  organic  foods  potentially  increases  the  risk  of  aflatoxins  production  for 
uncontrolled mold growth when no chemicals and preservatives are used. Therefore, a 
sensitive, fast, first level control is highly recommended, and this can be achieved with the 
present HTS method based on a 384 well format. A HTS screening is useful for a routine 
quality control of milk from different farms before mixing the different milk bulks, especially 
when the absence of aflatoxin M1 above the regulatory limit needs to be documented.  
Figure 3: Correlation of results obtained by both CL enzyme immunoassay and reference 
HPLC method on milk samples. The linear regression analysis yielded a good correlation 
between methods (y = 0. 98x + 1.71, r
2 = 0.98, n = 24). 
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Abbreviation Used 
BSA, bovine serum albumin; LOQ, limit of quantification; LOD, limit of detection; HPLC, 
high-performance  liquid  chromatography;  CL,  chemiluminescent;  HRP,  horseradish 
peroxidase;  EDAC,  1-ethyl-3-(3-dimethylaminopropyl)  carbodiimide;  FCA,  Freud's 
complete adjuvant; PBS, phosphate-buffered saline; aflatoxin M2a, hemi-acetal aflatoxin M1 
derivative; CR%, cross-reactivity; CV%, coefficient of variation; SD, standard deviation; 
RSD%, relative standard deviation; HTS, high-throughput screening.   
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CHAPTER  6  -  A  rapid  multiplexed  chemiluminescent 
immunoassay  for  the  detection  of  Escherichia  coli  O157:H7, 
Yersinia  enterocolitica,  Salmonella  typhimurium,  and  Listeria 
monocytogenes pathogen bacteria.  
 
A simple and rapid multiplexed sandwich chemiluminescent enzyme immunoassay has 
been  developed  for  the  simultaneous  detection  of  Escherichia  coli  O157:H7,  Yersinia 
enterocolitica,  Salmonella  typhimurium,  and  Listeria  monocytogenes.  To  achieve  the 
multiplexed detection of the four pathogens, a new polystyrene 96-well microtiter plate 
format has been designed, in which each main well contains in the bottom four sub-wells. 
The monoclonal antibodies specific for each bacteria were separately immobilized in the 
bottom of each sub-wells. When the samples were added to the main wells the bacterial 
able to specifically bind to the corresponding monoclonal antibody were captured in one of 
the four sub-wells. Subsequently, a mixture of peroxidase-labeled polyclonal antibodies 
against the four bacteria was added and the peroxidase activity of the bound polyclonal 
labeled  antibodies  in  each  well  was  measured  by  an  enhanced  luminol-based 
chemiluminescent cocktail using a low-light CCD imaging device. The assay was simple 
and fast and the limit of quantification was in the order of 10
4-10
5 CFU/mL for all bacterial 
species.  The  accuracy  of  the  method,  evaluated  by  comparison  the  results  with  a 
conventional culturing methodology was satisfactory, with recovery values ranging from 90 
to 120%. This method can be used as a screening test to evaluate the presence of these 
pathogen bacteria in different foodstuff. 
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6.1 Introduction 
 
Bacterial food-borne pathogens are a serious health threat worldwide. The World Health 
Organization (WHO) estimates that diarrhea-related diseases caused by the consumption 
of  contaminated  food  or  water  are  the  third  leading  cause  of  death  in  the  developing 
countries  (Mead,1999;  World  Health  Organization,  2002),  and  the  socio-economic 
implications of gastroenteritis are a major concern. Salmonella typhimurium, Escherichia 
coli  O157:H7,  Staphilococcus  aureus,  Clostridium  perfringens,  Campylobacter  jejuni, 
Yersinia  enterocolitica  and  Listeria  monocytogenes  are  the  major  bacterial  pathogens 
commonly  involved  in  foodborne  illnesses  (Institute  of  Food  Technologists,  2004). 
Therefore,  the  production  of  high  quality,  pathogen-free  food  and  the  assessment  of 
bacteria growth when foods and other biological materials are stored under inappropriate 
conditions  represent  priorities  for  the  agro-food  industry.  In  addition,  bacteria 
contamination is a matter of concern related to terrorist attack.  
Despite  the  continuous  improvements,  conventional  microbiological  methods  for  the 
detection and identification of pathogenic bacteria in food are still labor-intensive and time-
consuming (Vasavada, 1997) and therefore, the search for fast, accurate and sensitive 
alternative  methods  is  an  active  research  task  (Feng,  2001;  de  Boer,  1999;  Deisingh, 
2004). 
Immunological  methods  for  detecting  pathogenic  microrganisms  have  been  extensively 
studied since they potentially combine detection specificity and sensitivity with simple and 
economical  assay  format.  Most  of  commercially  available  immunoassay  for  bacteria 
detection  are  based  on  standard  sandwich  immunoassay  (Chapman,  1997),  which 
involves the formation of an immunocomplex between an immobilized antibody, the target 
bacteria and a secondary labelled antibody. Generally, the primary antibody is immobilized 
on  beads  (magnetic,  silica  or  gold  particles),  polystyrene  microtiter  plates,  filter 
membranes  or  directly  on  the  surface  of  transducers,  and  the  secondary  antibody  is 
labeled  with  enzymes  or  fluorescent  molecules.  The  detection  limits  of  immunoassays 
ranged  between  10
3–10
6  colony-forming  units  (CFU)/mL,  with  assay  times  from  ten 
minutes to several hours (Kerr, 2001; Blais, 2004).  
More recently, many interesting approaches have been reported in order to improve the 
immunoassay  detectability.  For  example,  Zhao  and  coworkers  (Zhao,  2004)  used 
antibody-conjugated silica fluorescent nanoparticles to develop a fast and ultrasensitive 
immunoassay  for  in  situ  pathogen  quantification  down  to  a  single  bacterium  without  
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amplification or enrichment. Unfortunately, most of these tests are expensive, laborious 
and often require specialized personnel and instrumentation. 
As  an  alternative,  DNA  microarray  technology  has  been  exploited,  which  allows 
simultaneous  detection  of  several  bacteria  but  the  construction  of  DNA  arrays  are  still 
limited to a restricted number of specialized centers (Garaizar, 2006). 
“Multiplex”  format  immunoassays  suitable  for  the  simultaneous  evaluation  of  different 
bacteria  in  a  sample  can  be  developed  to  increase  the  analytical  productivity  and 
drastically reduce analysis costs and sample and reagent consumption (Dunbar, 2003; 
Bhagwat,  2003).  Feasibility  studies  of  “multiplex”  immunometric  methods  in  microarray 
format, either “sandwich” or, more recently, competitive type (Delehanty, 2002; Kim, 2005) 
have been already reported, but none of them has been applied for detection of bacteria. 
In  this  work  we  report  the  development  of  a  simple,  multiplexed  sandwich 
chemiluminescent enzyme immunoassay (CL-EIA) for the simultaneous detection of four 
of  the  major  food-borne  pathogens:  Escherichia  coli  O157:H7,  Yersinia  enterocolitica, 
Salmonella typhimurium, and Listeria monocytogenes. 
Polyclonal  and  monoclonal  antibodies  were  produced  by  immunizing  rabbit  or  balb/c 
mices, respectively, with heat-inactivated and sonicated ATCC bacteria strains of the four 
pathogens. 
To achieve the simultaneous detection of the four pathogens, a new polystyrene 96x4-well 
microtiter  plate  format  was  designed.  The  microtiter  plate,  which  has  a  conventional 
12.8x8.6 cm frame size, consists of 96 main wells, each of them containing four internal 
sub-wells.  
The developed method involves the immobilization of four monoclonal antibodies, each 
specific for one bacterium, in the bottom of the different sub-wells of the main well. When 
the samples, were added to the main well and incubated, the bacterial cells were captured 
in one of the four sub-wells by the corresponding monoclonal antibody. Subsequently, a 
mixture of peroxidase (HRP)-labeled polyclonal antibodies was added and the peroxidase 
activity  was  determined  by  means  of  an  enhanced  luminol-based  chemiluminescent 
substrate. The light emitted was measured with an ultrasensitive, cooled low-light CCD 
imaging device. Chemiluminescence is particularly suited for these applications since the 
chemiluminescent signal is characterized by high detectability and specificity, fast kinetics 
and low background. In addition, CL detection techniques allow to localize and quantify the 
light emission on each sub well down to single-photon level (Roda, 2004). 
The  analytical  performances  of  the  method  in  term  of  specificity  and  its  preliminary 
validation will be discussed by comparison with conventional microbiological procedures.  
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For method application and validation, a total of 32 naturally contaminated faecal and meat 
samples have been analyzed. 
 
6.2 Materials and Methods 
 
Bacterial  strains.  Escherichia  Coli  O157:H7  ATCC  35150  (American  Type  Culture 
Collection Rockville, MD), Salmonella thyphimurium ATCC 14028, Yersinia enterocolitica 
ATCC 23715 and Listeria monocytogenes 13M ATCC 7644 were used for polyclonal and 
monoclonal (MAb) antibodies production and as positive control for antibodies screening. 
The specificity of each antibody was evaluated both against different bacterial species and 
other wild-type strains of the target bacteria. The bacteria used were either obtained by 
ATCC or kindly provided by the Istituto Zooprofilattico of Teramo. Stock cultures in 30 % 
glycerol were maintained frozen
 at -80° C. 
Monoclonal antibody production. Monoclonal antibodies were produced by immunizing 
Balb/c  mice  using  a  slightly  modified  published  protocol  (He,  1996).  Briefly,  heat-
inactivated  and  sonicated  ATCC  reference  strains  were  diluted  in  Freud’s  incomplete 
adjuvant (IFA) (Sigma Chemical Co., St. Louis, MO) to obtain a protein concentration of 50 
mg/mL and inoculated by intraperitoneal injection. The mice received their second injection 
at two weeks, two inoculations of 25 mg/mL were then administered. A booster injection of 
50 mg/mL was given 31 days after immunization, then the mice were sacrificed and the 
spleen  cells  were  fused  with  myeloma  cells.  Cell  fusion  and  hybridoma  cloning  were 
performed  using  Galfre’s  method  (Galfre,  1981)  with  some  modifications.  Briefly, 
splenocytes from the immunized mice were subjected to cell fusion with myeloma cells 
from  Sp2/O-Ag-14  mice  (American  Type  Culture  Collection  Rockville,  MD)  using  50% 
polyethylene  glycol  (PEG)  1550  solution.  Hybridomas  were  cultured  for  two  weeks  in 
Dulbecco’s  modified  Eagle’s  medium  (DMEM,  Sigma  Chemical  Co.,  St.  Louis,  MO) 
containing  20%  foetal  bovine  serum  (Euroclone,  UK),  2  mM  L-glutamine  (HybriMax®, 
Sigma  Chemical  Co.,  St.  Louis,  MO),  amphotericinpenicillin-streptomycin  100x  (APS, 
Sigma  Chemical  Co.,  St.  Louis,  MO),  50  mg/mL  gentamicin  (Gentamicin  Sulphate 
Solution, Sigma Chemical Co., St. Louis, MO), 10000 UI/mL nystatin (Nystatin suspension 
HybriMax
®, Sigma Chemical Co., St. Louis, MO) and HAT 50x (HAT Media supplement 
HybriMax
®, Sigma Chemical Co., St. Louis, MO). The hybridomas of interest were cloned 
by limiting dilution method (Campbell, 1987; Goding, 1993). MAbs were produced in vitro  
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on large scale by serial culturing of antibody-secreting hybridomas and collection of their 
supernatants.  
The cell culture fluids from actively growing hybridomas were screened using an indirect 
ELISA procedure against other isolated strains of the target bacteria and different bacteria 
species. Briefly, the hybridoma culture media, properly diluted, was added to well plate 
previously coated with the immunizing antigen. The plate was then incubated for 30 min at 
37° C  and,  after  washes,  HRP-labeled  anti  mouse  anti body  (purchased  from  Sigma, 
Chemical Co. St. Louis, MO) was added. The HRP activity was measured by adding a 
chromogenic  substrate  (TMB,  KPL,  Gaithersburg,  MD).  After  incubation,  the  enzymatic 
reaction was stopped with 2N H2SO4 and the absorbance at 450 nm was recorded using a 
Multiskan EX spectrophotometer microtiter reader (Labsystems, Helsinki, Finland). 
MAbs were screened in Immuno Western-blotting (Laemmli, 1970) and the MAb isotype 
was determinate with an isotyping kit (Pierce, Rockford, IL). IgG MAbs were purified by 
affinity chromatography using a protein A column (HiTrap rProtein A FF, 5 mL, Amersham 
Biosciences, Arlington Heights, IL) according to the manufacturer’s instructions. Protein 
concentration was determined by using a Bradford assay.  
 
Polyclonal antibody production. Polyclonal antibodies against the target bacteria were 
produced in rabbit following a previously described protocol (Harlow, 1988). Briefly, heat 
inactivated  and  sonicated  ATCC  reference  strains  were  diluted  in  Freud’s  complete 
adjuvant (FCA) (Sigma Chemical Co., St. Louis, MO) to a protein concentration of 200 
mg/mL and subcutaneously injected six times over 50 days. Antiserum with adequate titre, 
affinity, and specificity were obtained 3-4 months after the first immunization. The IgG-rich 
fraction  was  purified  using  the  same  procedure  for  IgG  MAb  purification.  Polyclonal 
antibodies were coupled to HRP (Sigma Chemical Co., St. Louis, MO) using the periodate 
method (NaKane, 1974). Quantitative chemiluminescent enzyme immunoassay. Microtiter 
plate format. To achieve the simultaneous detection of the four pathogens in the same 
sample a new polystyrene 96x4-well microtiter plate format was developed (Figure 1A). 
The microtiter plate consists of 96 main wells (volume 100 mL), each of them divided into 
four internal sub-wells. The presence of several sub-wells within the main well allows the 
immobilization  of  different  monoclonal  antibodies  in  separate  positions  (Figure  1B).  In 
addition, the plate has a standard frame size (12.8x8.6 cm) and can therefore be used with 
commercially  available  automation  systems  and  robotics  for  reagent
  dispensing, 
incubation, and washing steps.  
Two different prototypes, in black or white polystyrene, were produced. A similar microtiter  
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plate  but  with  7  subwells  have  been  already  used  by  us  to  develop  a  PCR-
chemiluminescent immunoassay method for the detection of seven most frequent high-risk 
Papillomavirus DNAs (Roda, 2002). 
 
Calibration Curves. Calibration curves were obtained using a mixture of the four bacteria. 
In particular, universal peptone broth (UPB) (Nam, 2004; Bailey, 1992) (Difco Laboratories, 
Detroit, MI) was inoculated with a mixture of the four bacteria, then incubated for 12-18 h 
at 37° C. An aliquot (2 mL) of cells suspension in U PB was centrifuged at 3000g for 10 min, 
the supernatant was carefully removed and the pellet was washed twice with phosphate-
buffered saline (PBS). Washed bacteria were diluted in PBS to give a 10
9 CFU/mL cell 
concentration(corresponding to an OD600 approximately of 0.8). The bacteria were then 
serially diluted in PBS to obtain suspensions in the range from 10
8 to 10
2 CFU/mL (total 
cell concentration), which were used as standards in CL-EIA method. For each dilution, 
the  actual  concentration  (CFU/mL)  of  each  bacterium  was  determined  by  colonies 
counting  on  selective  media  agar  plates.  The  obtained  CFU/mL  values  were  used  for 
calibration curve plots. Each calibration curve consist in seven points in the range from 10
3 
to 10
7 CFU/mL.  
 
Samples.  Spiked  human  faecal  and  bovine  meat  samples  were  used  to  evaluate  the 
analytical  performance  and  the  applicability  of  the  multianalyte  CL-EIA  method  for  the 
detection of bacteria. 
Faecal (obtained from healthy volunteers) and bovine meat (purchased from local food 
stores)  samples  were  previously  assayed  with  conventional  procedures  to  verify  the 
absence of the four bacteria. Then, they were divided in two portions: one portion was 
used as negative control and one was artificially contaminated with the four pathogens, 
alone or in combination, by using previously reported methods (Chandler, 2001; Ferretti, 
2001). The samples (25g) were inoculated with the appropriate amount of bacteria (final 
concentration of each species ranging from 1 to 100 CFU/g), homogenized in a stomacher 
bag  and  incubated  with  225  mL  of  buffered  peptone  water  (BPW)  for  3h  at  37° C. 
Subsequently, 1 mL of suspension was removed and incubated with 9 mL of UPB for 6 h 
at  37° C  with  shaking,.  then  assayed  using  the  CL-EI A  method.  For  each  sample  the 
bacteria concentration was also verified by using a conventional microbiological reference 
method.  
For validation of the newly developed CL-EIA method, we tested a total of 32 naturally 
contaminated  faecal  and  meat  samples  for  the  presence  of  the  four  bacteria,  and  the  
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results were compared with those obtained using a reference microbiological method. 
 
Multiplexed  chemiluminescent  enzyme  immunoassay  procedure.  The  four  MAbs, 
specific for each bacteria species, were immobilized in the different sub-wells of the main 
well.  In  particular,  10  mL  of  a  300  ng/mL  antibody  solution  in  coating  buffer  (0.05  M 
carbonate/bicarbonate buffer solution pH 9.6) were dispensed in
 each individual sub-well 
and the plates were incubated overnight at 4° C. Aft er washing with washing buffer (PBS 
containing  0.05%  Tween  20),  100  mL  of  blocking  solution  (PBS  containing  1%  bovine 
serum albumin)
 was added to each main well, and the plates were further incubated at 4° C 
for 2 h. The solution was discarded and the plates were washed three times with washing 
buffer and vacuum dried. The plates were either used immediately or sealed in plastic 
bags together with a 5-g package of silica
 gel desiccant (Sigma) and stored at 4° C until 
use. 
To  perform  the  assay,  100  mL  of  enriched  sample  suspension  or  bacteria  standard 
solutions were added to each main well of the microtiter plate and incubated for 30 min at 
37° C.  During  the  incubation  the  bacterial  cells  in  the  sample  were  captured  by  the 
corresponding MAb in one of the four sub-wells. After three washing, 100 mL of a mixture 
of the HRP-labeled polyclonal antibodies specific for the four bacteria species were added 
and incubated for 30 min at 37° C. The HRP activity  of the bound labeled antibodies was 
measured,  after  washing,  by  means  of  an  enhanced  luminol-based  CL  substrate 
(SuperSignal ELISA Femto, Pierce, Rockford, IL) and an imaging device (LB 981 Night 
Owl,  EG&G  Berthold,  Pforzheim,  Germany),  which  employs  a  highly  sensitive,  back-
illuminated, cooled CCD camera. Images were acquired using a 40-s exposure time and 
the CL signal of each sub-well was measured by integrating the photon emission over the 
sub-well area.  
Before data analysis, the blank signal was subtracted from all the sample and calibration 
curve signals (CL intensity). The concentration of each bacterium was then determined by 
interpolation on the calibration curves obtained using bacteria standard solutions. 
 
 
 
 
 
  
89 
6.3 Results and Discussion 
 
Monoclonal antibodies screening. The peculiarity of the monoclonal antibodies used in 
this study was their ability to recognize all the strains of the four target bacteria without any 
cross-reactivity with the other bacteria species tested. 
Approximately 3600 hybridoma supernatants were obtained and tested for each bacteria. 
Among  these,  200-400  clones  showed  positive  reaction  to  the  four  target  bacteria  by 
indirect ELISA test. Subsequently, a further ELISA screening with other bacterial antigens 
led to the identification of four MAbs (8B8C3, 54B11, 1B6D9 and 6F12C8) reacting with 
Escherichia  coli  O157:H7,  Yersinia  enterocolitica,  Salmonella  typhimurium  and  Listeria 
monocytogenes, respectively, and showing no cross-reaction to any other bacteria used in 
this study (Table 1 and Table 2). These MAbs, which were identified as IgG1 isotypes, 
were  used  for  the  development  of  the  CL-EIA  method. The  anti-Yersinia  enterocolitica 
monoclonal antibody was also used in a previously published work (Magliulo, 2006).  
90 
Table 1: Monoclonal antibody cross-reactions with various bacterial antigens evaluated by 
indirect ELISA.The percentage of cross reaction (CR%)  was calculated by dividing the 
OD450 value of each bacteria by the OD450 for the target bacteria. 
 
 
 
 
 
 
Bacterium  Source 
MAb 
8B8C3 
MAb 
54B11 
MAb 
1B6D9 
MAb 
6F12C8 
    CR%  CR%  CR%  CR% 
Escherichia           
E.coli O14  BGVV  2.1  1.1  2.2  1.1 
E.coli  ATCC 25922  1.2  2.1  2.2  1.2 
E.coli O157:H7  ATCC 35150  100  1.1  2.3  1.3 
E.coli O157:H7  Wild type strain  97  1.1  2.4  1.4 
E.fergussoni  Wild type strain  1.1  2.4  2.1  1.2 
Listeria           
L.innocua  ATCC 33090  3.1  1.3  3.1  4.3 
L.ivanovii  ATCC 19119  1.3  2.3  1.1  3.5 
L.monocytogenes  ATCC 7644  1.2  1.2  1.1  100 
L.monocytogenes  Wild type strain  1.3  1.3  1.2  97 
Salmonella           
S.bredeney  Wild type strain  2.1  1.1  3.4  2.1 
S.derby  Wild type strain  1.2  3.4  3.3  2.1 
S.enteritidis  ATCC 13076  1.1  2.2  2.3  2.2 
S.enteritidis  Wild type strain  2.1  3.2  1.2  2.2 
S.hadar  Wild type strain  1.2  2.3  1.1  2.3 
S. muenchen  Wild type strain  1.2  2.3  1.5  2.3 
S.panama  Wild type strain  1.2  2.2  1.2  2.3 
S. saint-paul  Wild type strain  0  1.2  1.2  2.1 
S.typhimurium  ATCC 14028  0  1.1  100  2.1 
S.typhimurium  Wild type strain  1.5  1.1  99  2.1 
Yersinia           
Y.enterocolitica  ATCC 23715  3.1  100  1.1  3.2 
Y.enterocolitica  Wild type strain  3.1  98  1.1  3.4  
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Table 2: List of other bacterial stains screened by indirect ELISA. The percentage of cross 
reaction (CR%) was calculated by dividing the OD450 value of each bacteria by the OD450 
for the target bacteria. 
 
 
 
Bacterium  Source  MAb 8B8C3  MAb 54B11  MAb 1B6D9  MAb 6F12C8
    CR%  CR%  CR%  CR% 
Bacillus           
B.cereus  ATCC 11778  1.1  1.3  1.2  1.1 
B.cereus  Wild type strain  2.2  2.3  1.3  1.2 
B.subtilis  Wild type strain  1.1  1.3  0  1.3 
Bordetella           
B.bronchiseptica  Wild type strain  1.1  1.2  1.2  2.1 
Citrobacter           
C.freundii  Wild type strain  1.1  1.3  1.2  1.2 
Enterobacter           
E. agglomerans  Wild type strain  0  2.3  2.2  1.1 
E.amnigenus  Wild type strain  2.2  2.3  2.3  1.1 
E.cloacae  Wild type strain  1.1  2.2  2.1  1.2 
E.faecium  Wild type strain  1.1  1.5  2.2  1.1 
Klebsiella           
K. Oxytoca  ATCC 49131  1.2  1.3  0  1.1 
K.pneumoniae  Wild type strain  1.2  2.4  0  1.1 
Proteus           
P. vulgaris  ATCC 49132  0  1.2  1.2  1.2 
Pseudomonas           
P.aeruginosa  Wild type strain  1.4  1.3  1.2  1.2 
Shigella           
S. flexneri  ATCC 12022  1.3  1.3  2.2  2.3 
Staphylococcus           
S.aureus  ATCC 25923  3.2  2.3  2.1  2.2 
S.epidermidis  Wild type strain  1.5  2.4  1.1  2.2 
Brucella           
B.abortuss train 99  Wild type strain  1.5  1.2  2.2  1.1 
B.melitensisisb biotype 1  Wild type strain  0  1.2  2.1  2.1 
B. abortus RB51  Wild type strain  1.5  1.4  2.2  1.1 
B.melitensisis biotype 2  Wild type strain  2.2  1.3  2.1  1.2 
B.melitensis biotype 3  Wild type strain  0  1.3  2.1  1.2  
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CL-EIA method. MAbs and HRP-labeled polyclonal antibodies concentrations. Preliminary 
experiments were performed to evaluate the optimal concentration of the four MAbs and 
the  HRP-labeled  polyclonal  antibodies.  Antibody  concentrations  were  optimized  by 
comparing dose-response curves obtained using different initial concentrations of MAbs 
(300,  400  and  600  ng/mL)  and different  dilutions  of  HRP-labeled  polyclonal  antibodies 
(1:40000,  1:60000,  1:80000  v/v),  according  to  an  optimized  experimental  design.  A 
satisfying  compromise  in  terms  of  linearity  of  the  dose–response  curve  and  limit  of 
detection was obtained by using a MAb concentration of 300 ng/mL in the immobilization 
step and a 1:60000 (v/v) HRP-policlonal antibody dilution in the detection step. 
Detection system. The developed CL-EIA assay allows to recognize simultaneously the 
four  target  bacteria  thanks  to  the  specificity  of  each  antibody  pair  and  the  use  of  an 
imaging detection technique based on an ultrasensitive CCD camera. 
A typical CL signal obtained using the new microtiter plate format is shown in Figure 1C: 
the emission signal is well-localized in the sub-wells, thus allowing the quantification of the 
signal of each sub-well by integrating the CL emission over the entire sub-well area (Roda, 
1998).  
Thanks to the spatial resolution of the imaging system and the high detectability of the 
HRP label enzyme by CL, the sensitive and rapid quantification of each bacterial species 
was performed in low reaction volumes without any interference of the CL signal among 
adjacent sub-wells even in presence of signals with different intensities. This assay format 
thus  prevents  cross-talk
  phenomena,  which  have  been  observed,  for  example,  in 
microarray systems (Ekins, 1998; Nielsen, 2004). In addition, because of the standard
 size 
of the plate, the measurement could be also performed
 in conventional microtiter plate 
luminometers with a custom programming
 of the xy position of the wells. However, the
 
sequential reading of all the sub-wells could require as long as
 2–5 min, depending on the 
signal integration time for each well, whereas an imaging device allows the simultaneous
 
measurement of the whole plate. Therefore, in the case of sequential measurements
 one 
would  have  to  check  the  constancy  of  the  light  output  over
  the  entire  period  of 
measurement, especially for high CL signals. 
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Figure 1: (A) Live image of the new 96x4-well microtiter plate. The plate contains 96 main 
wells, each of them divided into 4 sub-wells. (B) Position of the immobilized antibodies 
within each sub-well. (C) Chemiluminescent image of the microtiter plate obtained after a 
40-s exposure time (the position of standards and samples within the plate is also shown). 
 
 
 
Calibration curve. The calibration curves (Figure 2) obtained for the four bacteria were 
linear in the range between 10
4 and 10
7 CFU/mL and the relative standard deviation (RSD) 
of individual points ranged from 3% to 9%. The quantification limit (LOQ), calculated as the 
bacteria concentration giving a signal equal to the mean signal of negative controls plus 
ten times their standard deviations, were in the range 10
4-10
5 CFU/mL. 
Different  incubation  times  and  temperatures  were  also  examined  and  the  best 
performance was obtained when each incubation step was performed for 30 min at 37° C. 
Longer incubation times did not produce any significant improvement in the performance 
of the immunoassay. 
Within-assay and between-assay precision. The precision of the method was determined 
by analyzing replicates of meat and faecal samples spiked with the four target bacteria at 
three different concentrations: 1 (low level), 10 (medium level), and 100 (high level) CFU/g 
of  each  bacteria.  The  bacteria-fortified  samples  were  analyzed  after  enrichment  in  six 
replicates and in four different days to evaluate the within-assay and the between-assay  
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precision. Standard bacteria suspensions with initial concentrations ranging from 1 to 200 
CFU/mL of each bacteria were also subjected to enrichment to obtain calibration curves 
for assessing the initial concentration of pathogens in the spiked samples. The results 
obtained for Escherichia coli O157:H7 (mean and relative standard deviation calculated at 
each  theoretical  concentration  level)  are  summarized  in  Table  3.  Both  the  within-  and 
between-assay  relative  standard  deviations  were  below  15%.  Similar  results  were 
obtained for all the other bacteria species tested. 
Stability of the coated plates. Stability of the antibody-coated plates (vacuum dried and 
stored at 4° C) was investigated by comparing five c alibration curves obtained using plates 
stored either zero, one, three, six, or eight months. Experimental data show that storage of 
the antibody-coated plates up to six months did not significantly alter the performance of 
the assay in terms of limit of detection. 
 
Method  validation.  A  total  of  32  naturally  contaminated  faecal  (16)  and  meat  (16) 
samples  were  analyzed  for  the  presence  of  the  four  target  bacteria  with  both  the 
developed CL-EIA method and the reference microbiological method. No false negative or 
false positive results were observed and for all samples the bacteria strains detected using 
the  CL-EIA  method  corresponded  to  those  revealed  by  the  microbiological  reference 
method. In addition, there was a good agreement between the bacteria concentrations 
determined with the CL-EIA method and those measured with the microbiological one, as 
demonstrated by the recovery values ranging between 90 and 120%. 
The  obtained  results  prove  that  the  newly  developed  CL-EIA  method  allows  the 
simultaneous quantification of four pathogen bacteria in a given sample with accuracy and 
precision comparable to those achievable with the conventional microbiological methods. 
In  addition  the  multiplexed  assay  format  allows  reducing  assay  time  and  sample  and 
reagents  consumption  with  respect  to  conventional  single-analyte  immunoassays  and 
classical  culture  microbiology  procedures.,  Other  multiplexed  assays  could  be  also 
developed using the same approach i.e. by customizing the plate layout to divide each 
main well in the required number of sub-wells. 
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Figure 2: Representative calibration curves, obtained by averaging ten standard curves 
obtained  in  different  days,  for  the  determination  of  (A)  Escherichia  coli  O157:H7,  (B) 
Listeria monocytogenes, (C) Salmonella typhimurium and (D) Yersinia enterocolitica using 
the CL-EIA method. The curves are expressed as relative light units (RLU) against the 
bacteria concentration (CFU/mL). 
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Table  3.  Precision  of  the  CL-EIA  method.  The  table  reports  the  results  obtained  for 
Escherichia coli O157:H7 spiked meat samples. The values are expressed as CFU/g. 
 
Sample 
concentration 
(CFU/g) 
Found concentration 
(CFU/g) 
Mean ± SD 
RSD (%) 
Within-assay (n=6) 
1  1.10 ± 0.09  8.2 
10  9.72 ± 0.82  8.4 
100  99.2 ± 7.5  7.6 
Between-assay (n=6) 
1  1.22 ± 0.16  13.1 
10  9.33 ± 1.24  13.3 
100  99.5 ± 11.2  11.2 
 
 
 
Abbreviations used  
LOQ, limit of quantification; CL, chemiluminescent; HRP, horseradish peroxidase; CL-EIA, 
chemiluminescent enzyme immunoassay; FCA, Freud’s complete adjuvant; IFA, Freud’s 
incomplete  adjuvant;  MAb,  monoclonal  antibody;  UPB,  universal  peptone  broth;  PBS, 
phosphate-buffered saline; BPW, buffered peptone water; SD, standard deviation; RSD%, 
relative standard deviation; CFU, colony-forming units; RLU, relative light units; CR, cross 
reaction. 
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CHAPTHER – 7 An innovative, flow-assisted, non-competitive 
chemiluminescent  immunoassay  for  the  detection  of 
pathogenic bacteria. 
 
Flow-assisted  immunoassays  offer  several  advantages  with  respect  to  conventional 
microtiter solid-phase format immunoassays, including faster kinetic of the immunological 
reaction and easier automation. This study describes the implementation of gravitational 
field-flow fractionation (GrFFF) for the development of an innovative, non-competitive CL 
enzyme immunoassay for the detection of intact pathogenic bacteria in biological samples. 
Yersinia enterocolitica was chosen as model analyte. A peroxidase-labeled monoclonal 
antibody is added to the sample containing the bacteria, and the mixture is immediately 
injected into the GrFFF channel where the immunological reaction takes place. After 30 
min incubation, the free and bacterium-bound antibody fractions are separated by GrFFF 
in 15 min. The activity of the peroxidase-labeled bound fraction is online measured by a 
flow-through  chemiluminometer,  following  post-channel  infusion  of  an  enhanced 
H2O2/luminol-based  CL  substrate.  Calibration  was  performed  on  standard  bacteria 
suspensions and the method was validated on faecal samples. The detection limit of the 
method was 10
6 CFU/mL, and calibration curves were linear in the range between 10
5 and 
10
7 CFU/mL. Both run-to-run and day-to-day RSD were always ≤ 15%. Accuracy of the 
method was evaluated by comparing the results with those obtained with a conventional 
culturing method on selective media, and sample recovery resulted to be in the 90-120% 
range. The assay shows analytical performance that is similar that of to a microtiter plate 
format  with  a  cost  reduction  and  a  shorter  analysis  time  since  the  antibody  is  not 
immobilized, and only a single monoclonal antibody is needed for the detection of one 
bacterial species.  
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7.1 Introduction 
 
Each year, as many as 80 million cases of foodborne illness, caused by the consumption 
of  contaminated  food  or  water,  occur  in  the  United  States.  It  is  acknowledged  that 
approximately 30% of these cases are caused by bacteria and their related toxic products 
(Mead,  1999; World  Health  Organization,  2002).  The  bacteria  species  most  frequently 
responsible  for  food  contamination  are  Salmonella  typhimurium  (meat,  milk,  eggs), 
Escherichia coli O157:H7 (meat), Staphylococcus aureus (milk cream, meat), Clostridium 
perfringens  (sausages,  preserved  food),  Campylobacter  jejuni  (poultry,  eggs),  Vibrio 
parahaemolyticus  (shellfishes),  Yersinia  enterocolitica  (meat,  milk)  and  Listeria 
monocytogenes (dairy products) (Institute of Food Technologists, 2004). 
Conventional  microbiological  methods  for  the  identification  of  pathogenic  bacteria  are 
labor-intensive  (several  enrichment  steps)  and  time-consuming  (two  to  three  days  to 
obtain  results)  (Vasavada,  1997).  Currently,  new  rapid  procedures  based  on 
immunological,  DNA  hybridization  or  biosensing  methods  have  been  proposed 
(Bohaychuk, 2005; Deisingh, 2004). However, many of these rapid tests are expensive, 
laborious, and all of them are based on cultural enrichment to enhance sensitivity and 
selectivity before analysis. Simpler, faster and more sensitive diagnostic techniques are 
then  required  to  improve  food  safety  (food  production,  processing,  storage  and 
distribution) and to screen for potential bacterial infections in humans. Several immuno-
based detection methods for infectious agents have been recently developed (Kerr, 2001; 
Chapman, 1997). Such methods are of great diagnostic importance because they offer 
unique  detection  specificity  and  sensitivity,  with  relatively  simple  and  low-cost  assay 
formats. Most commercially available immunological methods for the detection of bacteria 
are based on conventional sandwich immunoassays, which involve the formation of an 
immunocomplex  with  an  immobilized  antibody,  the  target  bacteria,  a  second  labeled 
antibody,  and  the  separation  of  free  and  bound  antibody  fractions  by  washing  steps. 
Unfortunately,  these  separation  steps  reduce  the  assay  productivity,  so  alternative 
approaches are welcome. 
In  general,  flow-assisted  immunoassays  offer  advantages  with  respect  to  conventional 
microtiter  solid-phase  format,  mainly  related  to  a  faster  kinetic  of  the  immunological 
reaction, and to an easier automation (Bao, 1997; Bilitewski, 2003). The kinetic of reaction 
is fast because the immunological reaction takes place in a pseudo-homogenous phase, 
that is the antibody is not immobilized on a bulk surface. 
Field-flow  fractionation  (FFF)  is  an  analytical  technique  suited  for  the  
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separation  of  nano-  and  microsized  dispersed  analytes  (Shimpf,  2000).  Separation  is 
achieved through a relatively simple device, i.e. within an empty capillary channel by the 
combined action of a transporting laminar flow and a field applied perpendicularly to the 
flow. According to their physical features (size, density, surface properties, etc.), analyte 
particles are distributed at different positions within the parabolic flow profile, and are thus 
swept  down  the  channel  at  different  velocities,  i.e.  they  are  eluted  at  different  times 
(Reschiglian,  2005).  Recently,  we  proposed  a  flow-assisted,  competitive  immunoassay 
format based on flow FFF with chemiluminescent (CL) detection of microsized beads with 
immobilized antibodies (Roda, 2005). This new format did not require washing steps to 
separate free and bound tracer, which was quantified from void-peak and retained-peak 
area measurements, respectively.  
In this work we report the implementation of gravitational FFF (GrFFF), the simplest FFF 
variant that employs Earth’s gravity as the applied field, into an innovative whole-cell CL 
enzyme immunoassay format for the detection of pathogenic microorganisms in biological 
samples.  The  method  combines  the  high  sensitivity  of  CL  detection  with  the  GrFFF 
separation  capabilities  of  able  to  efficiently  separate  the  bound  bacterium-antibodies 
complex from the free antibodies. The immunoassay employs a horseradish peroxidase 
(HRP)-labeled  monoclonal  antibody  (MAb)  produced  against  the  target  bacterium  Y. 
enterocolitica, which is chosen as model analyte. The immunological reaction takes place 
on the whole bacterial cells, which constitutes the separate phase. 
 
7.2 Materials and Methods  
 
Monoclonal antibody production. Yersinia enterocolitica ATCC 23715 (American Type 
Culture Collection Rockville, MD) was used for monoclonal (MAb) antibody production and 
as positive control for MAb screening. The anti-Y. enterocolitica MAb was produced by 
immunizing balb/c mice with heat-inactivated and sonicated ATCC reference strain using a 
slightly modified published protocol (He, 1996; Harlow, 1998). Briefly, heat-inactivated and 
sonicated  ATCC  reference  strains  were  diluted  in  Freud’s  incomplete  adjuvant  (IFA) 
(Sigma Chemical Co., St. Louis, MO) to obtain a protein concentration of 50 mg/mL and 
inoculated  by  intraperitoneal  injection.  The  mice  received  their  second  injection  at  two 
weeks, two inoculations of 25 mg/mL were then administered. A booster injection of 50 
mg/mL was given 31 days after immunization, then the mice were sacrificed and the spleen 
cells were fused with myeloma cells. Cell fusion and hybridoma cloning were performed 
using Galfre’s method (Galfre, 1981) with some modifications. Briefly, splenocytes from  
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the immunized mice were subjected to cell fusion with myeloma cells from Sp2/O-Ag-14 
mice  (American  Type  Culture  Collection  Rockville,  MD)  using  50%  polyethylene  glycol 
(PEG)  1550  solution.  Hybridomas  were  cultured  for  two  weeks  in  Dulbecco’s  modified 
Eagle’s  medium  (DMEM,  Sigma  Chemical  Co.,  St.  Louis,  MO)  containing  20%  foetal 
bovine serum (Euroclone, UK), 2 mM L-glutamine (HybriMax®, Sigma Chemical Co., St. 
Louis,  MO),  amphotericinpenicillin-streptomycin  100x  (APS,  Sigma  Chemical  Co.,  St. 
Louis, MO), 50 mg/mL gentamicin (Gentamicin Sulphate Solution, Sigma Chemical Co., 
St. Louis, MO), 10000 UI/mL nystatin (Nystatin suspension HybriMax
®, Sigma Chemical 
Co., St. Louis, MO) and HAT 50x (HAT Media supplement HybriMax
®, Sigma Chemical 
Co., St. Louis, MO). The hybridomas of interest were cloned by limiting dilution method 
(Campbell, 1987; Goding, 1993). MAbs were produced in vitro on large scale by serial 
culturing of antibody-secreting hybridomas and collection of their supernatants.  
The cell culture fluids from actively growing hybridomas were screened using an indirect 
ELISA procedure against other isolated strains of the target bacteria and different bacteria 
species. Briefly, the hybridoma culture media, properly diluted, was added to well plate 
previously coated with the immunizing antigen. The plate was then incubated for 30 min at 
37° C  and,  after  washes,  HRP-labeled  anti  mouse  anti body  (purchased  from  Sigma, 
Chemical Co. St. Louis, MO) was added. The HRP activity was measured by adding a 
chromogenic  substrate  (TMB,  KPL,  Gaithersburg,  MD).  After  incubation,  the  enzymatic 
reaction was stopped with 2N H2SO4 and the absorbance at 450 nm was recorded using a 
Multiskan EX spectrophotometer microtiter reader (Labsystems, Helsinki, Finland). 
The  MAb  isotype  was  determined  using  an  isotyping  kit  (ImmunoPure  Monoclonal 
Antibody  Isotyping  Kit,  Pierce,  Rockford,  IL).  The  antigen-independent  method  was 
employed.  Microtiter  plates  were  coated  with  a  goat  anti-mouse  antibody,  and  the 
hybridoma  supernatant  was  added  to  the  plate  wells.  After  incubation  and  washing, 
subclass-specific anti-mouse immunoglobulins (IgG2a, IgG2b, IgG3, IgA and IgM) were 
added in separated wells. A horseradish peroxidase conjugated, goat anti rabbit IgG was 
then added and detected by spectrophotometry. The monoclonal antibody was screened 
by  immuno  Western-blotting  (Laemmli,  1970),  purified  by  affinity  chromatography  and 
coupled to HRP using the periodate method (NaKane, 1974). Protein concentration was 
determined by using a Bradford assay.  
 
Standard  bacterial  suspensions.  Standard  bacterial  samples  were  obtained  from  Y. 
enterocolitica  cultures.  For  the  isolation  of  bacteria,  colonies  were  transferred  from 
selective solid agar (Herellea Agar, Biolife, Milan, Italy) to 5-7 mL Luria-Bertani (LB) broth  
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(Bacto
® LB BROTH, LENNOX, DIFCO Laboratories, Detroit, MI), and were grown for 12-
18 h at 37° C. A 2 mL aliquot of cell suspension in  LB broth was centrifuged at 3000 x g for 
10 min, the supernatant was carefully removed, and the pellet was  washed twice with 
phosphate buffered saline (PBS). Washed bacteria were serially diluted in PBS to obtain 
concentrations  in  the  range  10
9  -  10
4  CFU/mL  which  were  used  as  standards  in  FFF 
immunoassay  method.  For  each  dilution,  the  actual  concentration  (CFU/mL)  of  each 
bacterium  was  determined  by  colonies  counting  on  selective  media  agar  plates.  The 
obtained CFU/mL values were used for calibration curve plots.  
 
Samples. Human faecal samples were used to evaluate the analytical performance and 
the applicability of the GrFFF immunoassay method for the detection of bacteria. 
Unsterilized faecal samples (obtained from voluntaries) were first assayed to verify the 
absence  of  Y.  enterocolitica,  and  then  they  were  artificially  contaminated  with  the 
bacterium. The samples (25 g) were inoculated with the appropriate amount of bacteria 
(final concentration ranging from 0 to 10 CFU/g), homogenized in a stomacher bag, and 
incubated with 225 mL of buffered peptone water for 2 h at 37° C. Subsequently, 1 mL of 
this solution was removed, and incubated with 9 mL Yersinia enrichment broth (Sigma, 
Chemical Co. St. Louis, MO) for 6 h at 37° C under s haking. For each sample, the actual 
bacterium  concentration  (CFU/mL)  was  determined  by  colony  counting  on  selective 
medium agar plates. 
For clinical validation, we evaluated a total of 15 faecal samples (ten positive and five 
negative) for the presence of Y. enterocolitica, and the results were compared with those 
obtained using a conventional microbiological method. 
 
GrFFF  system.  The  separation  device  was  a  home-made,  empty  and  flat  capillary 
channel.The  GrFFF  channel  was  built  in  the  laboratory  according  to  a  design  already 
reported for fractionation of biological samples (Sanz, 1996; Reschiglian, 2002) and the 
system was assembled as described elsewhere (Roda, 2005). The channel volume was 
cut out from a thin plastic foil that was sandwiched between two plastic walls, the one on 
top made of polycarbonate (PC; PlastiCenter, Bologna, Italy), and the one on bottom made 
of polyvinylchloride (PVC; PlastiCenter). Channel dimensions were 2.0 cm breadth, 0.014 
cm thickness and 30 cm length. Sample injection was performed by a Model 7125 valve 
(Rheodyne, Cotati, CA) equipped with a 20  L PEEK loop. The carrier liquid was PBS at 
pH  =  7.4,  added  with  0.05%  (w/v)  bovine  serum  albumin  (BSA).  The  carrier  flow  was 
delivered by a peristaltic pump (Miniplus 3, Gilson, Middleton, WI) at 0.3 mL/min flowrate,  
105 
and the channel outlet was connected to a flow-through luminometer (home modified FB12 
luminometer,  Berthold  Detection  Systems,  Pforzheim,  Germany).  To  generate  the  CL 
signal,  an  enhanced  luminol-based  CL  substrate  (SuperSignal  ELISA  Femto,  Pierce, 
Rockford,  IL)  was  used.  In  previous  work,  this  substrate  was  found  to  give  low 
background. (Roda, 2002; Roda, 2000). The substrate was 1:5 diluted in the carrier, and 
post-channel injected at 0.03 mL/min flowrate by a syringe pump (KdScientific, KDS100, 
Holliston, MA, US) through a low-volume “tee” reactor. The injection of the substrate was 
synchronized  with  the  elution  flow.  The  GrFFF-CL  instrumental  set-up  is  reported  in 
Figure 1. 
 
Figure 1: GrFFF-CL instrumental set-up. 
 
 
 
GrFFF-CL  immunoassay  method.  A  schematic  representation  of  the  GrFFF-CL 
immunometric  method  is  reported  in  Figure  2.  For  the  assay,  100  µL  MAb-HRP  was 
added to 100 µL standard or faecal sample; the mixture was vortexed for 30 s, and 20 µL 
was injected in the GrFFF channel. After injection, the flow was stopped for 30 min, during 
which sample relaxation and the immunological reaction between bacterial cells and MAb 
took  place.  After  relaxation,  elution  flow  was  restored.  The  free  and  bacterium-
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bound MAb fractions were eluted in ~15 min, with the MAb-bacterium immunocomplex 
eluted in a relatively broad band, the retention time of which was tr = 8.3 min. The excess 
of unbound labeled MAb was eluted within the void volume. The resulting CL fractogram 
was  thus  constituted  of  two  resolved  peaks:  a  void  peak  and  a  retained  peak 
corresponding to the free and bound MAb fractions, respectively. The activity of the HRP-
labeled bound fraction, which is proportional to the bacterial concentration, was measured 
from the entire area of the eluted immunocomplex band. 
 
Figure  2:  Schematic  of  the  GrFFF-CL  immunometric  method  for  the  determination  of 
Yersinia enterocolitica.  
 
 
7.3 Results and Discussion 
 
Monoclonal antibodies screening. The MAb specificity was evaluated both against other 
isolated strains of the target bacteria and different bacteria species using an indirect ELISA 
procedure.  As  negative  control  to  exclude  cross-reactivity,  IgG  MAbs  against  E.coli 
O157:H7, Salmonella thyphimurium, and Listeria monocytogenes were used. 
Approximately  1500  hybridoma  supernatants  against  the  target  bacteria  were  obtained 
and  tested.  Among  these,  200-400  clones  showed  positive  reaction  to  Yersinia 
enterocolitica by indirect ELISA test. Subsequently, a further ELISA screening with other 
bacterial antigens led to the identification of the MAb 54B11 reacting with Yersinia  
enterocolitica  and  showing  no  cross-reaction  to  any  other  bacteria  used  in  this  study 
(Table  1).  The  MAb  54B11,  which  was  identified  as  IgG1  isotypes,  was  used  for  the 
development of the GrFFF-CL immunoassay method. In addition, this monoclonal antibody 
was  also  used  to  develop  the  multiplexed  chemiluminescent  immunoassay  for  the 
detection of pathogen bacteria described above. 
GrFFF separation of free and  
bacteria-bound antibodies 
+ n
MAb - HRP  Bacterium  Immunocomplex 
Gravitational 
    Flow 
CL Sub 
“Tee” 
react 
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Table 1: Monoclonal antibody cross-reactions with various bacterial antigens evaluated by 
indirect ELISA.The percentage of cross reaction (CR%)  was calculated by dividing the 
OD450 value of each bacteria by the OD450 for the target bacteria. 
 
Genus  Species  Source  Mab 54B11 CR% 
       
Bacillus  B.cereus  ATCC 11778  1.3 
  B.cereus  Wild type strain  2.3 
  B.subtilis  Wild type strain  1.3 
Bordetella  B.bronchiseptica  Wild type strain  1.2 
Citrobacter  C.freundii  Wild type strain  1.3 
Enterobacter  E. agglomerans  Wild type strain  2.3 
  E.amnigenus  Wild type strain  2.3 
  E.cloacae  Wild type strain  2.2 
  E.faecium  Wild type strain  1.5 
Escherichia coli  E.coli O14  BGVV  1.1 
  E.coli  ATCC 25922  2.1 
  E.coli O157:H7  ATCC 35150  1.1 
  E.coli O157:H7  Wild type strain  1.1 
  E.fergussoni  Wild type strain  2.4 
Klebsiella  K. Oxytoca  ATCC 49131  1.3 
  K.pneumoniae  Wild type strain  2.4 
Listeria  L.innocua  ATCC 33090  1.3 
  L.ivanovii  ATCC 19119  2.3 
  L.monocytogenes  ATCC 7644  1.2 
  L.monocytogenes  Wild type strain  1.3 
Proteus  P. vulgaris  ATCC 49132  1.2 
Pseudomonas  P.aeruginosa  Wild type strain  1.3 
Salmonella  S.bredeney  Wild type strain  1.1 
  S.derby  Wild type strain  3.4 
  S.enteritidis  ATCC 13076  2.2 
  S.enteritidis  Wild type strain  3.2 
  S.hadar  Wild type strain  2.3 
  S. muenchen  Wild type strain  2.3 
  S.panama  Wild type strain  2.2 
  S. saint-paul  Wild type strain  1.2 
  S.typhimurium  ATCC 14028  1.1 
Shigella  S. flexneri  ATCC 12022  1.3 
Staphylococcus  S.aureus  ATCC 25923  2.3 
  S.epidermidis  Wild type strain  2.4 
  S.faecalis  ATCC 29212  2.1 
Brucella  B.abortuss train 99  Wild type strain  1.2 
 
B.melitensisisb  biotype 
1 
Wild type strain  1.2 
  B. abortus RB51  Wild type strain  1.4 
  B.melitensisis biotype 2  Wild type strain  1.3 
  B.melitensis biotype 3  Wild type strain  1.3 
Yersinia  Y.enterocolitica  ATCC 23715  100 
  Y.enterocolitica  Wild type strain  98  
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GrFFF-CL  method  optimization.  Because  it  is  known  that  interactions  between  the 
analytes and the channel in FFF can cause sample adhesion, specially when samples and 
wall surface have similar chemistry (particularly polarity), a procedure for conditioning the 
channel walls was considered in order to increase the surface hydrophobicity of the PVC 
accumulation wall and to increase sample throughput. This was achieved by adding 0.5% 
(w/v) BSA to the mobile phase and by continuously flushing it into the GrFFF channel. The 
BSA is known to reduce cell interactions and then to better preserve cell integrity [Battu, 
2001]. It is also commonly used to block plastic surfaces in cell adhesion tests that employ 
protein-covered plastic plates. Figure 3 shows the fractograms obtained under identical 
experimental  conditions  for  Yersinia  enterocolitica  elution  without  (Figure  3b)  and  after 
conditioning (Figure 3a) with BSA-containing isotonic PBS used as mobile phase; retention 
of bacteria can be observed in both.  
 
Figure 3: GrFFF fractogram obtained for Yersinia enterocolitica with and withouth BSA 
saturation. 
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In particular, for the fractogram obtained after the longer conditioning period, the overall 
sample throughput was quantitative, indicating that all the injected cells were eluted from 
the GrFFF channel, and recovery of the retained part of the cells was 90%. When the 
channel was not conditioned, the overall sample throughput was 40% of the injected cells, 
and the intense void peak compared with the peak of the retained cells indicates lower 
recovery than when conditioning is longer. These findings suggest that BSA can improve 
recovery and sample retention, if a long conditioning period is applied to the channel.  
To  avoid  system  cross-contamination,  a  cleaning  procedure  was  performed  after  each 
working day by flushing a solution of 30% (v/v) EtOH and 0.5% (w/v) SDS in water. Under 
these conditions, no run-to-run carry over was observed. 
Preliminary experiments were performed to assess the optimal MAb-HRP ratio. Antibody 
concentration was optimized by comparing the CL signal obtained using different MAb (90-
700 ng/mL) concentrations. The best results were obtained by using a MAb concentration 
of 350 ng/mL. 
 
GrFFF-CL method analytical performances. The calibration curve (Figure 4) obtained 
for Y. enterocolitica was linear in the range between 10
5 to 10
7 CFU/mL, and the detection 
limit (LOD) of the method was 10
6 CFU/mL (P = 95%). Analytical validation of the method 
was performed by using spiked human faeces. Bacterial concentration in faecal samples 
was  determined  by  interpolation  from  calibration  curve.  The  precision  was  satisfactory 
being both run-to-run and day-to-day relative standard deviation (RSD), determined by 
analyzing replicates (n=6) of spiked samples, ≤ 15%. Method accuracy was evaluated by 
comparing results with those obtained with a conventional culturing method on selective 
media, and concordance between the two methods was found.  
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Figure 4: Representative calibration curve, obtained by averaging ten standard curves 
from different days. The insets show CL fractograms obtained for the highest and lowest 
concentration level. 
 
 
 
 
 
Thanks to the MAb specificity, the method proved able to recognize all the wild strains of 
the target bacteria without any cross-reactivity with other species. In addition, the analysis 
of bacteria mixtures confirmed that no cross-reaction occurred. No CL signal was detected 
for negative mixtures, while it was possible to detect the target bacterium in mixture even 
at low relative concentration (Figure 5).  
 
 
 
 
 
 
 
b
0 1x10
7 2x10
7 3x10
7 4x10
7
0
500
1000
1500
2000
LOD = 
10
6 CFU/mL
P
e
a
k
 
a
r
e
a
 
(
R
L
U
/
1
0
3
)
Y. enterocolitica CFU/mL
0 100 200 300 400 500 600 700 800
0
500
1000
1500
2000
2500
3000
3500
4000
C
L
 
s
i
g
n
a
l
 
(
R
L
U
)
Retention time (s)
0 200 400 600 800 1000 1200
0
2000
4000
6000
8000
10000
12000
C
L
 
s
i
g
n
a
l
 
(
R
L
U
)
Retention time (s)
b
0 1x10
7 2x10
7 3x10
7 4x10
7
0
500
1000
1500
2000
LOD = 
10
6 CFU/mL
P
e
a
k
 
a
r
e
a
 
(
R
L
U
/
1
0
3
)
Y. enterocolitica CFU/mL
0 100 200 300 400 500 600 700 800
0
500
1000
1500
2000
2500
3000
3500
4000
C
L
 
s
i
g
n
a
l
 
(
R
L
U
)
Retention time (s)
0 200 400 600 800 1000 1200
0
2000
4000
6000
8000
10000
12000
C
L
 
s
i
g
n
a
l
 
(
R
L
U
)
Retention time (s)
0 1x10
7 2x10
7 3x10
7 4x10
7
0
500
1000
1500
2000
LOD = 
10
6 CFU/mL
P
e
a
k
 
a
r
e
a
 
(
R
L
U
/
1
0
3
)
Y. enterocolitica CFU/mL
0 100 200 300 400 500 600 700 800
0
500
1000
1500
2000
2500
3000
3500
4000
C
L
 
s
i
g
n
a
l
 
(
R
L
U
)
Retention time (s)
0 200 400 600 800 1000 1200
0
2000
4000
6000
8000
10000
12000
C
L
 
s
i
g
n
a
l
 
(
R
L
U
)
Retention time (s) 
111 
Figure 5: A) Fractionation of negative mixture (E.coli, Salmonella typhimurium, Listeria 
monocytogenes).  B)  Fractionation  of  positive  mixture  (E.coli,  Salmonella  typhimurium, 
Listeria monocytogenes, Yersinia enterocolitica). 
 
 
      A            B 
 
For clinical validation, we evaluated a total of 15 faecal samples (ten positive and five 
negative) for the presence of Y. enterocolitica, and the results were compared with those 
obtained using a conventional microbiological method. An 100% agreement was found 
between the two methods. 
The developed GrFFF-assisted, whole-cell, non-competitive immunoassay shows similar 
analytical performance, and many advantages with respect to a microtiter plate sandwich-
type format. Being a flow-assisted immunoassay, the antibody is not immobilized, and only 
a single MAb is required for the detection of one bacterial species. Costs and analysis time 
are then reduced, and the method is suitable for automation. The GrFFF channel could be 
easily microfabricated for disposable usage or designed in multichannel format for multi-
run analysis. Moreover, multiplexed immunoassays can be developed for simultaneous 
analysis of bacterial mixtures, since pathogenic bacteria present in the same sample with 
different morphological properties can be efficiently fractionated by GrFFF. For example, 
bacteria like Y. enterocolitica, E. coli O157:H7, S. typhimurium, and L. monocytogenes can 
be separated, detected and quantified in a single run using a mixture of MAbs, each Ab 
specific for one bacterium. For diagnostic purposes in clinical analysis, we expect that this 
method could be applied not only to bacteria but also to eukaryotic cells. 
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